Synthesis and 3D printing of hydroxyapatite scaffolds for applications in bone tissue engineering by Cox, Sophie C.
  
 
University of Warwick institutional repository: http://go.warwick.ac.uk/wrap  
 
A Thesis Submitted for the Degree of PhD at the University of Warwick 
 
http://go.warwick.ac.uk/wrap/60280 
 
 
This thesis is made available online and is protected by original copyright.  
Please scroll down to view the document itself.  
Please refer to the repository record for this item for information to help you to 
cite it. Our policy information is available from the repository home page.  
 
 
 
 
  
Synthesis and 3D Printing of 
Hydroxyapatite Scaffolds for 
Applications in Bone Tissue Engineering 
 
 
Sophie Constance Cox 
WMG 
University of Warwick 
 
A thesis submitted for the degree of 
Doctor of Philosophy 
September 2013
ii 
 
  
This thesis is dedicated to my grandfathers, 
Ernst Cox and John Port 
iii 
 
Table of Contents 
List of Figures .......................................................................................................... viii 
List of Tables ............................................................................................................. xv 
Acknowledgements .................................................................................................. xix 
Declaration ................................................................................................................ xx 
Publications .............................................................................................................. xxi 
Abstract ................................................................................................................... xxii 
List of abbreviations .............................................................................................. xxiii 
1. Introduction ....................................................................................................... 26 
Objectives ............................................................................................................... 27 
Thesis outline .......................................................................................................... 28 
2. Literature review .............................................................................................. 30 
Part one - clinical perspectives of bone as a hard tissue ......................................... 30 
2.1 Clinical need ................................................................................................... 30 
2.2 Bone diseases and defects .............................................................................. 31 
2.3 Bone tissue...................................................................................................... 32 
2.4 Cellular functions of bone .............................................................................. 38 
2.5 Mechanical properties of bone ....................................................................... 39 
2.6 Clinical solutions ............................................................................................ 39 
Part two - calcium phosphates ................................................................................ 44 
2.7 Chemical biomimetics .................................................................................... 44 
2.8 Calcium phosphates ........................................................................................ 44 
2.9 Hydroxyapatite (HA) ...................................................................................... 46 
2.10 Tricalcium phosphates .................................................................................... 48 
2.11 Dicalcium phosphates ..................................................................................... 49 
2.12 Synthesis of synthetic apatites ........................................................................ 50 
2.3.1 Physical structure ..................................................................................... 32 
2.3.2 Chemical composition ............................................................................. 35 
2.3.3 Crystal structure and composition of bone apatite .................................. 36 
2.6.1 Bone grafts ............................................................................................... 39 
2.6.2 Tissue engineering ................................................................................... 40 
2.9.1 Substituted hydroxyapatite ...................................................................... 46 
iv 
 
2.13 Thermal behaviour.......................................................................................... 59 
Part three - fabrication of bone tissue scaffolds ..................................................... 60 
2.14 Physical biomimetics ...................................................................................... 60 
2.15 Conventional techniques ................................................................................ 63 
2.16 ALM techniques ............................................................................................. 65 
2.17 Summary......................................................................................................... 71 
3. Feasibility study - hydroxyapatite synthesis ................................................... 74 
3.1 Synthesis methodology selection ................................................................... 74 
3.2 Materials and methods .................................................................................... 75 
3.3 Material characterisation ................................................................................ 78 
3.4 Results ............................................................................................................ 79 
3.5 Discussion....................................................................................................... 88 
3.6 Conclusions .................................................................................................... 91 
4. Precipitation of hydroxyapatite – influence of reaction conditions.............. 94 
4.1 Introduction .................................................................................................... 94 
4.2 Materials and methods .................................................................................... 94 
2.12.1 Solid-state synthesis ................................................................................ 51 
2.12.2 Aqueous precipitation (AP) ..................................................................... 53 
2.12.3 Hydrothermal and solvothermal techniques ............................................ 57 
2.12.4 Emulsion and microemulsion techniques ................................................ 57 
2.12.5 Sol-gel processing.................................................................................... 58 
2.12.6 Self-propagating combustion synthesis (SPCS) ...................................... 58 
2.15.1 Solvent casting ......................................................................................... 63 
2.15.2 Freeze casting .......................................................................................... 63 
2.15.3 Sol-gel techniques.................................................................................... 64 
2.15.4 Foam reticulation methods ...................................................................... 64 
2.15.5 Gelcasting ................................................................................................ 65 
2.16.1 Laser based ALM systems ....................................................................... 67 
2.16.2 Print based ALM systems ........................................................................ 69 
2.16.3 Nozzle based ALM systems .................................................................... 71 
3.2.1 Aqueous precipitation (AP) ..................................................................... 75 
3.2.2 Self-propagating combustion synthesis (SPCS) ...................................... 77 
3.2.3 Solvothermal synthesis (SS) .................................................................... 77 
3.3.1 X-ray diffraction (XRD) .......................................................................... 78 
3.3.2 Scanning electron microscopy (SEM) ..................................................... 79 
3.3.3 Differential thermal and thermogravimetry analysis (DTA-TGA) ......... 79 
3.4.1 Crystal structure ....................................................................................... 79 
3.4.2 Microstructural development ................................................................... 83 
3.4.3 Thermal behaviour ................................................................................... 85 
v 
 
4.3 Material characterisation ................................................................................ 99 
4.4 Results .......................................................................................................... 103 
4.5 Discussion..................................................................................................... 127 
4.6 Conclusions .................................................................................................. 134 
5. Precipitation of hydroxyapatite – influence of solvent system.................... 137 
5.1 Introduction .................................................................................................. 137 
5.2 Materials and methods .................................................................................. 137 
5.3 Materials characterisation ............................................................................. 138 
5.4 Results .......................................................................................................... 139 
4.2.1 Aqueous precipitation (AP) ..................................................................... 95 
4.2.2 In-vitro test methods ................................................................................ 95 
4.3.1 X-ray diffraction (XRD) .......................................................................... 99 
4.3.2 Fourier transform infrared spectroscopy (FTIR) ..................................... 99 
4.3.3 Scanning electron microscopy (SEM) ..................................................... 99 
4.3.4 Transmission electron microscopy (TEM) .............................................. 99 
4.3.5 Differential thermal and thermogravimetry analysis (DTA-TGA) ....... 100 
4.3.6 Energy dispersive spectroscopy (EDS) ................................................. 100 
4.3.7 X-ray fluorescence (XRF) ..................................................................... 100 
4.3.8 BET surface area measurements ............................................................ 100 
4.3.9 Zeta potential (ZP) ................................................................................. 101 
4.3.10 SBF test.................................................................................................. 101 
4.3.11   Live/dead staining................................................................................ 101 
4.3.12 MTT assay ............................................................................................. 101 
4.3.13 Hoechst assay ........................................................................................ 101 
4.3.14 Cellular internalisation .......................................................................... 102 
4.3.15 Statistical analysis.................................................................................. 102 
4.4.1 Development of solution pH .................................................................. 103 
4.4.2 Crystal structure ..................................................................................... 104 
4.4.3 Molecular structure ................................................................................ 108 
4.4.4 Microstructural development ................................................................. 111 
4.4.5 Thermal behaviour ................................................................................. 113 
4.4.6 Elemental analysis ................................................................................. 118 
4.4.7 Surface area ........................................................................................... 118 
4.4.8 Surface charge ....................................................................................... 118 
4.4.9 SBF test.................................................................................................. 119 
4.4.10 Live/dead assay ...................................................................................... 121 
4.4.11  MTT assay ............................................................................................ 121 
4.4.12 Hoechst assay ........................................................................................ 124 
4.4.13 Cellular internalisation .......................................................................... 125 
5.2.1 Aqueous precipitation (AP) ................................................................... 138 
5.2.2  In-vitro test methods ............................................................................. 138 
vi 
 
5.5 Discussion..................................................................................................... 152 
5.6 Conclusions .................................................................................................. 157 
6. Precipitation of hydroxyapatite – influence of divalent cation substitutions
 160 
6.1 Introduction .................................................................................................. 160 
6.2 Materials and methodology .......................................................................... 161 
6.3 Materials characterisation ............................................................................. 161 
6.4 Results .......................................................................................................... 162 
6.5 Discussion..................................................................................................... 174 
6.6 Conclusions .................................................................................................. 178 
7. Feasibility study - fabrication of hydroxyapatite scaffolds ......................... 181 
7.1 Fabrication methodology selection ............................................................... 181 
7.2 Materials and methodology .......................................................................... 182 
7.3 Scaffold characterisation .............................................................................. 183 
5.4.1 Development of solution pH in different solvent systems .................... 139 
5.4.2 Crystal structure ..................................................................................... 139 
5.4.3 Molecular structure ................................................................................ 141 
5.4.4 Microstructural development ................................................................. 142 
5.4.5 Thermal behaviour ................................................................................. 143 
5.4.6 Elemental analysis ................................................................................. 145 
5.4.7 Surface area ........................................................................................... 145 
5.4.8 Surface charge ....................................................................................... 146 
5.4.9 SBF test.................................................................................................. 146 
5.4.10 Live/dead assay ...................................................................................... 147 
5.4.11  MTT assay ............................................................................................ 147 
5.4.12 Hoechst assay ........................................................................................ 150 
6.2.1 Aqueous precipitation (AP) ................................................................... 161 
6.2.2  In-vitro test methods ............................................................................. 161 
6.4.1 Development of solution pH containing additional divalent cations .... 162 
6.4.2 Crystal structure ..................................................................................... 162 
6.4.3 Molecular structure ................................................................................ 164 
6.4.4 Microstructural development ................................................................. 164 
6.4.5 Thermal behaviour ................................................................................. 166 
6.4.6 Elemental analysis ................................................................................. 169 
6.4.7 Surface area ........................................................................................... 169 
6.4.8 SBF test.................................................................................................. 169 
6.4.9 Live/dead assay ...................................................................................... 170 
6.4.10 MTT assay ............................................................................................. 171 
6.4.11  Hoechst assay ........................................................................................ 173 
7.2.1 Method one - yeast as a pore forming agent (YP) ................................. 182 
7.2.2 Method two - 3DP ................................................................................. 183 
vii 
 
7.4 Results .......................................................................................................... 185 
7.5 Discussion..................................................................................................... 195 
7.6 Conclusions .................................................................................................. 197 
8. 3D printing of hydroxyapatite scaffolds ....................................................... 200 
8.1 Introduction .................................................................................................. 200 
8.2 Materials and methodology .......................................................................... 200 
8.3 Scaffold characterisation .............................................................................. 201 
8.4 Results .......................................................................................................... 207 
8.5 Discussion..................................................................................................... 241 
8.6 Conclusions .................................................................................................. 247 
9. Conclusions ...................................................................................................... 250 
9.1 Synthesis of HA ............................................................................................ 251 
9.2 3DP of HA scaffolds for applications in bone tissue engineering ................ 256 
10. Future work ..................................................................................................... 260 
References ............................................................................................................... 262 
Appendix A - modified ANOVA test .................................................................... 280 
 
 
7.3.1 X-ray diffraction (XRD) ........................................................................ 183 
7.3.2 Differential thermal and thermogravimetry analysis (DTA-TGA) ....... 184 
7.3.3 Scanning electron microscopy (SEM) ................................................... 184 
7.3.4 Computer tomography (CT) .................................................................. 184 
7.4.1 Characterisation of precursors used in YP and 3DP methods ............... 185 
7.4.2 Microstructural development of scaffolds ............................................. 188 
8.3.1 Precursor characterisations .................................................................... 201 
8.3.2 Green body characterisations................................................................. 205 
8.3.3 Characterisation of sintered constructs .................................................. 207 
8.4.1 Precursor materials ................................................................................ 207 
8.4.2 Green body scaffolds ............................................................................. 215 
8.4.3 Sintered constructs ................................................................................. 230 
9.1.1 Influence of pH, temperature and solute concentration ......................... 251 
9.1.2 Influence of solvent system ................................................................... 253 
9.1.3 Influence of divalent cations .................................................................. 254 
9.1.4 Summary of HA synthesis work ............................................................ 255 
 viii 
 
 
List of Figures 
Figure 2.1: Structure of the femur illustrating regions of cortical and cancellous bone 
[45] ............................................................................................................................... 33 
Figure 2.2: Key microscopic features of cortical bone [49] ........................................ 34 
Figure 2.3: Microstructure of cancellous bone adapted from [50] .............................. 34 
Figure 2.4: Assembly of collagen and bone apatite crystals [42] ................................ 35 
Figure 2.5: Structure of HA projected onto the (001) plane [2] .................................. 36 
Figure 2.6: XRD patterns of (a) powdered human bone femur, (b) crystalline HA with 
nanosized crystallites, and (c) well-crystallised HA illustrating the difference in crystal 
size and crystallinity between bone apatite and HA [1] ............................................... 38 
Figure 2.7: Solubility isotherms of CaP phases in water [121] ................................... 45 
Figure 2.8: Typical particle morphology of (a) HA visualised by TEM, and (b) α-TCP 
observed by SEM adapted from [11]............................................................................ 49 
Figure 2.9: High temperature phase diagram for 2CaO·P2O5 system ........................ 50 
Figure 2.10: Speciation diagram for the Ca(OH)2-H3PO4-H2O system at 37°C ......... 54 
Figure 2.11: Solubility diagram of a soluble salt with inverse solubility [195] .......... 55 
Figure 2.12: Pseudo-phase diagram showing the thermal stability of HA (HAp) [220]
 ...................................................................................................................................... 61 
Figure 2.13: ALM systems (a) laser, (b) print, and (c) nozzle adapted from [261] .... 66 
Figure 3.1: Influence of heat treatment on the average crystallite size calculated from 
XRD line broadening .................................................................................................... 80 
Figure 3.2: XRD patterns of preliminary samples (a) AP01, (b) AP02, (c) AP03, and 
(d) AP04 produced by AP ............................................................................................ 81 
Figure 3.3: XRD patterns of preliminary samples (a) SS01, (b) SS02, (c) SS03, and 
(d) SS04 produced by SS .............................................................................................. 81 
Figure 3.4: XRD patterns of preliminary samples (a) U01, (b) U02, (c) U03, and (d) 
U04 produced by USPCS ............................................................................................. 82 
Figure 3.5: XRD patterns of preliminary samples (a) C01, (b) C02, and (c) C03 
produced by CSPCS ..................................................................................................... 82 
Figure 3.6: Increase in average particle size observed by SEM between as-synthesised 
and sintered particles produce by preliminary methods ............................................... 83 
  
ix 
 
Figure 3.7: Typical particle morphology of preliminary samples (a) AP01, (b) AP04, 
(c) U01, (d) U04, (e) C01, (f) C03, (g) SS01, and (h) SS04 ........................................ 84 
Figure 3.8: Typical (a) globular particles and (b) polygonal agglomerates observed in 
USPCS samples ............................................................................................................ 85 
Figure 3.9: Thermal behaviour of AP01 ...................................................................... 86 
Figure 3.10: Thermal behaviour of U01 ...................................................................... 86 
Figure 3.11: Thermal behaviour of C01 ...................................................................... 87 
Figure 3.12: Thermal behaviour of SS01 .................................................................... 87 
Figure 4.1: Steel die and punch set used to prepare pellets ......................................... 96 
Figure 4.2: Preparation of pellets used for in-vitro tests ............................................. 96 
Figure 4.3: Uncontrolled reaction of Ca(NO3)2·4H2O and (NH4)2HPO4 at RT ........ 103 
Figure 4.4: Influence of pH value (>10) and control on crystal structure of as-
synthesised HA ........................................................................................................... 104 
Figure 4.5: Influence of solute concentration and temperature on crystal structure of 
as-synthesised HA (a) AP09, (b) AP11, and (c) AP12............................................... 105 
Figure 4.6: Influence of pH on CaP phase formation of as-synthesised (a) AP05, and 
(b) AP06 ..................................................................................................................... 105 
Figure 4.7: Influence of pH on the crystal structure of HA heated to 600°C ............ 106 
Figure 4.8: Influence of solute concentration and temperature on the crystal structure 
of HA heated to 600°C (a) AP09, (b) AP11, and (c) AP12 ....................................... 107 
Figure 4.9: XRD patterns of (a) AP07, (b) AP10, (c) AP08, and (d) AP09 heated to 
900°C .......................................................................................................................... 107 
Figure 4.10: Influence of pH on FTIR spectra (a) AP07, (b) AP10, (c) AP08, and (d) 
AP09 ........................................................................................................................... 109 
Figure 4.11: Influence of temperature and solute concentration on FTIR spectra .... 110 
Figure 4.12: FTIR spectra of powders heated to 600°C ............................................ 110 
Figure 4.13: FTIR spectra of powders heated to 600°C (a) AP09, (b) AP11, and (c) 
AP12 ........................................................................................................................... 111 
Figure 4.14: FTIR spectra of powders heated to 900°C ............................................ 111 
Figure 4.15: Influence of pH, temperature, and solute concentration on typical particle 
morphology (a) AP05, (b) AP06, (c) AP07, (d) AP08, (e) AP09, (f) AP10, (g) AP11, 
and (h) AP12............................................................................................................... 112 
Figure 4.16: Typical crystallite morphology of (a) AP07 100nm scale bar, and (b) 
AP07 20nm scale bar observed by TEM .................................................................... 113 
  
x 
 
Figure 4.17: Thermal behaviour of AP07 .................................................................. 114 
Figure 4.18: Thermal behaviour of AP09 .................................................................. 115 
Figure 4.19: Thermal behaviour of AP10 .................................................................. 115 
Figure 4.20: Thermal behaviour of AP12 .................................................................. 116 
Figure 4.21: ZP measurements over time for samples AP07 and AP09 in DMEM at 
37°C ............................................................................................................................ 119 
Figure 4.22: Pellet surface prior to immersion in SBF visualised by SEM .............. 120 
Figure 4.23: Surface roughness (Ra) of pellets immersed in SBF for up to 28 days . 120 
Figure 4.24: Typical morphology of surface apatite (a) AP10 day 7 (dotted blue circle 
= apatite layer, dashed red circle = pellet surface), and (b) AP12 day 14 (solid purple 
circle = needle-like morphology of apatite) ............................................................... 121 
Figure 4.25: Influence of pH, temperature, and solute concentration on the viability of 
MC3T3 osteoblast precursor cells seeded on substrates (green = live, red = dead) ... 122 
Figure 4.26: Influence of pH, temperature, and solute concentration on the metabolic 
activity of MC3T3 cells .............................................................................................. 123 
Figure 4.27: Proliferation of MC3T3 cells on substrates prepared under different pH, 
solute concentration, and temperatures assessed by Hoechst assay ........................... 124 
Figure 4.28: Combined bright field and fluorescence images of MC3T3 cells exposed 
to particle of (a – c) AP07, (d – f) AP08, (g – i) AP09, and (j – l) AP10. Images in 
columns 1 and 2 are slices from a confocal z stack taken through the middle of the 
cell, and column 3 at the top of the cell ...................................................................... 126 
Figure 5.1: Influence of solvent system on as-synthesised crystal structure of (a) 
AP09, (b) AP13, (c) AP14, and (d) AP15 .................................................................. 140 
Figure 5.2: Influence of solvent system on the crystal structure of samples heated to 
600°C .......................................................................................................................... 140 
Figure 5.3: Influence of solvent system on molecular structure of as-synthesised 
samples ....................................................................................................................... 141 
Figure 5.4: Influence of solvent system on molecular structure of samples heated to 
600°C .......................................................................................................................... 142 
Figure 5.5: Influence of solvent system on typical particle morphology .................. 142 
Figure 5.6: Thermal behaviour of AP13 .................................................................... 143 
Figure 5.7: Thermal behaviour of AP14 .................................................................... 144 
Figure 5.8: Thermal behaviour of AP15 .................................................................... 144 
Figure 5.9: Surface of pellets prior to immersion in SBF ......................................... 147 
  
xi 
 
Figure 5.10: Influence of solvent system on the morphology of surface apatite after 
SBF immersion (a) AP13 day 7 surface layer, (b) AP14 day 14 needle-like surface 
particles, and (c) AP15 day 7 spheroidal surface particles ......................................... 148 
Figure 5.11: Influence of solvent system on the viability of MC3T3 cells seeded on 
substrates (green = live, red = dead) ........................................................................... 148 
Figure 5.12: Influence of solvent system on metabolic activity of MC3T3 osteoblast 
precursor cells ............................................................................................................. 149 
Figure 5.13: Proliferation of MC3T3 cells on substrates prepared in different solvent 
systems assessed by Hoechst assay ............................................................................ 151 
Figure 6.1: Influence of cations on as-synthesised crystal structure of HA .............. 163 
Figure 6.2: Influence of cations on the crystal structure of samples heated to 600°C
 .................................................................................................................................... 163 
Figure 6.3: Influence of cations on molecular structure of as-synthesised samples .. 165 
Figure 6.4: Influence of cations on the molecular structure of samples heated to 600°C
 .................................................................................................................................... 165 
Figure 6.5: Influence of cations on typical particle morphology .............................. 166 
Figure 6.6: Thermal behaviour of AP16 (Sr) ............................................................ 167 
Figure 6.7: Thermal behaviour of AP17 (Mg) .......................................................... 167 
Figure 6.8: Thermal behaviour of AP18 (Zn) ............................................................ 168 
Figure 6.9: Surface of pellets containing cations prior to immersion in SBF ........... 170 
Figure 6.10: Influence of cations on the morphology of surface apatite grown in SBF 
(a) AP16 day 7, (b) AP18 day 14, and (c) AP16 day 28 (solid blue circle pellet surface, 
dashed red circle surface coating) .............................................................................. 170 
Figure 6.11: Influence of cations on the viability of MC3T3 cells seeded on substrates 
(green = live, red = dead) ........................................................................................... 171 
Figure 6.12: Influence of cations on metabolic activity of MC3T3 osteoblast precursor 
cells ............................................................................................................................. 172 
Figure 6.13: Proliferation of MC3T3 cells on substrates substituted with divalent 
cations assessed by Hoechst assay ............................................................................. 173 
Figure 7.1: CAD design of 3DP cylindrical scaffolds (1mm pores, 10mm height and 
diameter) ..................................................................................................................... 184 
Figure 7.2: XRD pattern of (a) supplied HA, (b) 50HA:50PVOH, and (c) HA sintered 
to 1300°C .................................................................................................................... 185 
Figure 7.3: Thermal behaviour of as-received HA used in YP and 3DP processes .. 186 
  
xii 
 
Figure 7.4: Thermal behaviour of ball milled PVOH used in the 3DP process ........ 187 
Figure 7.5: Thermal behaviour of Y02 25wt% HA bioceramic dough formed in YP 
process ........................................................................................................................ 188 
Figure 7.6: Micrographs of scaffolds produced via YP method and sintered at 1300°C
 .................................................................................................................................... 189 
Figure 7.7: Influence of DAY content on average pore size of YP scaffolds ........... 190 
Figure 7.8: Influence of HA loading on the development of pores within YP scaffolds
 .................................................................................................................................... 191 
Figure 7.9: Typical 3D distribution of pores in YP constructs .................................. 191 
Figure 7.10: Stability of 3D printed blocks ............................................................... 192 
Figure 7.11: Surface topography of 3D printed blocks (a – c) 50wt% HA 100% 
saturation, (d – f) 70wt% HA 194% saturation, and (g – i) 80wt% HA 194% saturation
 .................................................................................................................................... 193 
Figure 7.12: 50wt% HA green scaffolds produced via 3DP ..................................... 194 
Figure 8.1: Measurements to calculate angle of repose (R) ...................................... 202 
Figure 8.2: Measurements to assess the spreadability of composite powders........... 204 
Figure 8.3: Set up of compressed air method to de-powder scaffolds ...................... 205 
Figure 8.4: Compressive strength testing set-up (a) positioning of sample within 
loading cell, and (b) adjustment of loading cell ......................................................... 206 
Figure 8.5: Funnel test results for HA:PVOH precursor powders (n=3) .................. 208 
Figure 8.6: Particle size analysis of HA:PVOH precursor powders (ratios expressed as 
wt%) ........................................................................................................................... 209 
Figure 8.7: Bulk and tapped density of HA:PVOH precursor powders .................... 210 
Figure 8.8: Illustration of typical powder distributions for 50wt% HA (a) powder and 
build beds, (b) powder bed topography, (c) comparison of powder and build bed 
topographies, and (d) build bed topography ............................................................... 211 
Figure 8.9: Build to powder bed ratios of HA:PVOH precursors ............................. 212 
Figure 8.10: Typical clumping behaviour of 60wt% HA precursor (a) powder bed, (b) 
close up of powder bed, and (c) build bed .................................................................. 212 
Figure 8.11: Typical micrographs of (a - b) HA, (c - d) 50HA:50PVOH, and (e - f) 
PVOH precursors........................................................................................................ 213 
Figure 8.12: FTIR spectra of HA and PVOH raw materials ..................................... 214 
Figure 8.13: FTIR spectra of HA:PVOH precursors (a) 90HA:10PVOH, (b) 
80HA:20PVOH, ......................................................................................................... 215 
  
xiii 
 
Figure 8.14: Thermal behaviour of HA:PVOH precursors ....................................... 216 
Figure 8.15: Average amount of powder removed from 50wt% HA green scaffolds 
using ultrasound (n=3) ................................................................................................ 217 
Figure 8.16: Effectiveness of ultrasound treatment to remove loose powder from 
50wt% HA green bodies ............................................................................................. 217 
Figure 8.17: Effectiveness of compressed air to de-powder 50wt% HA green bodies 
(a) printed scaffold, (b) side view of de-powdered scaffold, and (c) top view of de-
powdered scaffold ...................................................................................................... 218 
Figure 8.18: Dried 50wt% HA green scaffolds ......................................................... 220 
Figure 8.19: Influence of post-processing on size of 50wt% HA green body scaffolds
 .................................................................................................................................... 221 
Figure 8.20: Influence of post-processing on weight of 50wt% HA green body 
scaffolds ...................................................................................................................... 221 
Figure 8.21: Influence of drying methods on composition of X-axis 50wt% HA green 
bodies .......................................................................................................................... 222 
Figure 8.22: Influence of post-processing methods on the height of designed pore 
channels of 3D printed green scaffolds ...................................................................... 223 
Figure 8.23: Influence of post-processing methods on strut width of 3D printed green 
scaffolds (significant difference observed compared with: *50PX, **50PY, #60PX, 
and ##60PY) ............................................................................................................... 223 
Figure 8.24: Influence of post-processing methods on average surface pore size of 3D 
printed green scaffolds (significant difference observed compared with: *50PX, 
**50PY, #60PX, and ##60PY) ................................................................................... 224 
Figure 8.25: Micrographs of 50wt% HA green scaffolds printed along X-axis ........ 226 
Figure 8.26: Average compressive yield strength of 50 and 60wt% HA 3D printed 
green scaffolds (n= 3) ................................................................................................. 227 
Figure 8.27: Average ultimate compressive strength of 50 and 60wt% HA green 
scaffolds (n= 3) ........................................................................................................... 228 
Figure 8.28: Average strain at onset of plastic deformation in 3D printed 50 and 
60wt% HA green scaffolds under compressive loading (n= 3) .................................. 229 
Figure 8.29: Average compressive strain of 3D printed 50 and 60wt% green scaffolds 
at failure (n= 3) ........................................................................................................... 229 
Figure 8.30: Typical failure mechanisms of printed 50wt% HA scaffolds (a – d) 
catastrophic failure of 50PX, and (e – h) plastic failure of 50PY .............................. 230 
  
xiv 
 
Figure 8.31: Sintered scaffolds heat treated using HT8 protocol (a) 50PX, (b) 50F2X, 
(c) 50F6X, (d) 50V2X, (e) 50V6X, (f) 50PY, (g) 50F2Y, (h) 50F6Y, (i) 50V2X, and 
(j) 50V6Y.................................................................................................................... 233 
Figure 8.32: FTIR spectrum of 50wt% HA scaffolds printed along X-axis and sintered 
using HT8 (a) 50wt% HA precursor post TGA analysis, (b) 50PX, (c) 50F2X, (d) 
50F6X, (e) 50V2X, and (f) 50V6X ............................................................................ 234 
Figure 8.33: FTIR spectrum of 50wt% HA scaffolds printed along Y-axis and sintered 
using HT8 (a) 50wt% HA precursor post TGA analysis, (b) 50PY, (c) 50F2Y, (d) 
50F6Y, (e) 50V2Y, and (f) 50V6Y ............................................................................ 235 
Figure 8.34: Bulk shrinkage of X-axis 50wt% HA scaffolds sintered using HT8 (n=3)
 .................................................................................................................................... 236 
Figure 8.35: Bulk shrinkage of Y-axis 50wt% HA scaffolds sintered using HT8 (n=3)
 .................................................................................................................................... 236 
Figure 8.36: Shrinkage of pore channel height for sintered scaffolds compared with 
green bodies (n=3) ...................................................................................................... 238 
Figure 8.37: Shrinkage of strut width for sintered scaffolds compared with green 
bodies (n=3) ................................................................................................................ 238 
Figure 8.38: Shrinkage of surface pores for sintered scaffolds compared with green 
bodies (n=3) ................................................................................................................ 239 
Figure 8.39: Micrographs of 50wt% HA sintered scaffolds printed along X-axis (a) 
50PX pore channel, (b) 50PX strut, (c) 50PX surface, (d) 50F2X pore channel, (e) 
50F2X strut, (f) 50F2X surface, (g) 50F6X pore channel, (h) 50F6X strut, (i) 50F6X 
surface, (j) 50V2X pore channel, (k) 50V2X strut, (l) 50V2X surface, (m) 50V6X pore 
channel, (n) 50V6X strut, and (o) 50V6X surface ..................................................... 240 
Figure 8.40: Micrographs of 50wt% HA sintered scaffolds printed along Y-axis (a) 
50PY pore channel, (b) 50PY strut, (c) 50PY surface, (d) 50F2Y pore channel, (e) 
50F2Y strut, (f) 50F2Y surface, (g) 50F6Y pore channel, (h) 50F6Y strut, (i) 50F6Y 
surface, (j) 50V2Y pore channel, (k) 50V2Y strut, (l) 50V2Y surface, (m) 50V6Y pore 
channel, (n) 50V6Y strut, and (o) 50V6Y surface ..................................................... 241 
 
 
  
  
xv 
 
List of Tables 
Table 2.1: Comparative composition and unit cell parameters of bone apatite and 
stoichiometric HA adapted from [11, 57] ..................................................................... 37 
Table 2.2: Summary of the mechanical properties of human cortical and cancellous 
bone .............................................................................................................................. 40 
Table 2.3: Summary of current graft types [83-85] ..................................................... 41 
Table 2.4: Hierarchical pore size distribution of an ideal bone tissue scaffold [99] ... 42 
Table 2.5: Summary of biologically relevant CaP [57] ............................................... 45 
Table 2.6: Summary of common synthesis methods for synthetic apatite .................. 52 
Table 2.7: Summary of reaction parameters reported to be influential in the AP of HA
 ...................................................................................................................................... 56 
Table 2.8: Comparison of common conventional and ALM techniques used to 
fabricate bone tissue scaffolds ...................................................................................... 62 
Table 2.9: Comparison of ALM techniques commonly used to fabricate bone tissue 
scaffolds ........................................................................................................................ 68 
Table 3.1: Selection of synthesis methods to produce HA according to defined product 
and efficiency criteria ................................................................................................... 76 
Table 3.2: Influence of heat treatment with respect to phase and average crystallite 
size of preliminary samples .......................................................................................... 80 
Table 3.3: Summary of the average size and typical morphology of particles observed 
by SEM ......................................................................................................................... 83 
Table 3.4: TGA analysis of as-synthesised preliminary samples ................................ 85 
Table 3.5: Feasibility of selected HA synthesis methods according to product and 
efficiency criteria .......................................................................................................... 92 
Table 4.1: Summary of varied pH, temperature and solute concentration conditions. 95 
Table 4.2: Fcrit values for data sets collected for MTT and Hoechst assays .............. 102 
Table 4.3: Development of solution pH..................................................................... 103 
Table 4.4: Influence of pH, temperature, and solute concentration on phase and XRD 
peak broadening.......................................................................................................... 108 
Table 4.5: IR band assignments reported for HA and CHA [296, 297] .................... 109 
  
xvi 
 
Table 4.6: Influence of pH, temperature, and solute concentration on average particle 
and agglomerate size (n=3) ........................................................................................ 113 
Table 4.7: Summary of DTG analysis ....................................................................... 114 
Table 4.8: Influence of pH, temperature, and solute concentration on the amount of 
water lost between temperature regions associated with Equations 2.3 – 2.5 ............ 116 
Table 4.9: Influence of pH, temperature, and solute concentration on chemical 
composition calculated from DTG analysis using Equations 2.3 – 2.5 ...................... 117 
Table 4.10: Infleunce of pH on Ca:P ratio calculated from EDS and XRF analysis . 118 
Table 4.11: Influence of pH, temperature and solute concentration on the surface area 
of as-synthesised powders .......................................................................................... 118 
Table 4.12: Influence of pH, temperature, and solute concentration on ZP of as-
synthesised particles measured in DI water at 25°C .................................................. 119 
Table 4.13: Influence of pH, temperature, and solute concentration on the proliferative 
rate of MC3T3 cells assessed by MTT assay between 1 and 7 days .......................... 123 
Table 4.14: Statistical analysis of MTT assay samples AP08 – AP12 ...................... 124 
Table 4.15: Influence of pH, temperature, and solute concentration on the proliferative 
rate of MC3T3 cells assessed by Hoechst assay between 1 and 7 days ..................... 125 
Table 4.16: Statistical analysis of Hoechst assay ...................................................... 125 
Table 5.1: Summary of varied solvent conditions ..................................................... 138 
Table 5.2: Development of solution pH in different solvent systems ....................... 139 
Table 5.3: Influence of solvent system on phase and XRD peak broadening ........... 141 
Table 5.4: Influence of solvent system on average particle and agglomerate size (n=3)
 .................................................................................................................................... 143 
Table 5.5: Influence of solvent system on the amount of water lost between 
temperature regions associated with Equations 2.3 – 2.5 ........................................... 145 
Table 5.6: Influence of solvent system on chemical composition calculated from DTG 
analysis using Equations 2.3 – 2.5.............................................................................. 145 
Table 5.7: Influence of solvent system on Ca:P ratio measured by EDS (n=3) ........ 145 
Table 5.8: Influence of solvent system on the surface area of as-synthesised powders
 .................................................................................................................................... 146 
Table 5.9: Influence of solvent system on ZP measured in DI water at 25°C ........... 146 
Table 5.10: Influence of solvent system on the proliferative rate of MC3T3 cells 
assessed by MTT assay between 1 and 7 days ........................................................... 150 
Table 5.11: Statistical analysis of MTT assay performed on samples AP13 – AP15 150 
  
xvii 
 
Table 5.12: Influence of solvent system on the proliferative rate of MC3T3 cells 
assessed by Hoechst assay between 1 and 7 days ...................................................... 151 
Table 5.13: Statistical analysis of Hoechst assay AP13 – AP15 ............................... 151 
Table 6.1: Summary of divalent cation substitutions ................................................ 161 
Table 6.2: Development of solution pH containing additional divalent cations ....... 162 
Table 6.3: Influence of cations on phase and XRD peak broadening........................ 164 
Table 6.4: Influence of cations on the position of characteristic XRD peaks compared 
with AP09 and HA reference pattern (09-432) .......................................................... 164 
Table 6.5: Influence of cations on the average particle and agglomerate sizes (n=3)166 
Table 6.6: Influence of cations on the amount of water lost between temperature 
regions associated with Equations 2.4 and 2.5 ........................................................... 168 
Table 6.7: Influence of cations on chemical composition calculated from DTG 
analysis using Equations 2.4 and 2.5 .......................................................................... 168 
Table 6.8: Accuracy of cation substitution levels measured by XRF ........................ 169 
Table 6.9: Influence of cation substitutions on the surface area of as-synthesised 
powders....................................................................................................................... 169 
Table 6.10: Influence of cations on the proliferative rate of MC3T3 cells assessed by 
MTT assay between 1 and 7 days ............................................................................... 172 
Table 6.11: Statistical analysis of MTT assay AP16 – AP18 .................................... 172 
Table 6.12: Influence of cations on the proliferative rate of MC3T3 cells assessed by 
Hoechst assay between 1 and 7 days of culture ......................................................... 173 
Table 6.13: Statistical analysis of Hoechst assay AP16 – AP18 ............................... 174 
Table 7.1: Summary of the reaction conditions used to fabricate scaffold structures via 
YP method (G = ground, UG = unground) ................................................................ 183 
Table 7.2: Summary of the average pore size of YP scaffolds (n=3) ........................ 190 
Table 7.3: Reproducibility of 50wt% HA scaffolds produced via 3DP (n=6) .......... 194 
Table 8.1: Flowability of HA:PVOH precursor powders using funnel tests (n=3) ... 208 
Table 8.2: Particle size percentiles of HA:PVOH precursor powders ....................... 209 
Table 8.3: Change in density due to ultrasound treatment ........................................ 210 
Table 8.4: Summary of typical microstructure observed for HA, 50HA:50PVOH, . 214 
Table 8.5: Summary of weight loss behaviour for HA:PVOH precursors ................ 216 
Table 8.6: Printability of scaffold structures fabricated from HA:PVOH precursor 
powders....................................................................................................................... 216 
Table 8.7: Summary of 3D printed green body scaffolds .......................................... 219 
  
xviii 
 
Table 8.8: Effect of drying processes on the microstructure of 3D printed green 
scaffolds (n=6) ............................................................................................................ 225 
Table 8.9: Heat treatment protocols employed on 50wt% HA scaffolds .................. 232 
Table 8.10: Effect of HT8 protocol on microstructure of sintered 50wt% HA scaffolds
 .................................................................................................................................... 237 
 
  
  
xix 
 
 
 
  
Acknowledgements 
I would like to thank my supervisor Dr Kajal Mallick for his support throughout this 
project and his confidence in my ability. I also must acknowledge and extend my gratitude 
to Professors Richard Walton and Liam Grover, Dr Greg Gibbons, Dr Stuart Coles and Dr 
Ben Douglas for the facilities they so kindly provided as well as their invaluable comments 
and feedback that helped to direct this work. Further thanks to Tom Skelhon and Adam 
Morgan for assistance with particle size, zeta potential and surface area measurements. 
Richard Williams is also recognised for his help with the cellular internalisation 
experiments. The University of Warwick Chancellor’s Scholarship is acknowledged for 
funding this project.  
Special recognitions must be made to Martin Davis and Parastoo Jamashidi. Martin has on 
so many occasions been the person I went to when I did not know where else to go and has 
always gone that extra mile to help me, which I am truly grateful for. Paras and I went on a 
journey to complete and understand the reported cell work. Throughout she offered me 
unrivalled professional support and a compassionate ear, thank you Paras. 
I would also like to extend my appreciation to Dr James Meredith who has offered me 
support throughout this project, invaluable careers advice and helped me organise an 
internship with Ceram. Thanks to Dr Phil Jackson and Ben McCarthy at Ceram for 
formulating such a challenging and enriching placement that has been an instrumental part 
of my career to date. 
Personally, I would like to thank all of my colleagues in room 359, close friends, and 
Warwick Judo who have supported me throughout this time, offered me ‘proactive’ 
procrastination and kept a smile on my face. 
Mum, Dad, Sam and Sami, thank you for giving me the belief, guidance and love that I 
have needed. And of course, Thomas, you’re the best and Squidger would not be where she 
is today without you. 
  
xx 
 
  
Declaration 
This thesis is the original work of the author and is submitted to fulfil the requirements of 
the degree of Doctor of Philosophy (PhD). The research was performed at WMG of the 
University of Warwick and the School of Chemical Engineering of the University of 
Birmingham between October 2010 and September 2013, under the supervision of Dr 
Kajal Mallick. This thesis has not been submitted in whole or in part as consideration for 
any other degree qualification at this or any other university. Where other work has been 
used it has been acknowledged. In accordance with the Degree Committee of the Faculty 
of Sciences, the length of this thesis is less than 70,000 words. 
 
Sophie Constance Cox 
WMG 
University of Warwick 
September 2013 
  
xxi 
 
Publications 
Journal articles: 
 Cox, S. C., Jamshidi, P., Grover, L. M., and Mallick, K. K., “Preparation and 
characterisation of nanophase Sr, Mg, and Zn substituted hydroxyapatite by aqueous 
precipitation”, J Maters Sci and Eng Part C, 2013  
 Cox, S. C., Jamshidi, P., Grover, L. M., and Mallick, K. K., “Low temperature 
aqueous precipitation of needle-like nanophase hydroxyapatite”, J of Maters Sci: 
Maters in Med, 2013 
Conference proceedings: 
 Cox, S. C. and Mallick, K. K., “Preparation of nanophase hydroxyapatite via self-
propagating high temperature synthesis”, Ceramic Transaction Book Series, Ed: Roger 
Narayan, Wiley-VCH, 2012 
 Cox, S. C. and Mallick, K. K.: “Preparation of porous hydroxyapatite scaffolds 
using yeast as a pore forming agent”, Ceramic Transaction Book Series, Ed: Roger 
Narayan, Wiley-VCH, 2011 
Book chapters (peer reviewed): 
 Mallick, K. K. and Cox, S. C., “Biomaterial Scaffolds for Tissue Engineering”, 
Frontiers of Bioscience, Special Edition: Next Generation Biomaterials, 
Encyclopaedia of Bioscience, Ed: Roger Narayan, 2011 
Oral presentations (peer reviewed): 
 MiMe International Conference, Oct 2013, Italy 
 Materials and Manufacturing Annual Conference, WMG, May 2013, UK  
 Annual Conference, UK Society of Biomaterials, June 2012, UK  
 MS&T 2011 Conference, American Ceramic Society, October 2011, USA  
 MS&T 2010 Conference, American Ceramic Society, October 2010, USA  
Poster presentations (peer reviewed): 
 MC11, Royal Society of Chemistry, July 2013, UK  
 Annual Conference UK Society of Biomaterials, June 2013, UK 
 World Biomaterials Congress, June 2012, China  
 Materials and Manufacturing Annual Conference, WMG, April 2012, UK  
 Annual Conference, UK Society of Biomaterials, 2011, UK 
White paper: 
 Cox, S. C., “Synthesis methods of hydroxyapatite”, Available online at 
www.ceram.com 
  
xxii 
 
Abstract 
It is known that chemical and physical features of bone contribute to its functionality, 
reactivity and mechanical performance. This knowledge is the fundamental rationale 
for this project. The aim of this thesis is to study the influence of synthesis conditions 
on material composition and ultimately the biological performance of hydroxyapatite 
(HA) as well as to fabricate scaffold structures that physically emulate bone tissue. 
Concurrent characterisation of physiochemical properties and evaluations of in-vitro 
cytocompatibility, and the degree of osteoblast proliferation on CDHA substrates 
precipitated under different reaction conditions provides a novel contribution. 
Non-viability of cells seeded on substrates prepared in a solution adjusted to pH 10 
(AP07) was confirmed after 1 day of culture. Dead cells were also observed after 3 
days on CDHA prepared at 70°C under a controlled pH level of 11 (AP12). XRD 
found no discernible difference between these samples and CDHA substrates shown to 
be cytocompatible. The source of cytotoxicity was concluded to be the presence acidic 
DCPD in AP07, and positive surface charges for AP07 and AP12 that were revealed 
by FTIR, DTA-TGA and ZP measurements. Control of pH, increased solute 
concentration, the use of Toluene, and substitutions of 10mol% Mg or 2mol% Zn were 
shown to enhance the proliferative rate of cells seeded on CDHA synthesised at RT.  
CDHA prepared in a 60 Toluene: 40 DI water (% v/v) solvent system with a lower 
dielectric constant (AP14) exhibited marked XRD peak broadening and 20% larger 
surface area compared with CDHA prepared in DI water (AP09). These features are 
suggested to explain the enhanced proliferation of cells on AP14, which was shown to 
be more than double the fluorescence exhibited for AP09 after 7 days. XRF was used 
to confirm the presence of Sr, Mg, and Zn that were selected due to their key 
biological roles in bone apatite. Evidence of lattice incorporation of these divalent 
cations was supported by XRD analysis that demonstrated shifts of characteristic HA 
peaks. Mg ions inhibited the crystallisation process, which caused a 45% reduction in 
the crystallite size, 60% increase in particle surface area and thermal conversion to 
whitlockite at 600°C. The relatively low crystallinity and larger surface area of Mg 
and Zn doped substrates is proposed to explain the respective 80 and 40% increase in 
cell proliferation compared to a pure sample prepared under the same conditions. 
Flowability of HA:PVOH precursor materials correlated well with the mechanical 
stability, microstructure and porosity of 3D printed scaffolds. Anisotropic behaviour of 
constructs and part failure at the boundaries of interlayer bonds was highlighted by 
compressive strength testing. A trade-off between the ability to facilitate removal of 
PVOH thermal degradation products during sintering and the compressive strength of 
green parts was revealed. The maximum green scaffold strength of 0.85MPa was 
exhibited by parts that were air or vacuum dried for 6hrs. Critically, the pores of 3D 
printed constructs could be user designed ensuring interconnectivity and the imperfect 
packing efficiency of precursor powders created an inherent surface roughness and 
microporosity within scaffold struts. These features are known to be favourable for 
osteogenesis, osteoconduction and osteointegration in-vivo. 
This work establishes that changes to precipitation conditions cannot be deemed trivial 
since they may alter material composition, which ultimately determines 
cytocompatibility as well as the proliferative rate of cells. Due to the highly complex 
structure of bone there are understandably a number of on-going medical challenges 
and while the application of 3D printed HA bone tissue scaffolds is promising, the 
name apatite derived from the Greek ‘απαταο’, meaning to deceive is concluded to be 
very fitting.  
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1. Introduction 
There is an increasing clinical demand to repair and/or regenerate bone defects since 
millions of people worldwide are diagnosed with numerous diseases, genetic 
abnormalities or endure traumatic injuries that compromise or fall outside of the self-
healing capacity of this hard tissue. Traditionally bone grafts (BGs), most commonly 
autografts, have been used to fill or heal such defects. Despite being the ‘gold 
standard’ there are several disadvantages of autologous BGs, including painful 
harvesting surgery, limited supply, and long recovery times. These short-comings have 
driven the research community to investigate alternative solutions that incorporate the 
use of synthetic biomaterials. 
Specifically, an alternative strategy to traditional BGs is to create a temporary 
surrogate structure, which guides and encourages tissue regeneration. In order for such 
a strategy to be successful it is necessary to combine expertise of cells, biochemical 
factors, and biomaterial science. This interdisciplinary field of research is known as 
tissue engineering and the structural component of this strategy, referred to as a 
‘scaffold’ is the focus of this project. 
Ideally, scaffolds should emulate the chemical and physical structure of the native 
tissue, thus it is crucial that an understanding of the properties that infer the 
functionality of bone is developed. Bone is an inorganic-organic biocomposite that 
largely comprises of nanosized non-stoichiometric carbonated multi-ion substituted 
apatite particles incorporated in a collagen matrix. These phases deduce the 
compressive strength and stiffness, as well as the elasticity and fracture toughness of 
bone, respectively. It is important to note that the porous interconnected 3D structure 
exhibited by cancellous bone enables mass transfer of nutrients, vascularisation, and 
migration of bone cells. 
Much attention has been given to calcium phosphate (CaP) based biomaterials since 
generally they are chemically similar to bone apatite. In particular, hydroxyapatite 
(HA) has been shown to exhibit a comparable crystal structure and is an FDA 
approved CaP [1-4]. However, this material is known to exhibit poor bioresorbability 
and bioactivity compared to natural bone mineral due to the high stability of synthetic 
HA under physiological conditions [5-7]. Substitution of trace elements that naturally 
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occur in bone and the use of nanosized HA (nHA) have been shown to enhance the 
solubility, bioactivity and response of bone cells to this synthetic material in-vitro and 
in-vivo [8-11]. Much effort has been focused on the synthesis of this bioceramic due 
to the potential applications of HA as a bone replacement material [12-17]. However, 
the majority of such studies are restricted to the preparation and structural 
investigation of HA without an evaluation of biological performance [18]. 
Numerous authors have reported the fabrication of pure or composite HA scaffold 
structures using a variety of techniques [19-23]. In recent decades focus has been 
directed to the use of additive layer manufacturing (ALM) systems to manufacture 
such constructs since they can be user defined, which inherently improves 
reproducibility and enables the creation of patient-specific products. It is relatively 
common that commercially purchased HA is used as a precursor material and as such 
the motivation of such studies is narrowed to the influence of physical attributes. That 
is despite the fact that the reactivity of bone mineral is largely determined by its 
composition and crystal structure, which is determined by the synthesis method and 
reaction conditions [2]. 
This thesis focuses on understanding the effect of both the synthesis technique and 
reaction conditions on characteristic material properties of HA, including crystallinity, 
surface charge, chemical composition, and thermal behaviour. Novelty and 
contribution to knowledge is gained through relating any observed physical, chemical, 
or crystallographic changes with the results of acellular and cellular in-vitro tests. An 
investigation of the potential to fabricate scaffold structures suitable for use in the 
repair and replacement of cancellous bone by 3D printing (3DP) is also presented. 
This section serves as a basis for future work that aims to ‘optimise’ the scaffold by 
combining enhanced self-synthesised HA and 3DP. 
Objectives 
1) To experimentally assess the feasibility of selected synthesis techniques to produce 
nHA 
2) To synthesise nHA using the selected methodology under various conditions 
3) To characterise the physiochemical properties of the synthesised HA, assess the 
cytocompatibility and ability of substrates to support cell proliferation 
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4) To experimentally assess the feasibility of selected fabrication techniques to 
construct a scaffold structure that mimics the physical properties of cancellous bone 
5) To recommend ‘optimised’ synthesis conditions for future bulk production of nHA 
to use in combination with the selected fabrication process 
Thesis outline 
The introduction in Chapter 1 provides a summary of the research background and 
presents the objectives as well as outline of this thesis. Relevant background literature 
is discussed in Chapter 2, which has been divided into three parts concerning the 
structure of bone, calcium phosphates (CaPs), and scaffold fabrication techniques to 
reflect the organisation of the experimental chapters and project objectives. Attention 
is focussed on bone mineral, pure as well as substituted HA, synthesis of HA via 
aqueous precipitation, and 3DP of bone tissue scaffolds. 
Chapter 3 presents a feasibility study to determine the most appropriate synthesis 
technique and the conclusions drawn set the foundations for further experimental 
work. Chapters 4 – 6 focus on the synthesis of HA via aqueous precipitation. 
Specifically the influence of pH, temperature and solute concentration were assessed 
in Chapter 4. Chapter 5 presents an investigation of the effects of different solvent 
systems, namely containing Toluene and/or Ethanolamine in combination with DI 
water, on the physiochemical properties of HA. In an effort to emulate natural bone 
mineral more closely substitution of Sr, Mg, and Zn into HA was explored in Chapter 
6. Acellular and cellular in-vitro tests were performed on HA prepared under the 
various conditions reported in Chapters 4 – 6. 
From Chapter 7 onwards the research is focused on the fabrication of HA bone tissue 
scaffolds. Initially the viability of producing appropriate structures via a novel non-
aqueous salt leaching technique utilising yeast as a natural pore forming agent was 
compared with a promising ALM method, namely 3DP. Chapter 8 extends the 3DP 
method introduced in Chapter 7 and a more detailed characterisation of the scaffold 
properties is presented, including compressive strength. 
The overall project conclusions and recommended future work are discussed in 
Chapters 9 and 10, respectively. 
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2. Literature review 
Literature reviewed in this thesis has been split into three parts for clarity and to reflect 
the structure as well as rationale of this project. Part one provides the clinical 
perspectives of bone as a hard tissue, covering: the clinical need for bone replacement 
or repair strategies, common bone diseases and defects, the physical, chemical as well 
as crystallographic structure of bone, and clinical solutions. In summary, this section 
describes the clinical motivation of this thesis. Literature presented in parts two and 
three contain background information as well as scientific rationale for the 
experimental chapters. Specifically, part two summarises key aspects of the group of 
materials used in this project, CaPs. Sub sections include: HA, synthesis methods, and 
the thermal behaviour of CaPs. Finally, part three presents selected literature 
concerning the fabrication of bone tissue scaffolds, which encompasses a discussion of 
common conventional and ALM methods used to manufacture CaP constructs. 
Part one - clinical perspectives of bone 
as a hard tissue 
2.1 Clinical need 
Bones perform several vital functions within the body, primarily structural support and 
protection of bodily organs. The ability of bone to self-repair and remodel to meet 
different mechanical demands makes it a unique structural composite material [24, 
25]. Bone also serves as an: attachment site for muscles to enable limb movement and 
joint mobility, a reservoir for minerals (e.g. calcium and phosphorous), and the 
primary site for the synthesis of blood cells. 
The capacity of bone to function healthily can be affected by pathological conditions, 
diseases, and it is also well known that bone degenerates with age [26]. Furthermore, 
the ability of bone to self-repair is limited by what is known as the ‘critical size 
defect’, defined by Schmitz and Hollinger as “the smallest intraosseous wound in a 
particular bone and species of animal that will not heal spontaneously during the 
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lifetime of the animal” [27]. The ‘critical’ size is dependent on a number of patient 
specific properties such as age, bone health and defect location. This makes it difficult 
to comprehensively define an explicit ‘critical’ size. It has been proposed that defects 
≥1cm in length and ≥50% of the diameter of the dense outer bone layer (i.e. cortical 
bone diameter) can be deemed critical [28]. 
Major alterations in bone structure due to injury or disease can lead to discomfort and 
a reduced quality of life [29], and defects outside of the limitations of natural self-
repair may require surgical intervention, thus creating a demand for appropriate 
clinical strategies. However, due to the highly organised and complex structure of 
bone this clinical need presents an on-going medical challenge. 
2.2 Bone diseases and defects 
Millions of people in the UK are affected by bone tissue related diseases, such as 
osteoporosis (OP) or osteoarthritis (OA). Cancerous primary and metastasised bone 
tumours can also occur but are less common with only 500 cases reported in 2011 [30, 
31]. Furthermore, osteomyelitis, infection of bone or bone marrow can lead to 
significant tissue destruction. This bacterium or more rarely fungus, most commonly 
originates from a skin wound or a bone fracture site. In chronic cases tissue necrosis 
may occur, which requires removal and replacement. An average of 7,000 adults are 
treated in the UK each year for osteomyelitis [31]. 
Complex interactions between genetic and environmental factors throughout the 
lifespan of bones causes them to age and after the fourth decade of life this is 
accompanied by a substantial loss of matter [32, 33]. There are a number of factors 
involved in these age related changes, including: imbalance between resorption and 
formation of bone, adjustments in architecture, accumulation of microfractures, 
localised inconsistency in the concentration of deposited minerals, and changes in 
bone tissue mineral deposits as well as protein content [34]. As a result, the 
mechanical integrity and resistance of bone to bending stress is compromised making 
them more susceptible to fracture [35, 36]. Occasionally, these changes can progress 
to a stage where they significantly affect normal functioning. 
OP and OA are the most common chronic degenerative bone diseases and the leading 
causes of musculoskeletal morbidity in the elderly [37, 38]. The NHS has reported that 
Chapter 2: Literature review 
32 
 
3 and 10 million people in the UK are affected by OP and OA, respectively [31, 39]. 
OP is characterised by low bone mass and micro-architectural deterioration of bone 
tissue, leading to enhanced bone fragility and as a consequence increased risk of 
fracture [40]. OA can be defined as a heterogeneous group of conditions that lead to 
joint symptoms and signs, which are associated with defective integrity of articular 
cartilage relating to changes in the underlying bone at the joint margins [41]. 
The capacity of bone to heal may be compromised by the conditions described above 
as well as many other diseases and genetic abnormalities. Furthermore, defects caused 
by trauma are common and nearly 350,000 bone fractures were reported in the UK 
between June 2009 and May 2010 [31]. All of these issues create a clinical need for 
bone repair or replacement strategies. Before potential clinical solutions are 
considered an understanding of the physical structure, chemical composition, and 
crystallographic arrangement of bone must be developed. 
2.3 Bone tissue 
2.3.1 Physical structure 
Bone is a hierarchical composite that exhibits an irregular heterogeneous and 
anisotropic structure that comprises different components at a range of length scales 
[42]. These can be divided into well-defined domains: macrostructure (>500μm), 
microstructure (1 – 500μm), and nanostructure (<100nm – 1μm). 
2.3.1.1 Macrostructure 
Macroscopically bone is distinguished into cortical, otherwise known as compact, and 
cancellous, also referred to as trabecular or spongy bone. Cortical and cancellous bone 
can be easily distinguished by their degree of porosity: 4 – 28%, and 40 – 95%, 
respectively [43]. The denser structure of cortical bone forms the outer region of all 
types of bone, the diaphysis (shaft) of long bones, and flat bones providing protection 
and support for the inner regions. In contrast, cancellous bone exhibits macro-sized 
pores, filled with bone marrow, which is found in the centre of all bones. The 
respective densities of cortical and cancellous bone are 1.8 – 2Mg/m3 and 0.07 – 
0.97Mg/m
3
 [44]. The structure of the femur, a typical long bone, comprising cortical 
and cancellous bone is illustrated in Figure 2.1.  
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Figure 2.1: Structure of the femur illustrating regions of cortical and cancellous bone [45] 
 
2.3.1.2 Microstructure 
Cortical bone is precisely organised into lamellar Haversian systems, otherwise known 
as osteons (microscopic cylinders of bone matrix). Osteons are typically 200 – 250μm 
in diameter and run roughly parallel to the long axis of bone. At their centre are 
Haversian canals, which have a diameter of approximately 50μm and encompass 
blood and lymphatic vessels, as well as nerves [46]. Surrounding these canals are 
concentric rings of lamellae, a hard intercellular substance made up of mineralised 
collagen fibres 3 – 7μm thick [47]. Between the lamellae are spaces, called lacunae, 
which contain osteocytes (mature bone cells). Waste products and nutrients are 
transported to and from osteocytes by a branching network of microscopic channels, 
called canaliculi, which are connected to adjacent lacunae. Osteons communicate by 
Volkmann’s canals, that contain blood vessels which join with the vessels in 
Haversian canals  and this arrangement is shown in Figure 2.2 [48]. 
In contrast, the structure of cancellous bone is an irregular honeycomb lattice of thin 
plates of trabeculae 50 – 400μm thick and the cavities between are filled with bone 
marrow. Nutrients are received by blood vessels embedded in the marrow and 
osteocytes, osteoclasts (bone resorbing cells), osteoblasts (bone forming cells), and 
lamellae make up the trabeculae (Figure 2.3).  
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Figure 2.2: Key microscopic features of cortical bone [49]  
 
 
Figure 2.3: Microstructure of cancellous bone adapted from [50] 
 
2.3.1.3 Nanostructure 
At the nanoscale osteons are predominantly composed of collagen fibres 0.2 – 12μm 
in diameter, which consist of bundles of collagen fibrils. Collagen consists of arranged 
arrays of tropocollagen molecules, typically 300nm long and 1.5nm wide [51]. These 
molecules are composed of three left-handed helices of peptides (monomers of 
proteins composed of amino acid sequences) known as α-chains, which are bound 
together in a right-handed triple helix making up the collagen fibril that exhibits an 
average diameter of 100nm. Fibrils themselves are type I and V collagen and display a 
repeated banding pattern every 64nm [52]. 
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Found within collagen fibrils in discrete 40nm holes reside bone apatite crystals [53]. 
These inorganic apatite crystals are in the form of plates or needles and vary in size, 
characteristically 40 – 60nm in length, 5 – 25nm in width, and 1.5 – 5nm thickness 
[54, 55]. The assembly of collagen molecules and bone apatite is shown schematically 
in Figure 2.4.  
 
Figure 2.4: Assembly of collagen and bone apatite crystals [42] 
 
2.3.2 Chemical composition 
90wt% of bone comprises of its inorganic and organic components, and the remaining 
10wt% is attributed to water. Inorganic bone apatite crystals are 65 – 70wt% of the dry 
weight and contribute to the compressive strength as well as modulus, and stiffness of 
bone. FTIR and NMR studies have confirmed that bone mineral is a nonstoichiometric 
carbonated multi-ion substituted apatite with calcium (Ca) to phosphorus (P) ratio 
between 1.37 and 1.87 [51]. The remaining 30 – 35wt% is composed predominantly of 
type I collagen (90%) and non-collagenous proteins (e.g. glycoproteins, growth 
factors) that bind the inorganic phase to the collagen fibres. The organic phase confers 
the tensile strength, elasticity and fracture toughness of the bone matrix.  
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2.3.3 Crystal structure and composition of bone apatite 
A vast group of ionocovalent compounds, called apatites, are represented by the 
general formula Me10(XO4)6Y2, where Me is a bivalent ion, XO4 a trivalent ion, and Y 
a monovalent ion [2]. Bone mineral can be described as a non-stoichiometric apatite 
that exhibits a similar crystal structure to hydroxyapatite [Ca10(PO4)6(OH)2 – HA]. 
Figure 2.5 illustrates the crystal structure of HA that exhibits a hexagonal 
arrangement. Two ion channels (3Å diameter) run parallel to the  c axis [17]. The first 
is filled with Ca
2+ 
(Ca(I) site) and the second with OH
-
. Six Ca
2+ 
(Ca(II) site) and six 
PO4
3-
 tetrahedra are arranged hexagonally around the hydroxide channel. This system 
enables partial or total replacement of ions, and in bone apatite numerous biologically 
relevant ionic substitutions occur (Table 2.1), thus contributing to the typical low 
degree of crystallinity. Divalent cations (e.g. Mg
2+
) and monovalent cations (e.g. K
+
) 
can substitute for Ca
2+
, and anions such as fluoride (F
-
) or chloride (Cl
-
) may substitute 
for OH
-
 groups. Furthermore, some ions such as carbonates can substitute for OH
-
, 
PO4
3-
 or both, which are referred to as A, B and AB type substitutions, respectively 
[2]. Therefore an appropriate formula for bone apatite can be expressed as (Ca, 
X)10(PO4, CO3, Y)6(OH, Z)2 with X as substituting cations, and Y and Z being the 
substituting anions, with the indices 10, 6 and 2 changing according to the degree of 
stoichiometry [56]. 
 
Figure 2.5: Structure of HA projected onto the (001) plane [2] 
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Table 2.1: Comparative composition and unit cell parameters of bone apatite and stoichiometric 
HA adapted from [11, 57] 
Composition Bone  Bone  HA 
Calcium (wt %) 34.8 36.6 39.6 
Phosphorus (wt %) 15.2 17.1 18.5 
Carbonate (wt %) 7.40 4.8 - 
Sodium (wt %) 0.90 1.0 - 
Magnesium (wt %) 0.72 0.6 - 
Chloride (wt %) 0.13 0.1 - 
Pyrophosphate (wt %) 0.07 - - 
Potassium (wt %) 0.03 0.07 - 
Fluoride (wt %) 0.03 0.1 - 
Strontium (wt %) - 0.05 - 
Zinc (ppm) - 39 - 
Chromium (ppm) - 0.33 - 
Cobalt (ppm) - <0.025 - 
Manganese (ppm) - 0.17 - 
Silicon (ppm) - 500 - 
a axis (Å)
 
9.410 - 9.430 
c axis (Å) 6.890 - 6.891 
 
X-ray diffraction (XRD) patterns of bone apatite confirm that the lattice arrangement 
is consistent with HA standards but peak broadening and intensity vary due to the 
difference in crystallite size, crystallinity and ionic substitutions. Figure 2.6 shows 
typical XRD patterns of: (a) bone apatite, (b) crystalline HA with nanosized crystals, 
and (c) well-crystallised HA. The marked broadening of the characteristic (211), 
(112), (300) and (202) peaks in patterns (a) and (b) indicate a small crystallite size and 
the large amorphous fraction of bone apatite is signified by the relatively low intensity 
above background. When compared with stoichiometric HA (=100), bone apatite 
exhibits a crystallinity of 33 – 37 [57]. 
There are a number of reports in the literature that propose the surface of bone apatite 
exhibits a structured hydrated layer [58, 59]. This model is suggested to be responsible 
for the high reactivity and ion exchange capacity of biological apatites. Mobile ionic 
species are contained within this layer, including non-apatitic environments such as 
HPO4
2-
 and it is possible that precipitated synthetic apatites may also exhibit this 
structural model [2, 60]. 
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Figure 2.6: XRD patterns of (a) powdered human bone femur, (b) crystalline HA with nanosized 
crystallites, and (c) well-crystallised HA illustrating the difference in crystal size and crystallinity 
between bone apatite and HA [1] 
 
2.4 Cellular functions of bone 
Three cells are important in the maintenance and remodelling of bone: (1) osteoblasts 
(bone forming cells), (2) osteocytes (mature bone cells), and (3) osteoclasts (bone 
resorbing cells). Each is highly specialised, differentiated and generally does not 
replicate [51]. Instead less differentiated cells, known as stem cells, control cell 
population. Bone stem cells are normally referred to as osteogenic cells and originate 
from the mesenchymal bone marrow stromal cell line. Local osteogenic cell 
populations are increased when biochemical signalling molecules are stimulated 
during bone remodelling and fracture healing. Depending on the vascularity (i.e. the 
availability of nutrients and oxygen) of the local environment different differentiation 
routes can be undertaken by osteogenic cells. A highly vascularised environment is 
required for bone to form since it cannot diffuse oxygen over long distances due to its 
dense mineralised structure. Bone relies on an internal vascular network to circulate 
vital oxygen and nutrients, which are then diffused over short distances [51]. If a 
differentiating osteogenic cell is surrounded by a highly vascularised environment it 
will differentiate into an osteoblast, which will produce bone.   
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Osteoblasts are connective tissue cells found at the surface of bone and once enclosed 
can be stimulated to proliferate and differentiate into mature osteoblast cells known as 
osteocytes, which are derived by a complex change of form and activity. Osteocytes 
are involved with the maintenance of local bone, specifically metabolism, and the 
exchange of nutrients as well as waste products by blood. In contrast, osteoclasts 
perform the opposite function of osteoblasts and are responsible for the majority of 
resorption as well as degradation of existing bone. Specific signalling proteins cause 
the migration of mononuclear monocytes to resorption sites that may fuse with each 
other to establish multi-nucleated macrophages, which differentiate into specialised 
osteoclasts [61]. Monocytes and macrophages are involved in bone resorption during 
remodelling and fracture repair [62]. 
2.5 Mechanical properties of bone 
Mechanical properties of bone at the macrostructural level vary from one bone to 
another as well as within different regions of the same bone [63-65]. This has been 
attributed to differences in microstructure [66]. Ageing and diseases can also affect the 
mechanical integrity of bone [26]. Table 2.2 provides a summary of the mechanical 
properties of human cortical and cancellous bone. 
2.6 Clinical solutions 
2.6.1 Bone grafts 
A bone graft (BG) is the transplantation bone from one location to another and can be 
used to fill skeletal defects, bridge joints, or promote union at a site of delayed union, 
non-union or fracture [67]. An estimated 2.2 million bone grafting procedures were 
undertaken worldwide in 2005 [68]. Due to the ageing of the world population, 
increasing life expectancy, and the growing dynamism of life this number is only 
expected to increase [69]. 
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Table 2.2: Summary of the mechanical properties of human cortical and cancellous bone 
(F) = Femur, (T) = Tibia, (Fi) = Fibula, (H) = Humerus, (R) = Radius, (U) = Ulna, and orientation 
is longitudinal unless otherwise stated 
 
There are four essential elements of bone regeneration: (1) osteogenesis (the ability for 
cells to survive transplantation, proliferate and differentiate into bone cells), (2) 
osteoinduction (activation and stimulation of host cells), (3) osteoconduction 
(facilitation and alignment of blood-vessels), and (4) osteointegration (surface bonding 
between host and grafting material). To qualify as a bone graft, the material must 
provide at least one of these functions [80]. Table 2.3 summarises the three types of 
bone grafts: (1) allogeneic, (2) autologous, and (3) xenogeneic. Autografts, bone taken 
from another part of the patient’s body, have been regarded as the ‘gold standard’ for 
many years because they provide osteogenic, osteoconductive, and osteoinductive 
properties. Hence they are considered the benchmark for other BGs or synthetic 
substitutes. However, supply of autologous bone is limited and harvesting is connected 
with numerous complications, such as revision surgery and sensory loss. Furthermore, 
it has been reported that autografts can fail in clinical practice as osteogenic cellular 
elements may not survive transplantation [81]. 
2.6.2 Tissue engineering 
The issues associated with current BGs have created the need for the development of 
alternative clinical solutions to replace or repair bone tissue. Tissue engineering is an 
Property Cortical bone Cancellous bone Reference 
Compressive 
Modulus 
(GPa) 
15.2 – 35.3 
(15.2-18.1 (F), 17 (F), 11.5 (F, 
transverse), 25.9-35.3 (T)) 
0.0011 - 9.8 [63, 70, 71] 
Compressive 
Strength 
(MPa) 
114.8 – 213 
(150.3-209 (F), 158.9-213 (T), 122.6 
(Fi), 132.4 (H), 114.8 (U)) 
0.15 – 22.5 
(0.15 – 22.5,  
3.36 – 11.36 (F)) 
[63, 70-73] 
Tensile 
Modulus 
(GPa) 
11.5 – 29.2 
(15.6-19.4 (F), 17 (F), 11.5 (F, 
transverse), 18.0-29.2 (T), 18.5 (Fi), 
17.2 (H), 18.5 (R), 18.4 (U)) 
- [70, 74] 
Tensile 
Strength 
(MPa) 
120 – 161 
(120 – 161 (F), 140.3-161 (T), 146.1 
(Fi), 122.6 (H), 149.1 (R), 148.1 (U)) 
1.47 - 2.99 [70, 75] 
Torsion 
Modulus 
(GPa) 
3.17 – 5.0 
3.3-5.0 (F), 3.17-3.58 (F) 
- [70] 
Fracture 
Toughness  
(MPa m
0.5
) 
1.77 – 14.8 
(5.0-6.4 (F), 2.12-4.32 (T), 1.88-14.8 
(T), 1.77 (H)) 
0.04-0.6 (F) [76-79] 
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interdisciplinary field that aims to combine the knowledge of cells, biomaterials, and 
suitable biochemical factors to create a surrogate structure to guide and regenerate new 
tissue [82]. Ideally, the structural ‘scaffold’ component should be made from 
appropriate biomaterials and fabricated so as to mimic the physical and chemical 
structure of the host tissue. 
 
Table 2.3: Summary of current graft types [83-85] 
Cells Donor - receiver Advantages Disadvantages 
Allogeneic Human - human 
 Provides 
structural 
stability 
 Osteogenic 
behaviour 
 Immunogenic response to foreign 
tissue 
 Graft rejection leading to 
inflammatory reaction 
 Disease transmission 
 Donor shortages 
 Risk of additional surgeries 
Autologous Human - human 
 Avoids 
possibility of 
transfection 
 Osteogenic 
behaviour 
 Donor site morbidity 
 Limited harvesting sites 
 Harvesting is expensive and 
painful 
 Unpredictable resorption 
characteristics 
Xenogeneic Animal - human 
 Range of sizes 
and shapes 
available 
 Risk of immunological 
reactions/infections 
 Risk of additional surgeries 
 
2.6.2.1 Tissue engineered bone scaffolds 
In addition to the essential bone regeneration elements (section 2.6.1) there are a 
number of specific features and properties that a scaffold must exhibit to be successful 
in bone tissue applications. However, due to the complexity and variability of native 
bone there are many aspects that are not yet fully understood. 
Porosity 
The porosity of native bone allows the migration and proliferation of osteoblasts and 
mesenchymal cells in-vivo, which facilitates ingrowth of new tissue. To ensure 
uniform distribution, survival, proliferation, and migration of cells in-vitro it is 
recognised that bone scaffolds must exhibit a highly porous surface and bulk structure 
[86]. Using a rat model Kuboki et al. demonstrated direct osteogenesis on porous 
structures whereas no formation was observed on solid particles [87]. In addition to 
bulk or macroporosity (pore size >50μm), microporosity (pore size <10μm) has also 
been reported to facilitate the attachment of osteoblasts and is considered vital for 
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capillary ingrowth [88]. It is critical that nutrients and gases be readily diffused and 
metabolic waste be removed, both of these processes are expedited by the degree of 
scaffold porosity and pore interconnectivity [89]. A porous surface has been found to 
improve mechanical interlocking between the scaffold and surrounding bone tissue 
[90], which reduces interfacial mechanical instability. A bulk increase in porosity 
notably leads to an overall reduction in the mechanical strength and therefore an upper 
functional limit of porosity should be considered. 
Pore size and distribution 
Scaffold pores provide a surface and space for cells to adhere and for bone to form in. 
Early studies by Hulbert et al. suggested a minimum pore size of 100μm [91], since 
below this limit pores can become occluded by cells and prevent cellular penetration 
as well as neovascularisation of the inner structure [19]. More recently, experimental 
research has led to the general acceptance that pore sizes should range between 200 
and 900μm. Larger pores have been found to favour direct osteogenesis as they enable 
a vascular network to form throughout the structure leading to high oxygenation [20, 
84, 92, 93]. Narrower ranges of 150 – 800, 100 – 400, 150 – 500, and 250 – 300μm 
have also been reported [92, 94-97]. Conversely, Holy et al. recommended larger 
pores ranging from 1.2 – 2.0mm offering the benefit of a higher surface to volume 
area despite the reduced mechanical strength resulting in limited applications [98]. 
Table 2.4 summarises the distribution of pore sizes required for full bone regeneration 
reported by Salcedo et al. [99]. 
 
Table 2.4: Hierarchical pore size distribution of an ideal bone tissue scaffold [99] 
Scaffold pore 
size (μm) 
Biochemical effect/function 
> 1 
Interaction with proteins 
Responsible for bioactivity 
1 – 20 
Type of cells attracted 
Cellular development 
Orientation and directionality of cellular ingrowth 
100 – 1000 
Cellular growth 
Bone ingrowth 
Predominant function in the mechanical strength 
> 1000 
Implant functionality 
Implant shape 
 
Despite several reports of contradictory pore size ranges it is indisputably accepted 
that the size and distribution of scaffold pores are crucial features for bone 
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regeneration, which should be balanced with the necessary mechanical attributes of the 
scaffold required for the intended clinical application [100-102]. 
Interconnectivity 
The benefits of scaffold porosity and pore size are constrained if the structure is not 
interconnected since discontinuous pores limit blood vessel invasion, cell migration 
and mass transport, in particular to the core of the structure [103]. Cell necrosis or 
decreased metabolic activity may result if cells are more than 200μm away from a 
blood supply [104]. Klawitter and Hulbert recommended a minimum interconnection 
size of 40 – 100μm for blood vessels to anastomose (diverge and reconnect) and 5 – 
15μm to facilitate mineralised bone ingrowth [105]. 
Surface properties 
Surface characteristics including area, morphology, topographical features and 
physiochemistry can influence and control protein adsorption, cellular adhesion and 
proliferation, as well as tissue formation [106, 107]. Rough surface topography, with 
nano to macro scale features provide cells with more secure fixation points in 
comparison to smooth surfaces and results in improved osteoconductive properties 
[108, 109]. Initial stability and bone to scaffold shear strength also correlate positively 
with an increasing degree of surface roughness [110, 111]. It is well known that 
surface charge plays a key role in the adhesion process of cells and the morphology of 
adhering cells has been shown to depend on the sign of any charge [112].  
Mechanical 
It is vital that scaffolds provide adequate temporary mechanical support to withstand 
the continuous loading of bone, therefore it is crucial that structural integrity is not 
compromised during optimisation [113]. The scaffold must function in tandem with 
the host tissue sharing mechanical demands and infiltration of cells is known to 
improve mechanical strength. Specifically, Sopyan et al. reported an increase in 
compressive strength from 2 to 20MPa over a 3 month period for a porous HA 
scaffold [96].  In regards to degradation of the scaffold, it is necessary for the kinetics 
to be tuned to the rate of new tissue growth in order to ensure that mechanical stability 
is maintained throughout the lifetime of the construct [114]. 
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Part two - calcium phosphates 
2.7 Chemical biomimetics 
The majority of the dry weight of bone comprises inorganic nanocrystals of 
nonstoichiometric apatite (section 2.3). To ensure similar properties to native bone the 
strategy used for this thesis is to fabricate an appropriate scaffold structure from a 
material that chemically mimics the composition and physiochemical characteristics of 
the natural apatite structure. Due to the chemical and crystallographic similarity of 
CaPs to native bone mineral they are commonly used in bone replacement 
applications. Their popularity is based on their ability to form chemical bonds with 
native bone tissue (i.e. bioactive), as well as support the adhesion, proliferation and 
differentiation of osteoblasts (i.e. osteoconductivity) [115]. 
2.8 Calcium phosphates 
Stoichiometric CaPs are formed from different precursor phosphates, such as ortho- 
(PO4
3-
) and pyro- (P2O7
4-
) phosphates. The degree of osteoconductivity, bioactivity, 
and resorbability of these materials differ in-vivo due to the variation of chemical 
composition [116]. Resorbability is known to depend on composition, particle 
morphology, and porosity. CaPs have been utilised for a range of different applications 
due to the range of mechanical and biological properties exhibited. Table 2.5 
summarises the key features of biologically relevant CaPs.  
CaPs in the form of Ca10(PO4)6(OH, F, Cl)2, for example HA,  exhibit an apatitic 
structure. These bioceramics are ranked very highly due to their excellent 
biocompatibility, compositional similarity to natural bone mineral, osteoconductivity, 
and bioactivity [117]. In addition, anionic and cationic substitutions of calcium apatite 
can readily occur, as exhibited in human bone apatite and may result in improved 
reactivity (Table 2.1). 
With the exception of MCPM, CaP phases exhibit an inverse solubility relationship 
with increasing alkalinity. Solubility isotherms represent the saturation boundary and 
suggest the conditions required for synthesis. HA is the least soluble CaP phase above 
pH 4.5 and below this level DCPA is the stable phase (Figure 2.7). Under 
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physiological conditions (37°C and pH 7.4) HA exhibits the lowest solubility and thus 
slowest dissolution rate followed by β-TCP, and α-TCP displays the fastest. Although 
TCPs display a faster degradation rate in comparison to HA, which in-vivo is resorbed 
over a number of years, they do not exhibit the same level of osteoconductivity [118]. 
The dissolution rate of CaPs is not only dependent on composition (Ca:P ratio), 
particle and crystal size, but notably ionic substitutions and crystallinity also play an 
influential role [119]. Reduced particle size and crystallinity have been reported to 
improve the dissolution properties of CaPs [119, 120]. 
 
Table 2.5: Summary of biologically relevant CaP [57] 
 
 
Figure 2.7: Solubility isotherms of CaP phases in water [121]  
Compound Formula 
Ca:P 
ratio 
Solubility 
at 25°C, -
log(KSP) 
Monocalcium phosphate 
monohydrate (MCPM) 
Ca(H2PO4)2·H2O 0.5 1.14 
Dicalcium phosphate dihydrate 
(DCPD) 
CaHPO4·2H2O 1.0 6.59 
Dicalcium phosphate anhydrate 
(DCPA) 
CaHPO4 1.0 6.9 
β-Calcium pyrophosphate  β-Ca2P2O7 1.0 - 
Octacalcium phosphate (OCP) Ca8(HPO4)2(PO4)4·5H2O 1.33 96.6 
α-Tricalcium phosphate (α-TCP) α-Ca3(PO4)2 1.5 25.5 
β-Tricalcium phosphate (β-TCP) β-Ca3(PO4)2 1.5 28.9 
Amorphous calcium phosphate 
(ACP) 
Cax(PO4)y·nH2O 
1.2-
2.2 
Cannot be 
measured 
precisely 
Calcium-deficient 
hydroxyapatite (CDHA) 
Ca10-x(HPO4)x(PO4)6-x(OH)2-x  
(0<x<1) 
>1.5, 
<1.67 
85.1 
Hydroxyapatite (HA) Ca10(PO4)6(OH)2 1.67 116.8 
Tetracalcium phosphate (TTCP) Ca4(PO4)2O 2.0 38 - 44 
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2.9 Hydroxyapatite (HA) 
HA is a stable, dense (3.16g/cm
3
) CaP that exhibits chemical and crystallographic 
similarity to bone apatite, which explains its inherent biocompatibility and bioactivity. 
This has led to significant research being performed to develop the physical and 
chemical preparation as well as morphological control of HA. However, due to its 
brittleness and potential to fail catastrophically, HA is typically used for relatively low 
loading applications. In addition, if used in a dense form its reactivity is low and 
exhibits poor bioresorbability [5-7]. To compensate for these shortcomings reinforced 
biocomposites of HA and polymers may be used. Porous HA constructs that 
encourage rapid bone in-growth to augment or improve mechanical performance can 
also be used and have been approved by the FDA for the treatment of bone defects 
caused by trauma [3, 4]. The use of nanosized HA, compared to micron sized 
equivalents, has been shown to improve the formation and adhesion of bone cells [8, 
9]. 
Stoichiometric HA has a Ca:P ratio of 1.67 but stable phases are found to exist 
between 1.3 and 1.8 [122]. A Ca:P > 1.67 indicates the presence of calcium rich or 
carbonated HA [Ca10(PO4)6-x(CO3)x(OH)2 – CHA]. Whereas, a Ca:P < 1.67 suggests 
that the apatite is calcium deficient (CDHA) or contains impurities [123].  
Of the two known crystal forms of HA – monoclinic and hexagonal – only the 
hexagonal phase is of practical importance since the monoclinic structure is 
destabilised by even a small amount of foreign ions [11]. The hexagonal crystal 
structure of HA was previously described (section 2.3.3) and the unit cell dimensions 
have been reported as a=b=0.943nm and c=0.689nm [11, 57]. 
2.9.1 Substituted hydroxyapatite 
In order to more closely mimic the composition and crystal structure of native apatite, 
naturally occurring trace elements can be incorporated into synthetic HA (Table 2.1). 
As a result in-vivo functions, such as solubility or bioactivity, can be enhanced [10].  
2.9.1.1 Cationic substitutions 
Bone diseases, such as OP, may lead to changes in the composition of the bone matrix. 
Termination of bone growth, decreased osteoblast and osteoclast activity, as well as 
mechanical instability are all consequences of magnesium (Mg) reduction in the bone 
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matrix [124, 125]. Mg depletion has also been found to adversely affect bone 
metabolism. Due to the vital role of Mg in native bone apatite many researchers have 
studied Mg substituted HA [126-128]. Mg is found to inhibit apatite crystallisation in 
solution and favours thermal conversion to β-TCP. The expected reduction in the 
lattice parameters of HA, due to the smaller ionic radii of Mg
2+
 (0.065nm) in 
comparison to Ca
2+
 (0.099nm), is typically observed when Mg is incorporated into its 
lattice structure. Since Mg destabilises the HA structure an upper limit of 25.4wt% 
substitution has been reported [129-131]. Mg substituted HA generally exhibits 
reduced crystallinity, resulting in increased solubility due to the inhibitory effect of 
Mg on crystallisation of HA [14].  
Strontium (Sr) can fully replace Ca in the apatite structure and due to its larger ionic 
radii (0.12nm) it causes an expansion of the lattice [11]. This destabilises the apatite 
structure and increases the solubility of HA [132]. Sr concentrations between 0.5 and 
1.3wt% have been found to stimulate osteoblast activity as well as differentiation 
[133] and levels as low as 0.2wt% have been shown to influence osteoclast 
proliferation [11]. These effects are beneficial in the treatment of bone diseases, such 
as OP [134, 135].  
As well as inhibiting osteoclast differentiation, zinc (Zn) has been reported to promote 
osteoblast activity, thus resulting in increased bone formation [136]. Deficiency of Zn 
has been associated with a reduction in bone density and ductility, resulting in an 
increased susceptibility to fractures [137, 138]. A 30wt% substitution for Ca is 
possible and a reduction in lattice parameters has been observed up to 15wt%, which 
is consistent with the smaller ionic radii of Zn
2+ 
(0.075nm) [139]. Zn has also been 
shown to inhibit the crystal growth of HA during synthesis resulting in smaller crystal 
sizes and reduced thermal stability [140, 141]. 
2.9.1.2 Anionic substitutions 
4 – 8wt% of carbonate (CO3
2-
) substitution is found to be abundant in bone apatite 
[142, 143]. Since carbonate ions can substitute OH
-
, some researchers suggest this 
explains why there is a low degree of hydroxylation in bone apatite [144]. Phosphate 
groups can also be replaced by carbonate. The substitutions of OH
-
 and PO4
3- 
by CO3
2-
 
are referred to as type-A and type-B substitutions, respectively [145]. Synthesis of HA 
containing similar levels of carbonate (8wt%) to native bone has been reported to 
Chapter 2: Literature review 
48 
 
result in structural disorder, which increased solubility and in-vivo dissolution [16, 
143, 146]. However, prolonged substitution times of up to 2 months may be required 
and achieving controlled bulk substitution as opposed to surface absorbance has been 
described as challenging [147, 148].  
Silicon (Si) substituted HA has attracted much interest due to its reported enhanced in-
vivo and in-vitro bioactivity in comparison to HA [149, 150]. Incorporation is limited 
to 5wt% but levels as low as 0.8wt% Si, present as a silicate group, have been found to 
elicit improvements in the biological activity of HA [151]. Substitution of silicate has 
also been shown to increase the fraction of amorphous phase and reduce the mean 
crystallite size of HA. Due to the greater electronegativity of silicate, finer 
microstructure and increased solubility leading to enhanced dissolution has been 
observed [7]. 
Fluorine (F) and chlorine (Cl) are widely considered anionic substitutions for the 
hydroxyl site of HA and both can fully substitute for OH
-
 in the apatite structure to 
form fluoro- or chloroapatite, respectively. However, chloroapatite is not considered 
an effective biomaterial since it enhances local acidity leading to fast solubilisation of 
alkaline salts. Full substitution of OH
-
 with F
-
 results in decreased lattice constants due 
to the smaller ionic radii of F
-
 (0.132nm) in comparison to OH
- 
(0.168nm). F
-
 is known 
to improve the chemical and thermal stability of HA as well as stimulate the 
proliferation and differentiation of osteoblasts [152, 153]. In contrast, Cl
-
 may activate 
osteoclasts due to the potential creation of an acidic environment, and its larger ionic 
radii (0.181nm) in comparison to OH
-
 can lead to an expansion of the lattice [154].  
2.10 Tricalcium phosphates 
Tricalcium phosphates (TCPs) have a Ca:P ratio of 1.5 but do not exhibit an apatitic 
structure. At ambient conditions there are at least two different phases of 
stoichiometric crystalline TCP: (1) α-TCP, and (2) β-TCP. Both forms can be prepared 
by thermal decomposition of other CaPs, such as CDHA. β-TCP may also be prepared 
by high temperature solid-state reactions but neither α-TCP or β-TCP can be obtained 
from solution [155]. Due to high temperature preparation TCP particles typically 
exhibit distinctly different morphologies in comparison to CaPs phases, such as HA, 
that can be prepared at RT (Figure 2.8). 
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Figure 2.8: Typical particle morphology of (a) HA visualised by TEM, and (b) α-TCP observed by 
SEM adapted from [11]  
 
β-TCP exhibits a rhombohedral crystal structure and is obtained at temperatures above 
800°C. According to the phase diagram for the 2CaO·P2O5 system β-TCP is stable up 
to 1125°C (Figure 2.9). In comparison, the unit cell of α-TCP is monoclinic and is 
formed from β-TCP at temperatures above 1125°C.  
HA, compared to TCP, exhibits slow bioresorbability and this has led to the use of β-
TCP as a biodegradable replacement for bone tissue [156]. However, the use of pure 
β-TCP as a hard tissue augmentation has shown that its rate of biodegradation can be 
too fast [157]. One solution proposed is to use a composite of HA and β-TCP [86, 
158]. 
2.11 Dicalcium phosphates 
Dicalcium phosphate dihydrate (DCPD), commonly referred to as brushite, exhibits a 
monoclinic crystal structure and its lattice comprises of CaP chains that are layered 
parallel to water molecules. DCPD has been detected in fracture callus as well as bone 
and is sometimes considered as a precursor of bone apatite [159-161]. 
Brushite is metastable and can be converted into dicalcium phosphate anhydrate 
(DCPA) below pH 6 or HA above pH 7 [121]. DCPA, otherwise known as monetite, is 
the anhydrous form of brushite and is the most stable CaP at pH levels below 4.5 
(Figure 2.7). Monetite is generally formed by the recrystallization of DCPD and, this 
conversion occurs quickly in water, at high temperatures and under acidic conditions 
[162]. Both DCPD and DCPA are reported to be biocompatible and biodegradable in-
vivo [163, 164]. 
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Figure 2.9: High temperature phase diagram for 2CaO·P2O5 system 
○ liquidus temperature, ∆ temperature of α-TCP to α-TCP transition, x temperature of initial 
liquid formation, and □ points at which determinations were made by focusing X-ray Guinier 
camera on quenched specimens, C = CaO, P = P2O5, l = liquid, and ss= solid solution [17] 
 
2.12 Synthesis of synthetic apatites 
There are numerous conventional techniques that have been used to synthesise 
synthetic HA. Notable methods are aqueous precipitation [165-168], sol-gel 
processing [169-171], solid-state synthesis [172, 173], emulsion or micro-emulsion 
techniques [174-177], and hydrothermal reactions [55, 178-181]. Other less common 
techniques, for example self-propagating combustion synthesis (SPCS) and 
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solvothermal synthesis (SS) have also been explored. Table 2.6 summarises these 
synthesis methods and highlights key process and product features, such as 
temperature and particle size. 
2.12.1 Solid-state synthesis 
This procedure relies on the solid state diffusion of ions when powdered raw materials 
are sintered. Relatively high reaction temperatures (1050 – 1250°C) are required to 
initiate such thermodynamic reactions. This method is simple when compared to other 
common synthesis techniques but there are a number of physiochemical variables that 
need to be considered, such as addition of additives, binders or organic vehicles, 
balling milling to sufficiently reduce particle size and ensure homogeneity, crushing 
and compaction of samples, as well as the sintering protocol. In some cases it is 
necessary to repeat process steps, such as sintering, to refine the crystal structure or 
reduce particle sizes [172].  
The production of phase pure HA by solid-state synthesis has been reported, for 
example Rhee et al. [182]. However, the high reaction temperatures required to initiate 
ionic diffusion may result in mixed phase products [172]. Any phase changes that 
occur will result in an irreversible alteration of the bulk chemical (e.g. dissolution 
behaviour) as well as physical (e.g. mechanical) material properties, and final 
compositions may be difficult to reproduce. 
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Table 2.6: Summary of common synthesis methods for synthetic apatite 
a
Cost of 1kg of calcium and 500g of phosphate sources as well as minimal amounts of any additional reagents 
Synthesis 
method 
Method description 
Particle 
size (µm) 
Process 
time 
(</> 24hrs) 
Reaction 
temperature 
(°C) 
Material 
costs
a 
Scalability Comments References 
Solid state 
synthesis 
Reactants used in solid 
forms. Thermal 
treatment required to 
start reaction. HA 
formed via solid-state 
ionic diffusion 
> 2.0 > 1050 – 1250 276% Medium 
Involves long ball milling, drying, 
compression and sintering steps 
May need to repeat process steps to improve 
quality and reduce particle size 
Slow and difficult to achieve a complete 
reaction leading to a mixed phase product 
Poor reproducibility 
[172, 173] 
Aqueous 
precipitation 
Solutions combined 
under controlled 
reaction parameters 
resulting in nucleation 
and crystal growth 
> 0.1 > 
RT  
– 85 
100% 
(£97.10) 
High 
Most common method 
Two step procedure; requires sintering after 
processing 
Difficulties with reproducibility due to lack 
of precise control 
[165-168] 
Hydro- and 
solvothermal 
Reaction occurs in a 
closed aqueous system 
under high temperature 
and pressure 
> 0.05 < 150 – 400 
89 – 
175% 
Medium 
Homogeneous crystal shapes and sizes can 
be produced 
Single step process to form crystallised HA 
Cost dependent on particle morphology 
[55, 178-
181, 183-
186] 
Emulsion 
and micro-
emulsion 
Droplets of immiscible 
liquids react in a 
heterogeneous mixture 
> 1.0 
(emulsion) 
> 0.005 
(micro) 
> RT - 50 163% 
Low - 
medium 
Porous particles can be formed 
High temperature calcination and sintering 
steps required 
Highly dependent on oil and surfactants used 
[174-177] 
Sol-gel 
‘Sol’ solution is formed 
that evolves into a gel 
system; a mixture of 
particles and a polymer 
network 
> 0.001 > 37 – 85 
120 – 
180% 
Low 
Molecular mixing improves chemical 
homogeneity 
Involves more than 3 processing steps 
HA prepared exhibits inferior crystallinity 
and thermal stability 
[169-171] 
SPCS 
Particles formed via 
temperature induced 
combustion of a fuel 
and oxidiser in solution 
> 0.45 < 170 – 500 
118 – 
136% 
Unknown 
Reaction time <20 minutes 
Uncontrollable high temperature front can 
lead to mixed phases 
Particle morphology dependent on fuel used 
[187-189] 
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2.12.2 Aqueous precipitation (AP) 
AP methods are the most common technique used to produce HA due to the use of 
relatively cheap raw materials, compared with reagents used in other synthesis 
methods. Low reaction temperatures also incur minimal operating costs [190, 191]. 
However, AP reactions cannot be regarded as trivial due to the simultaneous 
occurrence of crystal nucleation, growth, and coarsening and/or agglomeration. These 
underlying scientific mechanisms are not easy to differentiate and as a result 
reproducibility as well as the control of particle flocculation remain common factors 
for improvement [3, 192, 193]. The sensitivity of phosphates and the need to fine tune 
the experimental conditions (e.g. pH, temperature) of AP reactions is reflected in the 
literature by the ranging phase purity, particle morphologies as well as sizes, 
crystallinity, stoichiometry and thermal stability. Despite the shortcomings of AP 
methods, the potential to produce HA containing various ionic substitutions and its 
high scalability make it an attractive methodology, particularly for industrial scale 
production [11]. 
During the precipitation process specific stoichiometric solutions containing Ca and P 
ions are molecularly mixed. In order to transform into a suspension of precipitates 
solution supersaturation must be established. Supersaturation is the driving force of 
crystallisation and is defined as the difference between actual concentration and the 
solubility concentration. Once established, ions randomly assemble together forming a 
molecule that serves as a nucleus for further growth, this process is referred to as 
nucleation. When the size of the nuclei reaches a critical size grain growth occurs. 
Equations 2.1 and 2.2 describe the two most common reagent combinations used in 
the precipitation of HA: (1) calcium hydroxide and phosphoric acid, and (2) calcium 
nitrate with ammonium phosphate dibasic and ammonium hydroxide, respectively. 
Since the only by-product of the first reaction is water and the system contains no 
foreign elements, generally this reaction is favoured for industrial use [12]. 
Nonetheless, it has been reported that it is challenging to obtain stoichiometric HA by 
this method, which may result in the formation of other phases after sintering [194]. 
 
                                                     (2.1) 
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                            (2.2) 
In an effort to optimise the precipitation of stoichiometric HA the influence of a 
number of reaction parameters have been investigated (Table 2.7). Fundamentally, the 
solubility of most CaPs, including HA are inversely proportional to pH (Figure 2.7). 
Other authors have reported the precipitation of HA between pH levels of 7.5 and 
12.5. It is important to note the influence of pH on the relative concentration of a 
number of Ca and P ions in solution (Figure 2.10). 
 
Figure 2.10: Speciation diagram for the Ca(OH)2-H3PO4-H2O system at 37°C 
(1) Ca
2+
, (2) [CaOH]
+
, (3) [Ca(OH)2]
0
, (4) [CaHPO4]
0
, (5) [CaH2PO4]
+
, (6) [CaPO4]
-
, (7) PO4
3-
, (8) 
HPO4
2-
, (9) H2PO4
-
, and (10) H3PO4. Total Ca concentration is 10mol l
-1
 [17] 
 
Generally, CaPs exhibit an inverse solubility relationship with temperature. Figure 
2.11 illustrates a typical solubility diagram for a soluble salt of inverse solubility 
where equilibrium is represented by the solid line and A represents an equilibrium 
point. Deviation from equilibrium conditions isothermally (AB), by increasing 
temperature (AC), or varying both temperature and concentration (AD) may result in 
metastability. Metastable phases can return to equilibrium; however there is a limit to 
the extent of deviation defined as the labile region. Precipitation of HA of various 
degrees of crystallinity and crystallite sizes between temperatures of 15 and 99°C have 
been reported (Table 2.7).  
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Figure 2.11: Solubility diagram of a soluble salt with inverse solubility [195] 
 
The Ca and P ion concentrations within solution determine the relative degree of the 
supersaturation of ionic species (e.g. Figure 2.10). At high concentration levels 
precipitation may occur spontaneously and this can result in the formation of an 
unstable precursor phase. Composition of this phase is dependent on reaction 
conditions, at pH>7 ACP is usually formed and DCPD forms under acidic conditions 
[196-199]. 
A number of expensive surfactants (e.g. cetyltrimethylammonium bromide) and 
dispersants, such as polyethylene glycol have been investigated with the aim of 
reducing particle agglomeration that occurs if surface charges are not great enough to 
repel neighbouring particles [200-202]. Moreover, alternative solvents to DI water, 
such as ethanol have been investigated (Table 2.7). 
To accelerate the process of crystallisation, commonly ageing and heat treatment 
protocols are employed to precipitated HA, which typically exhibits low crystallinity 
[121]. These treatments, in turn, may result in exaggerated crystal growth, changes in 
density and composition, increased microstructural coarseness, reduced mechanical 
strength and can also be accompanied by morphological changes [203, 204]. 
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Table 2.7: Summary of reaction parameters reported to be influential in the AP of HA 
Reaction 
parameter 
Reported to 
influence 
Reported range Comment(s) Reference(s) 
pH Phase 7.5 – 12.5 
Generally CaPs exhibit a decrease in solubility with increasing pH  
OH
-
 presence in basic pH favours the precipitation of hydroxylated CaP, such as HA 
HA least soluble phase above pH 4.5 
[12, 15, 165, 
205-208] 
Reaction 
temperature 
Crystallinity, 
crystallite size and 
morphology 
15 – 99°C 
HA exhibits inverse temperature solubility relationship 
Higher temperatures lead to increased reaction energy resulting in improved 
crystallinity once these energies are overcome  
Temperature influences rate of reaction 
Morphology reported to vary from needle-like to acicular with increasing temperature 
[15, 167, 191, 
207, 209] 
Concentration 
of reagents 
Crystallinity, 
crystallite and 
particle size 
0.0006 – 0.41M 
Increasing reagent concentrations leads to increased supersaturation of solution leading 
to improved long range order and larger crystals due to prolonged growth 
[165, 210] 
Solvent Particle size N/A Ethanol reported to effect supersaturation causing particles to grow more quickly [166] 
Surfactants or 
dispersant 
Particle size N/A 
Dispersants are generally charged molecules that attach to particles causing them to 
repel each other, which has been reported to reduce agglomeration and thus resultant 
particle sizes of HA 
Surfactants lower surface tension and may be used as a dispersant to reduce particle 
agglomeration 
[165, 166] 
Heat treatment 
protocol 
Crystallinity, 
particle size 
600 – 1250°C 
Calcination and sintering leads to improvement in crystallinity and particle coalescence 
due to an associated reduction of the specific surface area 
Post-sintered composition greatly influenced by initial Ca:P ratio 
Stoichiometric HA stable up to 1250°C 
[157, 190, 204, 
205, 207, 211, 
212] 
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2.12.3 Hydrothermal and solvothermal techniques 
Many current synthesis methods of HA are considered too slow and the reaction 
kinetics difficult to control. Hydrothermal and solvothermal techniques offer a 
solution to overcome these problems as inorganic nanomaterials can be produced 
rapidly in a single step and enable a higher degree of control [213, 214]. 
Hydrothermal and solvothermal processing involve the use of a solvent, which is 
heated in a sealed vessel. If the solvent used is water the process is defined as 
hydrothermal synthesis, which is more common than solvothermal methods to produce 
HA [215]. The temperature of the solvent can be brought above its boiling point since 
the autogeneous pressure within the vessel exceeds the ambient pressure meaning that 
experimental variables can be controlled to a higher degree because the solubility and 
reactivity is increased. This results in a more predictable and thus reproducible 
reaction. In general, reaction temperatures and times, pH, solvent choice, additives, as 
well as vessel geometries are parameters that can be readily altered to control the 
resultant particle size and morphology [3]. 
Both of these methods are considered environmentally friendly due to the substantially 
lower reaction temperatures used compared with other techniques, such as solid-state 
synthesis (Table 2.6). Furthermore, since it is possible to directly form crystalline HA 
by hydrothermal or solvothermal techniques post-synthesis high temperature 
treatment, commonly used in other low temperature methods (e.g. AP and sol-gel), 
may be avoided. Relatively low cost precursor reagents and short reactions times have 
been reported for these processes [14-18, 21-24]. Despite these inherent advantages, 
the scalability of these techniques is limited primarily due to the size of the reaction 
vessel. Selection of appropriate surfactants and solvents require tweaking to optimise 
this process. 
2.12.4 Emulsion and microemulsion techniques 
Emulsions can be described as heterogeneous mixtures of at least one immiscible 
liquid dispersed in another in the form of droplets [175]. These systems are often 
described as water-in-oil (W/O) or oil-in-water (O/W), and the first phase indicated is 
dispersed. Generally, O/W systems are used to produce HA. Depending on the size of 
the aqueous drops (i.e. the size of the reaction domains) this technique can be referred 
to as an emulsion or microemulsion. Typically, the droplet diameter is 10 – 100nm for 
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microemulsion and >0.1m for emulsions. A reaction takes place when two different 
droplets containing the reactants collide with each other. Nano and micron sized 
particles of HA have been formed by microemulsion and emulsion techniques, 
respectively [174-177]. A reported benefit of producing HA by microemulsion 
methods, compared with emulsion techniques is a reduction in the level of 
agglomeration [176]. 
2.12.5 Sol-gel processing 
Sol-gel techniques have attracted much attention due to the associated inherent 
advantages of this method: homogeneous molecular mixing, low processing 
temperature (<400°C), and the ability to generate nanosized particles. However, the 
energy saving gained from the low temperatures used is offset by the high cost of the 
reactants, typically alkoxides and organometallics. Furthermore, in comparison to 
other low temperature methods, sol-gel techniques have very limited scalability due to 
the sensitivity of the process to numerous reaction conditions (e.g. hydrolysation and 
mixing time). If the process is not optimised large fractions of other CaPs, such as -
TCP may be produced [216]. 
The first stage of this process is to form a ‘sol’, which is defined as a dispersion of 
solid particles, otherwise known as colloids in a liquid. This is achieved by 
mechanically mixing precursor materials (e.g. calcium nitrate and ammonium 
phosphate) in a solvent at a pH that prevents precipitation. Hydrolysis and 
polycondensation reactions occur by linking monomer units and forming bonds within 
the sol. This process, referred to as gelation causes the viscosity of the sol to increase. 
The result is a ‘gel’, which can be defined as a diphasic system consisting of solid and 
interstitial liquid phases. Forming a gel without flocculation can be difficult. The gel is 
then dried to remove the liquid phase, which is usually accompanied by shrinkage and 
densification. Lastly, a sintering protocol is employed. 
2.12.6 Self-propagating combustion synthesis (SPCS) 
SPCS was first reported in the 1980s and since then has attracted much attention due 
to the ability to rapidly produce nanomaterials at relatively low energies. 
Conventionally SPCS is performed in a solid state but it can also be accomplished in a 
solution. The success of the formation of HA by solution based SPCS is dependent on 
the homogeneous molecular mixing of a suitable fuel with an oxidising agent in an 
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aqueous medium containing calcium and phosphate ions. Increasing the temperature 
of this solution initiates a vigorous exothermic redox reaction between the fuel and 
oxidiser, which causes the gaseous products to spontaneously combust. It is this high 
local temperature reaction front that causes the formation of a solid powder as it 
propagates through the sample. Depending on the reagents used, the ignition 
temperature of this redox reaction is typically 170 – 500°C and full combustion can 
occur in a matter of minutes (Table 2.6). 
The heat energy evolved from the reaction is dependent on the fuel used as well as the 
ratio of fuel to oxidiser. Citric, tartaric and succinic acids as well as urea, sucrose and 
glycine have all been used as fuels to form HA by solution SPCS processes [188, 189]. 
Generally, nitric acid is used as the oxidising agent. Variation of these parameters has 
been reported to result in the formation of different CaP phases and/or particle 
morphologies [188, 189]. Depending on the fuel used the HA formed can either be 
crystalline or amorphous. Nevertheless, SPCS products typically require calcining to 
remove organic residues and reactions that result in amorphous or low crystallinity 
products may also need to be sintered. 
Viability of using this method on a large scale to produce HA is uncertain, as 
insufficient work has been carried out to determine the sensitivity of SPCS processes 
to reaction parameters that are recognised as influential, such as the fuel to oxidiser 
ratio. 
2.13 Thermal behaviour 
It is well known that heat treatment protocols, including calcination and sintering can 
be used to improve the crystallinity of apatites [157, 190, 204, 205, 207, 211, 212]. 
During such processes high temperature phase changes can also occur as a result of 
non-stoichiometry or crystal imperfections. 
Specifically, DCPD is known to lose its water of crystallisation slowly at ambient 
temperatures and at 180°C DCPA may form according to Equation 2.3 [217]. Further 
heating of DCPA yields β-calcium pyrophosphate (Ca2P2O7) between 320 and 340°C 
(Equation 2.4) [217, 218]. 
 
                                                                                               (2.3) 
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                                                                                             (2.4) 
 
It is possible that non-stoichiometric HA (i.e. CDHA) may exhibit lattice substitutions 
of non-apatitic HPO4
2-
, for example in the model of Ca10-x(HPO4)x(PO4)6-x(OH)2-x 
(Table 2.5). Any presence of acid phosphate ions may result in the formation of β-
Ca2P2O7 according to Equation 2.4, which has been reported to occur slowly between 
250 and 700°C [219]. Between 700 to 800°C any formed β-Ca2P2O7 can convert to 
HA and β-TCP according to Equation 2.5 [219].  
 
                           
                                        
i.e.     
             
                       (2.5) 
 
Figure 2.12 illustrates the influence of the Ca:P ratio on the high temperature thermal 
stability of HA formed via Equation 2.1. This diagram highlights that stoichiometric 
HA (i.e. Ca:P = 1.67) is thermodynamically stable up to 1250°C. The transformation 
of calcium proficient HA (Ca:P > 1.67) to HA and CaO above 850°C, and CDHA to 
HA and TCP above 650°C are also demonstrated. Notably, in-vivo degradation would 
be increased by the presence of either TCP or CaO phases since they are both less 
stable than HA under physiological conditions. 
Part three - fabrication of bone tissue 
scaffolds 
2.14 Physical biomimetics 
Tissue engineered scaffolds are a viable clinical solution to bone defects caused by 
disease or trauma (section 2.6.2.1). The concept of chemical biomimetics was 
introduced in section 2.7, i.e. the scaffold structure should chemically mimic the host 
tissue. In addition there are also a number of key physical features of bone (section 
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2.3.1) that an ideal scaffold should exhibit in order to be a successful component of the 
tissue engineering strategy. 
 
Figure 2.12: Pseudo-phase diagram showing the thermal stability of HA (HAp) [220] 
 
Broadly, scaffold fabrication methods can be grouped as conventional or additive layer 
manufacturing (ALM) techniques. Notably, ALM is also referred to as rapid 
prototyping in the literature. As well as bearing in mind the physiochemical criteria, in 
general the fabrication method should adhere to: (1) does not adversely affect the 
chemical composition, mechanical properties or cytocompatibility of the material, (2) 
the technique should be accurate so pore size and morphology can be defined by the 
user, and (3) minimal variation in physical form between batches (i.e. consistency) 
[221]. Typical properties of bone scaffolds fabricated by common techniques are 
summarised in comparison to bone in Table 2.8. 
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Table 2.8: Comparison of common conventional and ALM techniques used to fabricate bone tissue scaffolds 
a
high = majority of pores interconnected, medium = pores mostly connected, low = few interconnections 
Technique Method Material(s) Pore size (μm) 
Porosity 
(%) 
Interconnectivity 
(High, medium, low)
a
 
Compressive 
strength 
(MPa) 
References 
N/A Bone 
Composite of organic matrix and 
inorganic calcium phosphate 
crystals 
1 – 3500 50 – 90 High 0.15 – 230 [63, 222] 
Conventional 
Solvent casting Ceramics, polymers 1 – 800 40 – 93 
Medium (dependent on 
salt particles touching) 
≤9.3 [223-225] 
Freeze casting 
Ceramics, glass-ceramics, 
polymers 
1 – 200 31 – 95 
Medium (dependent on 
temperature gradient 
achieved during 
solidification of slurry) 
2 – 36 [22, 226, 227] 
Sol-gel 
techniques 
Ceramics, polymers, glasses 
composites 
0.001 – 1000 50 – 88 Medium 2 – 20 [228-231] 
Foam reticulation  Ceramics, glasses, metals 20 – 1000 30 - 98 
High (dependent on 
foam and slurry 
infiltration) 
0.1 – 32.6 [232, 233] 
Gelcasting Ceramics, polymers, composites 20 – 1000 < 90 Low 4.4 – 32.6 [234, 235] 
ALM 
Stereolithography 
Ceramics, polymers, hydrogels, 
composites 
Features: > 2 
Layers: > 1 
30 – 80 
(defined 
by CAD 
model) 
 
Defined by CAD model 
1.3 – 30 [236-239] 
Selective laser  
sintering 
Ceramics, polymers, composites 
Features: >45 
Layers: >76 
2 – 50 [240-243] 
3D printing 
Features: >45 
Layers: >20 
16.1 – 31 [244, 245] 
Fused deposition 
modelling 
Features: >260 
Layers: >250 
2.6 – 15 [246, 247] 
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2.15 Conventional techniques 
Scaffolds of complex shapes with a range of process dependent porosities from 30 – 
98% can be produced by conventional techniques (Table 2.8). In contrast to ALM 
technologies, conventional processes require small capital input but typically scaffolds 
made using these techniques perform poorly mechanically in comparison to native 
bone. Reproducibility is another issue associated with these methods due to the 
inability to precisely control scaffold characteristics, such as pore size, pore 
interconnectivity and spatial distribution of pores [248, 249]. Conventionally 
fabricated constructs commonly fail to meet the demand to create highly porous 
networks necessary for cell growth, flow of nutrients and metabolic waste [23]. Often, 
these techniques also require the use of organic solvents, such as chloroform, which if 
any residues remain in the structure may be toxic and/or carcinogenic to cells. 
2.15.1 Solvent casting 
Solvent casting, otherwise known as particulate leaching is a widely used method for 
the preparation of scaffolds at RT. The structure is produced by casting a solution of 
the biomaterial into a mould containing an insoluble porogen (e.g. salt crystals) using 
either traditional or freeze casting. The final porous network is formed by leaching out 
the porogen using an appropriate solvent. Resultant pores are dependent on the 
morphology and size of the porogen and the porosity is reliant on the ratio of porogen 
to biomaterial. 
Although a popular technique, notable disadvantages are the common use of highly 
toxic solvents, potential crystal deposition, and difficulty in ensuring a homogeneous 
distribution of interconnected pores. 
2.15.2 Freeze casting 
This technique, otherwise known as freeze drying, is dependent on the thermally 
induced separation of a biomaterial slurry. Scaffolding material(s) are mixed with an 
organic monomer, and both synthetic and natural polymers have been reported [250, 
251]. A dispersant may be required and porogens can be used to increase porosity and 
induce microporosity [252]. The final solution is cast into a precooled mould and the 
initial green body is freeze dried to induce separation of phases. Once stabilised 
sublimation can be used to remove the solvent phase and the resultant foam structure 
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may then be post processed, for example sintering. Similar to scaffolds fabricated by 
other conventional techniques, freeze cast constructs generally lack mechanical 
stability. Commonly pores produced are less than 100μm in diameter, which can limit 
cell ingrowth (Table 2.4). Notably, it is possible to produce highly directional pores by 
this method [22]. 
2.15.3 Sol-gel techniques 
The principal of the sol-gel process was previously described in section 2.12.5. In 
order to use this technique to form a scaffold the sol must be cast into a mould before 
gelation occurs. The gel is then immersed in a liquid and allowed to age until it has 
developed sufficient strength to resist cracking during the drying phase. The interstitial 
liquid of the gel is removed during the drying stage to form a porous scaffold and is 
finally dehydrated as well as chemically stabilised before sintering. Fabrication of 
nanoscale pores has been reported using this method and porosities as high as, for 
example 88% [231], have been produced using this technique [253]. The 
disadvantages of this technique, as mentioned previously, are the high costs of 
reagents and the difficulty of forming a gel without flocculation. 
2.15.4 Foam reticulation methods 
The foam reticulation technique is a common method for fabricating open-cell porous 
ceramics and has been adopted by many to form highly porous (≤98%) scaffold 
structures [232, 254-256]. This method is performed by impregnating porous open 
celled foams with a desired biomaterial slurry. Generally, the scaffolding material is 
dissolved in a solvent with an appropriate binder under stirring conditions to produce 
the slurry and a dispersant can be added to improve homogeneity. The foam is soaked 
in the slurry, dried and then burnt out leaving behind the porous scaffold by the 
process of consolidation achieved by sintering. 
Scaffolds with highly interconnected pores (99.9%) and complex architectures have 
been manufactured by this method from a range of synthetic and natural sponge 
structures [233, 257]. However, sourcing foams with the correct pore structures to 
meet the clinical need remains a challenge. More critically, due to the isotropic nature 
of manufactured polymer sponges the pore size distribution is usually very small, 
typically at most 200μm. Mechanical strength can also be an issue since the struts 
formed are hollow and microcracks may develop during sintering resulting in 
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structural defects. In order to obtain scaffolds with an acceptable strength by this 
method sintering rate, stirring time, and the concentration of the biomaterial in the 
initial slurry must be optimised [254].  
2.15.5 Gelcasting 
Gelcasting was traditionally used for the fabrication of dense ceramics. However, due 
to the ability to produce a homogeneous structure this method has more recently been 
used to produce porous (<90%) parts [258, 259]. The process begins with the 
formation of a slurry containing the scaffolding materials, dispersant, organic 
monomer binder, and cross-linking agents. This suspension is foamed by adding 
surfactants, which reduce particle surface energy and generate stable bubbles [260]. 
Prior to initiation of the polymerisation reaction the solution is casted into a mould. 
Gelation of the foamed suspension causes particle consolidation, immobilising the 
scaffolding material in the shape of the mould. Commonly a chemical initiator and/or 
catalyst are used to initiate the polymerisation process [235]. Finally, the part is 
unmoulded and dried to obtain a green body, which requires heat treatment to burn out 
the binder.  
Despite high levels of porosity being achieved by this technique typically pores are 
poorly interconnected with non-uniform size distribution as a result of the volatility of 
the formed foam. Furthermore, during the gelation and drying stages inner stresses in 
the mould as well as microcracks can be induced, which may adversely affect 
mechanical strength. 
2.16 ALM techniques 
There are a variety of ALM systems that are based on computer aided design (CAD) 
and manufacture (CAM). These techniques were first used for biomedical applications 
in the 1990s and can be categorised into three groups: (1) laser, (2) print or ‘ink’, and 
(3) nozzle systems (Figure 2.13). ALM processes can begin with data generated from 
a scan (CT or MRI) of the patient, a model created from 3D object digitising systems, 
or a CAD model, which is converted into stereolithography format that uses triangular 
facets to represent the surface of the structure. 2D cross sections of the file are then 
numerically produced and fabricated layer by layer. Desired levels of hierarchical 
complexity can be built into the part, which is advantageous when trying to mimic the 
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physical structure of bone. Material composition may also be regulated and in the most 
advanced ALM systems multiple constituents can be used. 
 
Figure 2.13: ALM systems (a) laser, (b) print, and (c) nozzle adapted from [261] 
 
ALM techniques overcome many of the common limitations of conventional methods, 
such as lack of geometry control, poor reproducibility and inability to readily 
customise products. Several also operate without the use of organic solvents. 
Generally, ALM systems reduce design constraints, enable rapid fabrication of 
complex structures and reduce manual interaction. Due to the higher level of structural 
control it is also possible to produce scaffolds with superior mechanical properties in 
comparison to conventionally manufactured counterparts (Table 2.8). Furthermore, 
improved bone regeneration has been reported for these designer structures, which has 
been attributed to a higher degree of interconnectivity [261]. 
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Despite the potential of these processes there are still a number of challenges that need 
to be addressed. Since each ALM system requires a specific input form (powder, 
filament, solution) this limits the range of materials that can be used for individual 
techniques. Processing temperatures may also limit material selection. Surface 
properties influence cell-scaffold interactions (section 2.6.2), although powder based 
ALM systems produce rough surfaces, others create structures with a smooth surface 
that can hinder cell adhesion. Post surface modifications or coating may therefore be 
required [249]. There are also some inherent disadvantages of ALM systems: 
resolution is restricted by machine specific parameters, loose powder or liquid can 
become trapped in internal holes, and the sterility of commercial ALM systems is 
questionable [262]. Table 2.9 summarises the characteristic resolution, advantages and 
disadvantages of common ALM systems used to fabricate bone tissue scaffolds. 
2.16.1 Laser based ALM systems 
2.16.1.1 Stereolithography (SLA) 
The ability of photopolymers to solidify when irradiated with an energy source of a 
specific wavelength is utilised in the SLA process. The part is built up on a table 
moveable along the y-axis and contained in a vat filled with liquid photopolymer resin. 
The low molecular weight resins undergo chain reaction to form solid long chain 
polymers when initiated by a laser, commonly UV. Once the first layer of the structure 
has been solidified the table is lowered by one cross-sectional thickness and is 
recoated with liquid photopolymer. This process is repeated layer-by-layer until the 
full structure is formed. The part is then removed, cleaned and fully cured in a UV 
oven. The common spot size used in SLA is approximately 250μm but research is 
currently being conducted on small-spot systems that enable layers of less than 1μm 
and a resolution finer than 10μm (Table 2.9). 
The direct use of bioceramics, such as HA in SLA have been investigated [263]. 
Generally, the ceramic is mixed with the photopolymer prior to fabrication and the 
green part is heat treated to remove the polymer as well as sinter the ceramic. 
Alternatively, ceramic parts can be made indirectly by creating an initial polymer 
mould [264]. 
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Table 2.9: Comparison of ALM techniques commonly used to fabricate bone tissue scaffolds 
 
ALM 
system 
ALM 
process 
Resolution 
(elements/mm
3
) Advantages Disadvantages 
Present Ultimate 
Laser 
SLA 3152 13300000 
Established technology 
High layer fabrication speed capacity 
High resolution capacity 
Low imaging specific energy 
Relatively easy to remove support material 
Relatively easy to achieve small features 
Complex process 
Requires support 
Limited to photopolymerisable materials 
Material creep 
Expensive materials 
SLS 211 244000 
No support required 
Very little waste material 
Large number of possible materials 
Relatively higher part strength 
Cheap 
High imaging specific energy 
High processing temperature 
Separate curing step required for some materials 
Biodegradable materials may degrade in chamber 
Print 3DP 1900 244000 
Range of materials can be used 
Self-supporting 
Low imaging specific energy 
Minimal heating effect on materials 
Cost efficient 
Low green part strength 
Post processing may be required 
De-powdering can be difficult 
Powder can become trapped inside the part 
Mechanical anisotropy 
Nozzle FDM 15200 157000 
Low material cost 
Waste material limited to the support material; 
no material trapped 
Low imaging specific energy 
Multiple materials possible in same object or 
layer 
Poor surface finish and grainy appearance 
Thermoplastic polymer required 
Limited to materials with low melting point 
High processing temperatures 
Mechanical anisotropy 
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2.16.1.2 Selective laser sintering (SLS) 
During the SLS process a laser is passed over powdered material, which raises the 
local surface to the glass transition temperature resulting in the fusion of neighbouring 
particles in the working layer and those in the layer below. Generally, IR lasers are 
used due to their high power density. The build platform is then lowered by the 
thickness of one layer and a counter-rotating roller applies a new coat of powder on 
top. Typically, the powder particles used are 80 – 120μm in size and the estimated 
overall resolution of the technique is 24400elements/mm
3
 when a minimum energy 
laser beam of 16μm diameter is used [265]. 
Limitations of SLS include the power of the laser and the thermal diffusion of the 
material, specifically the glass transition temperature must be considered. Despite 
exhibiting lower dimensional accuracy and porosity in comparison to SLA parts, 
scaffolds produced by SLS have an inherent advantage since they do not require high 
temperature post processing. If a ceramic part is to be produced it must be mixed with 
a polymer that acts as a low melting point binder, which may need to be burnt out after 
fabrication if it is not biocompatible. Furthermore, since powdered stock materials are 
used the surface of SLS parts is much rougher and this is considered as advantageous 
for adhesion of osteoblasts [21]. 
2.16.2 Print based ALM systems 
2.16.2.1 3D printing (3DP) 
3DP employs inkjet technology to process powdered materials. Stock material(s) in 
powdered form are compacted into the powder bed and then a counter-rotating roller 
spreads a user defined thickness onto a building bed. Liquid binder is propelled onto 
the powder by a printer head causing adjacent particles of the same and neighbouring 
layers to bind together. Powder that does not form part of the structure acts as a 
support during building and must be removed once the final part has dried. Ceramic 
parts may require sintering after printing. Typically, this procedure is performed at 
RT.  
The minimum resolution of a characteristic 3D printer is 1900elements/mm
3
, which is 
limited by the powder particle size and the adhesive. A number of raw material 
characteristics (e.g. morphology, particle size distribution, bulk and tapped density, 
and specific surface area) affect the flowability and wettability of precursor powders, 
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which are crucial in defining the printability of 3DP systems [266]. Therefore 
appropriate materials must be selected or created for the 3D printer. 
It is essential that the powdered material used has an ability to flow to enable adequate 
recoating of the part by the counter-rotating roller during layer-based manufacture. 
Particle size, morphology, and density have been reported to be critical factors in 
determining powder flowability [266, 267]. A high level of flowability contributes 
towards an improvement in the resolution of the final part and vice versa. However, if 
the flowability is too high the powder bed can become unstable. Currently, flowability 
is typically measured using simple funnel methods, either adopting the approach of 
measuring the time taken for an amount of powder to exit a defined funnel (ISO 6186) 
or by calculating the angle of repose by measuring the height of a powder pyramid 
(ISO 4324). The faster the time to exit the funnel or the smaller the angle of repose the 
more flowable the powder. More complex alternative methods have also been used, 
for example Schulze suggested using a ring shear tester [268]. Due to the difficulty 
involved in experimentally estimating flowability there is on-going research in this 
area [269]. 
Wettability of the powder particles by the binder solution is another crucial factor as it 
influences both resolution and mechanical strength of the 3D printed part. There are a 
number of parameters that influence powder wetting, including the contact angle 
between binder solution and powder, binder viscosity, topography of the powder bed 
surface (which itself is dependent on particle shape and size), and any chemical 
reactions between the binder and powder [270]. The ballistic and dynamic impacts of 
binder drops at a high speed on a loose powder bed are complex and difficult to 
analyse [266]. Powder bed stability has been defined as the capacity of the bed to 
withstand ballistic impact or deposition of a new powder layer [266]. Binder drop size 
is a highly critical factor since it determines the ballistic impact on the bed. 
Good cell-biomaterial interactions have been reported for 3D printed parts due to the 
inherent roughness created because of imperfect packing efficiency (i.e.<1) [271, 272]. 
Numerous authors have reported the fabrication of porous CaP structures by 3DP 
[273]. Pure CaP powders, for example α- and β-TCP [266], TTCP [274], and HA 
[275] as well as composites of CaPs mixed with organic polymers, such as poly(L-
lactide-co-glycolide)-copolymer (PLGA) [276], have been utilised as stock materials. 
Material combinations that require the use of organic solvents as a binder, for example 
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PLGA and β-TCP binded with chloroform [276], have an inherent disadvantage as 
complete removal of the solvent is rather difficult due to the inherent porosity of 3D 
printed structures. Despite the numerous studies that have been published on the 3DP 
of CaPs there is still a need for new biocompatible powder-binder systems that enable 
accurate printing of porous ceramic scaffolds with sufficient mechanical strength 
[274]. 
2.16.3 Nozzle based ALM systems 
2.16.3.1 Fused deposition modelling (FDM) 
FDM uses a temperature controlled extruder to feed filaments of semi molten 
thermoplastic into a nozzle, which deposits onto a working area in a continuous strand. 
This causes the material of the previous layer to soften and solidify as one piece. The 
polymer is heated slightly above its melting point meaning that there is only a small 
window where it remains molten. A soluble wax, can be used to fill up any unfilled 
areas to act as a support during building and is dissolved post fabrication. Typical 
FDM machines have a droplet diameter of 50μm, which corresponds to a resolution of 
15200elements/mm
3
. FDM has been used to create pure polymer scaffolds as well as 
polymer-ceramic composites [246, 247, 277, 278]. 
2.17 Summary 
The physical structure and chemical composition of bone was reviewed in this chapter, 
and can be summarised as a hierarchical arrangement of organic and inorganic 
components at different length scales. Specifically, bone mineral is a multi-substituted 
calcium deficient carbonated apatite. It is this crystal structure as well as nanosized 
crystallites that are responsible for the reactivity of this biological apatite phase. 
A clinical strategy that can be used to replace or repair bone is the use of a construct 
referred to as a scaffold, which ideally should emulate the chemical composition and 
physical structure of the native tissue. In relation to the above idea a group of 
materials, namely CaPs, were reviewed due to their chemical and crystallographic 
similarity to native bone mineral, as well as their reported bioactive and 
osteoconductive behaviour. Common conventional and ALM techniques used to 
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fabricate ceramic scaffolds were described and compared to a number of physical 
properties of bone that are known to be crucial to the success of the implant. 
HA was highlighted as a candidate material since it exhibits an apatitic structure that is 
capable of incorporating ionic substitutions that play key roles in the response of bone 
cells. Synthesis techniques were reviewed and the low cost as well as high scalability 
of AP methods were highlighted. Chapter 3 outlines the criteria and presents the 
experimental procedures used to select a methodology to prepare HA. The following 
work concerning HA synthesis explores the influence of a number of reaction 
parameters reported in this chapter to determine key material properties, such as phase, 
particle size, and crystallinity. 
ALM systems were emphasised as promising fabrication methods since they overcome 
many of the common issues associated with conventional techniques, such as lack of 
pore interconnectivity. Specifically, the inherent ability to produce scaffolds with a 
rough surface via 3DP is advantageous since this may improve osteointegration. The 
feasibility of producing HA scaffolds that exhibit features highlighted to be vital to the 
success of bone implants was experimentally investigated (Chapters 7 and 8). Risks 
associated with the use of organic solvents in conventional fabrication methods were 
also emphasised in the literature. In an effort to address this issue the viability of using 
yeast as a natural pore forming agent in a novel non-aqueous salt leaching technique 
was studied in Chapter 7. 
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3. Feasibility study - hydroxyapatite 
synthesis 
3.1 Synthesis methodology selection 
Native bone apatite is chemically and crystallographically similar to HA. Common 
methodologies to synthesise synthetic apatites, such as HA, were reviewed in section 
2.12. To investigate the feasibility of a number of selected techniques to produce 
phase pure HA each procedure was rated according to a defined selection criteria. 
It is known that osteoblasts proliferate up to 60% more when exposed to nHA in 
comparison to micron-sized equivalents [279]. Guo et al. reported a significantly 
higher cell density on nHA after 90min incubation of osteoblasts. The authors 
concluded that these materials not only promote cell adhesion, attachment and 
spreading but also improve long-term cell proliferation and differentiation in 
comparison to micron HA [280]. Therefore, the ability of the reviewed synthesis 
methods to produce HA with a particle size less than 1μm shall be a product criterion. 
The degree of crystallinity of HA has also been reported to influence the adhesion of 
osteoblasts [281]. Hence the synthesis method should ideally enable a degree of 
control of crystallinity in order to ensure crystallographic similarly to native apatite, 
known to exhibit a large amorphous fraction. Additionally, the selected techniques 
should also have the potential to alter the stoichiometry of HA by substitution of 
elements that naturally occur in bone mineral so as to emulate the native 
crystallographic structure and reactivity more closely. Table 2.1 presents a summary 
of the composition of bone apatite in comparison to stoichiometric HA. It is important 
here to consider the scalability of each synthesis technique to ensure a suitable amount 
of product can be produced for the fabrication of 3D bone tissue scaffolds.  
Besides the product criteria discussed above, the efficiency of each synthesis method 
was also considered, namely in relation to energy (i.e. reaction temperature) and time 
(i.e. processing time). In summary, the product criteria used to select feasible 
techniques were defined as: (1) phase pure HA, (2) particle size <1μm, (3) degree of 
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control of crystallinity, (4) ability to alter stoichiometry by substituting naturally 
occurring ionic species into the HA structure, and (5) ease of process scalability. 
Each of the synthesis methods described in section 2.12 was rated according to the 
product criteria outlined above and the results presented in a weighted matrix (Table 
3.1). The efficiency of all the methods that met the product criteria were also 
considered and ranked. Three synthesis methods met all of the product criteria and 
were selected for experimental investigation: (1) solvothermal, (2) aqueous 
precipitation, and (3) self-propagating combustion synthesis. Preliminary experimental 
procedures were designed and conducted to test the feasibility of these techniques to 
adhere to the outlined product and efficiency criteria. 
3.2 Materials and methods 
Analar grade reagents were purchased from Sigma Aldrich (UK) and used without 
further purification unless otherwise stated. 
3.2.1 Aqueous precipitation (AP) 
HA was prepared by an AP method [279]. 0.025M and 0.015M of calcium nitrate 
tetrahydrate [Ca(NO3)2·4H2O >99%] and ammonium phosphate dibasic [(NH4)2HPO4 
>99%], respectively were dissolved separately in 50mL of DI water. The pH of both 
solutions was measured using a pH Tester10 (Eutech Instruments, UK) and adjusted to 
10±0.05 using an appropriate amount of ammonium hydroxide [NH4OH 28 – 30%]. 
The Ca
2+
 solution was added dropwise to the PO4
3- 
solution using a burette while 
being continuously stirred at 300rpm. After 2hrs the solution pH was readjusted to 
10±0.05 and stirred for a further 12hrs at 300rpm. The precipitate formed was filtered, 
washed with DI water twice, oven dried, and finely ground using a pestle and mortar. 
Samples were heat treated to 600, 900 or 1100°C with a ramping up and down rate of 
1°C/min and dwell time of 1hr in an air atmosphere. 
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Table 3.1: Selection of synthesis methods to produce HA according to defined product and efficiency criteria 
a
Rated 0 – 1 where 0 = no and 1= yes, brated in order where 1 = highest and 3 = lowest, crated in order where 1 = longest and 3 = shortest  
 
Synthesis 
technique 
Product criteria Efficiency criteria 
Efficiency 
total Reported pure HA?
a
 
Reported 
particle size 
<1μma 
Reported 
crystallinity 
control
a
 
Ionic substitutions 
reported in 
literature
a 
Scalability 
medium/high
a
 
Typical reaction 
temperature
b
 
Typical 
processing time
c
 
Solid State 
0.5 
Likely phase transition 
due to high 
temperatures 
0 1 1 1 Does not meet all product criteria N/A 
Aqueous 
Precipitation 
1 1 1 1 1 3 1 4 
Hydro/Solvothermal 1 1 1 1 
0.5 
Limited by reaction 
vessel size 
2 3 5 
Emulsion 1 0 
0.5 
Typically 
controlled by 
sintering protocol 
alone 
1 0 
Reported to be 
sensitive processes 
Does not  meet all product criteria N/A Microemulsion 1 1 1 
Sol-gel 1 1 1 
SPCS 1 1 1 
0.5 
Only reported on small 
scale for HA but 
industrially used to 
produce other materials 
1 2 3 
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3.2.2 Self-propagating combustion synthesis (SPCS) 
Two different fuels were investigated for the SPCS process, both in combination with 
nitric acid as an oxidising agent. 
3.2.2.1 Urea self-propagating combustion synthesis (USPCS) 
0.025M of Ca(NO3)2·4H2O and 0.015M of (NH4)2HPO4 were added to 100mL of DI 
water to form a white opaque solution. An appropriate amount of concentrated nitric 
acid (HNO3,70%) was added to make the solution clear while stirring at 250rpm. 12g 
of powdered urea [(NH2)2CO ≥98%] was added to this solution, which was stirred at 
250rpm for a further 5mins at RT. The final solution was poured into an alumina 
crucible and placed in a furnace preheated to 500°C until combustion occurred. 
Products of combustion were ground using a pestle and mortar and heat treated as 
described in section 3.2.1. 
3.2.2.2 Citric acid self-propagating combustion synthesis (CSPCS) 
0.02M of Ca(NO3)2·4H2O and 0.02M citric acid (C6H8O7, 99%) were dissolved in 
50mL of DI water and stirred for 10mins at 250rpm. Solution pH was measured and 
adjusted to 10±0.05 using an appropriate amount of NH4OH. A stoichiometric amount 
of (NH4)2HPO4 (0.012M) was dissolved in 50mL of DI water and added dropwise to 
the Ca
2+
 containing solution while stirring at 250rpm to form a white opaque solution. 
This solution was made clear by adjusting the pH to 1±0.05 by adding an appropriate 
amount of HNO3. The final solution was stirred at 250rpm and 70°C for 2hrs. After 
transferring into an alumina crucible the final mixture was placed in a preheated 
furnace at 450°C until combustion occurred. Powdered precursors were calcined at 
900°C for 2hrs to remove carbonaceous combustion products and then sintered at 900 
or 1100°C as described in section 3.2.1. 
3.2.3 Solvothermal synthesis (SS) 
HA was prepared by adapting a reported SS method [186]. In a typical process, 
solution I was formed by dissolving 0.0003M of Ca(NO3)2·4H2O into solvent A 
(0.8mL DI water, 0.8mL n-butanol, and 3.1mL n-octane). 0.8g of cetyl 
trimethylammonium bromide (C19H42NBr - CTAB) was then dissolved into solution I 
under stirring conditions (200rpm). Solution II was formed separately by dissolving 
0.00018M of (NH4)2HPO4 into solvent A. An appropriate amount of 2M sodium 
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hydroxide (NaOH >97%) solution was added to solution II to adjust the pH to 
10±0.05. While stirring at 400rpm solution II was added to solution I, which was then 
stirred for 30mins, transferred into a 20mL Teflon lined autoclave and placed in a 
furnace preheated to 160°C for 24hrs.  
The formed precipitate was separated from the final suspension by centrifugation 
(4000rpm for 10mins) and the supernatant decanted off. The precipitate was washed 
firstly with DI water and then thrice with a mixture of methanol and dichloromethane 
(1:1 volume). Drying and heat treatment were then performed as described in section 
3.2.1. 
3.3 Material characterisation 
To assess whether the HA produced met the outlined criteria several characterisation 
techniques were used to determine phase purity, crystallinity, crystallite and particle 
size, particle morphology, and thermal stability. 
3.3.1 X-ray diffraction (XRD) 
XRD analysis was performed on ground as-synthesised and calcined samples using a 
Bruker D5000 diffractometer in Bragg-Brentano geometry with a monochromatic 
CuKα radiation (λ=1.54056Å) and aluminium sample holders. The data was collected 
over a 2θ range of 5 – 60° with a step size of 0.02° and a count time of 5s. Phase 
identification was achieved by matching diffraction patterns with Joint Committee on 
Powder Diffraction Standards (JCPDS) using Eva software. Line broadening analysis 
was performed on the (002) peak of as-synthesised HA samples using Equation 3.1: 
 
     
  
     
                                                                                                     (3.1) 
 
where    crystallite size,    Scherrer constant (≈0.9),     -ray wavelength 
(CuKα=1.54056Å),    peak width (in radians), and    Bragg angle. The (002) 
diffraction peak was specifically chosen since it is isolated from other characteristic 
HA peaks. 
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3.3.2 Scanning electron microscopy (SEM) 
The morphology and size of as-synthesised and sintered (1100°C) particles were 
analysed using a scanning electron microscope (Zeiss Supra55 FEGSEM) operating at 
20kV. Powders were dispersed onto double adhesive carbon tabs attached to an 
aluminium stub and sputter-coated with a thin layer of gold in an argon-purged 
chamber for 90s prior to characterisation. Image J software was used to measure the 
size of particles and an average was calculated (n=5).  
3.3.3 Differential thermal and thermogravimetry analysis (DTA-
TGA) 
The thermal behaviour of dried powders was determined by simultaneous DTA-TGA 
using a TGA/DSC-1 STARe instrument (Mettler-Toledo, UK) with STARe software. 
10±5mg of samples were heated in alumina crucibles from 30 – 1300°C at a constant 
ramp rate of 20°C/min in flowing air. A reference alumina crucible was used and data 
collected for an empty crucible under the same conditions was blank-subtracted. 
3.4 Results 
3.4.1 Crystal structure 
XRD patterns were matched to JCPDS reference files and the average crystallite size 
determined by line broadening analysis (Table 3.2). For clarity, the influence of heat 
treatment temperature on the average crystallite size is graphically shown (Figure 3.1). 
XRD patterns of AP01, AP02, and SS01 – SS04 exhibited all of the major peaks of 
HA (09-432), including characteristic (002), (211), (112) and (300) peaks at 2θ values 
25.88, 31.77, 32.20 and 32.90°, respectively. These samples were not matched to any 
other CaP phases. Heat treatment of AP samples above 600°C (AP03 and AP04) 
resulted in the formation of a biphasic mixture of HA and β-TCP (70-2065) (Figure 
3.2). In contrast, SS03 and SS04 were matched only to HA (Figure 3.3). 
As-synthesised samples prepared by USPCS (U01) and CSPCS (C01) were matched 
to characteristic peaks of HA and β-TCP. Heat treatment up to 1100°C did not result 
in any phase change but an increase in the intensity of characteristic peaks of USPCS 
samples was observed (Figure 3.4). In contrast, no discernible change was 
demonstrated between samples C01 – C03 (Figure 3.5). 
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Table 3.2: Influence of heat treatment with respect to phase and average crystallite size of 
preliminary samples 
a
Calculated using Scherrer equation on (002) peak of HA, 
b
sample formed after combustion 
Sample 
Synthesis 
method 
Heat treatment 
temperature (°C) 
Phase(s) 
identified 
Average crystallite 
size
a
 (nm) 
AP01 
AP 
As-synthesised 
HA 
25 
AP02 600 33 
AP03 900 HA, 
β-TCP 
38 
AP04 1100 48 
SS01 
SS 
As-synthesised 
HA 
41 
SS02 600 46 
SS03 900 48 
SS04 1100 58 
U01 
USPCS 
As-synthesised
b 
HA, 
β-TCP 
32 
U02 600 34 
U03 900 37 
U04 1100 60 
C01 
CSPCS 
As-synthesised
b
 
HA, 
β-TCP 
64 
C02 900 79 
C03 1100 80 
 
 
Figure 3.1: Influence of heat treatment on the average crystallite size calculated from XRD line 
broadening  
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Figure 3.2: XRD patterns of preliminary samples (a) AP01, (b) AP02, (c) AP03, and (d) AP04 
produced by AP 
 
 
Figure 3.3: XRD patterns of preliminary samples (a) SS01, (b) SS02, (c) SS03, and (d) SS04 
produced by SS  
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Figure 3.4: XRD patterns of preliminary samples (a) U01, (b) U02, (c) U03, and (d) U04 produced 
by USPCS 
 
 
Figure 3.5: XRD patterns of preliminary samples (a) C01, (b) C02, and (c) C03 produced by 
CSPCS 
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3.4.2 Microstructural development 
The typical morphology of as-synthesised and sintered (1100°C) particles were 
observed by SEM and average sizes were calculated (Table 3.3). An increase in 
particle size due to sintering was demonstrated for all synthesis methods (Figure 3.6). 
Distinct morphological differences were observed amongst synthesis techniques, and 
between as-synthesised and sintered particles (Figure 3.7). Bulk morphological 
homogeneity was exhibited for particles, except for those prepared by USPCS that 
revealed two different morphologies: (1) small globular particles (200 – 400nm), and 
(2) polygonal shaped agglomerates (12 – 20μm) (Figure 3.8). 
 
Table 3.3: Summary of the average size and typical morphology of particles observed by SEM 
Synthesis 
method 
As synthesised Sintered at 1100°C 
Typical morphology 
Average size 
(μm) 
Typical 
morphology 
Average 
size (μm) 
AP 
Single domain, 
globular, 
agglomerated 
0.57 ± 0.07 
Single domain, 
uniform 
globular, 
agglomerated 
0.73 ± 0.05 
USPCS 
Single domain, 
globular 
agglomerates 
5.81 ± 1.50 
Two 
morphologies: 
globular and 
polygonal 
agglomerates 
8.97 ± 6.39 
CSPCS 
Single domain, 
polygonal, 
agglomerated 
11.38 ± 5.08 
Single domain, 
polygonal, 
agglomerated 
19.45 ± 2.80 
SS 
Single domain, 
globular, 
agglomerated 
2.00 ± 0.19 
Single domain, 
globular 
agglomerates 
4.74 ± 0.84 
 
 
 
Figure 3.6: Increase in average particle size observed by SEM between as-synthesised and 
sintered particles produce by preliminary methods 
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Figure 3.7: Typical particle morphology of preliminary samples (a) AP01, (b) AP04, (c) U01, (d) 
U04, (e) C01, (f) C03, (g) SS01, and (h) SS04  
a) b) 
c) d) 
e) f) 
g) h) 
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Figure 3.8: Typical (a) globular particles and (b) polygonal agglomerates observed in USPCS 
samples 
 
3.4.3 Thermal behaviour 
A notable variation in the total weight loss recorded between 30 and 1300°C by TGA 
was observed (Table 3.4). SS01 exhibited a lower than average weight loss, and in 
contrast U01 and C01 demonstrated a higher than average loss. All samples displayed 
a weight loss below 100°C corresponding to an endothermic reaction, which is 
ascribed to the removal of non-bound surface water (Figures 3.9 – 3.12). AP01 (Figure 
3.9), C01 (Figure 3.11), and SS01 (Figure 3.12) exhibited an endotherm between 200 
and 300°C that is attributed to loss of bound surface water. The weight loss observed 
in all samples, except SS01, at approximately 500°C, is suggested to be due to the 
removal of lattice water. Any weight loss after this temperature was attributed to the 
dehydroxylation of the respective CaP phase(s). 
 
Table 3.4: TGA analysis of as-synthesised preliminary samples 
Sample 
Total weight loss 
(wt%) 
Residue 
(wt%) 
AP01 9.39 90.61 
U01 13.79 86.21 
C01 12.08 87.92 
SS01 4.53 95.47 
Average 9.95 90.05 
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Figure 3.9: Thermal behaviour of AP01 
 
Figure 3.10: Thermal behaviour of U01 
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Figure 3.11: Thermal behaviour of C01 
 
Figure 3.12: Thermal behaviour of SS01 
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3.5 Discussion 
XRD investigations showed that uncalined (AP01 and SS01) and calcined (AP02, 
SS02, SS03 and SS04) samples produced by the AP and SS methods matched to HA 
alone and no secondary phases were identified. Uncalcined precipitates exhibited 
broadened and poorly defined characteristic XRD peaks, which has been reported as 
typical for HA prepared by AP methods [121]. XRD peaks of as-synthesised samples 
produced by SS were comparable, in terms of the degree of broadening, to AP01 and 
this suggests that a higher temperature or longer solvothermal treatment time is 
required to noticeably improve crystallinity. The heat treatment of AP and SS samples 
at 600°C increased peak intensity but characteristic (211), (112), and (300) peaks were 
still observed to overlap. A significant improvement in the refinement of HA peaks 
resulted at sintering temperatures of 900 and 1100°C for SS samples (Figure 3.3). A 
steady increase in crystallite sizes was observed for AP and SS samples up to 900°C 
due to densification of powders (Figure 3.2). Between 900 and 1100°C an increase in 
the rate of crystallite growth was observed, which is associated to a higher degree of 
particle consolidation at these temperatures. 
Partial phase transition to β-TCP was observed in samples AP03 and AP04, as 
indicated by the formation of peaks at 2θ values that did not match the standard HA 
reference pattern (09-432). This thermal instability suggests that the precipitates 
formed via this preparation method were CDHA, i.e. Ca:P ratio <1.67 (e.g. Figure 
2.12). In comparison, corresponding SS samples (SS03 and SS04) were matched to 
HA alone suggesting a Ca:P ratio closer to the stoichiometric value of 1.67. TGA 
analysis supports this assertion since SS01 exhibited over 50% less weight loss 
between 30 and 1300°C compared to AP01, notably stoichiometric HA is reportedly 
thermodynamically stable up to 1250°C [220]. Equations 2.4 and 2.5 describe 
reactions that may occur over this temperature range if CDHA is present. Thus the 
higher weight loss and resultant phase change exhibited for AP samples strongly 
suggests AP01 is CDHA. 
XRD patterns of samples formed after combustion using urea or citric acid as fuels for 
SPCS suggest they comprised of a biphasic mixture of β-TCP and HA. Since β-TCP is 
formed from the thermal decomposition of CaPs, such as CDHA above 800°C, these 
results suggest that the respective combustion reactions of urea or citric acid with 
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nitric acid formed a high temperature reaction front. A sharp increase in intensity and 
lower degree of peak broadening was observed between U03 and U04 corresponding 
to an increase in average crystallite size of over 60%. These changes demonstrate that 
an improvement in the crystallinity occurred above 900°C, thus suggesting that as-
synthesised USPCS powders exhibited a poor long range crystal order. This is 
attributed to the relatively fast formation of the CaP phase from a solution containing 
numerous ionic species (e.g. Figure 2.10) due to the instant combustion of urea and 
nitric acid at the appropriate temperature. In contrast, an increase of only 25% was 
calculated between the average crystallite sizes of C01 and C03. The degree of 
broadening and intensity of the XRD peaks were not significantly altered by the heat 
treatment protocols employed (Figure 3.5). This suggests that the crystal structure was 
predominantly defined during the initial combustion reaction between citric and nitric 
acid. The following factors of the SPCS methods are suggested to cause the formation 
of biphasic CaPs: (1) high reaction front temperatures, (2) volatile molecular 
dispersion of numerous ionic species within the initial solutions, and (3) spontaneous 
ignition of the fuel and oxidiser. The importance of the fuel to oxidiser ratio in SPCS 
methods is recognised as an influential factor since if any constituents are left 
unreacted undesirable carbonaceous by-products may remain. 
Typical SEM micrographs of as-synthesised and sintered samples of AP and SS 
particles illustrated a similar single domain globular morphology with bulk 
agglomeration. The CSPCS technique investigated produced monomorphic particles in 
a polygonal form. In contrast, sintering of USPCS samples resulted in the formation of 
polygonal agglomerates as well as globular particles as shown by characteristic SEM 
micrographs of samples U01 and U04. This observation is suggested to explain the 
increase in the rate of crystallite growth between 900 and 1100°C (Figure 3.1). The 
agglomeration behaviour demonstrated for particles produced by all methods is linked 
with the high particle energy associated with nanosized crystallites, which causes them 
to clump together. However, the higher degree of agglomeration and larger average 
particle size of as-synthesised particles produced by both SPCS methods is suggested 
to be due to the high reaction temperatures that occur during the spontaneous 
combustion of respective fuels and oxidisers. The marked difference in the 
morphology of particles formed via SPCS methods compared to AP and SS is 
attributed to the characteristically different morphologies of CaP phases formed at low 
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and high temperatures (Figure 2.8). Furthermore, the vast differences in particle 
morphology reflect the differences in material composition. Line broadening analysis 
confirmed crystallites of all samples were within the nanoregime (Table 3.2).  
To complement XRD results the thermal stability of as-synthesised samples was 
assessed by simultaneous DTA-TGA between 30 and 1300°C. An average weight loss 
of 9.95% was recorded over this temperature regime and the majority of this is 
attributed to the removal of surface and lattice water. Removal of surface water is 
ascribed to any weight loss occurring below 200°C and the loss of lattice water is 
proposed to take place up to 700°C (Equation 2.4). To reiterate, any reduction in 
weight above this temperature is owing to the dehydroxylation of CaP phases formed 
during heating due to non-stoichiometry of HA (Equation 2.5). The thermal stability of 
powders produced by the SS method is illustrated by the lower than average weight 
loss recorded by TGA and no detection of secondary phases in XRD patterns of 
sintered samples. Thus it is suggested that SS01 is predominantly HA. In contrast, 
both SPCS methods exhibited a larger weight loss below 700°C compared with SS and 
AP samples, which suggests greater deviation from stoichiometry. Furthermore, a 
weight loss of 1.61% for U01 between 700 and 1300°C was observed, which was 
notably greater than other samples and may be linked with further thermal degradation 
of the CaP phases present. It should be noted that some weight loss of SPCS samples 
should be attributed to the removal of carbonaceous by-products of the respective 
combustion reactions. 
The feasibility of producing phase pure HA with an average particle size less than 
1μm by AP, SS and SPCS methods was experimentally assessed in this chapter. Table 
3.5 summarises the ability of each technique to meet the previously defined product 
criteria: (1) phase pure HA, (2) particle size less than 1μm, (3) degree of control of 
crystallinity, and (4) ability to alter stoichiometry by substituting naturally occurring 
ionic species into the HA structure. In addition, those criteria that were not directly 
measured (i.e. crystallinity control and an ability to alter stoichiometry), as well as 
scalability, reaction temperature and processing time were commented on. 
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3.6 Conclusions 
XRD analysis of as-synthesised AP and SS samples did not identify any prominent 
secondary phases and in contrast both SPCS methods resulted in the production of 
mixed phase CaPs. The sensitivity of the AP process is demonstrated by the 
relationship observed between the dominate phase and heat treatment temperature, 
which highlights the need to optimise reaction conditions in an effort to control 
stoichiometry. The formation of β-TCP above 600°C suggests the phases precipitated 
were CDHA, which although suggests that the as-synthesised sample was not ‘phase 
pure’ HA, a degree of nonstoichiometry is likely to be beneficial since a reduction in 
the Ca:P ratio is associated with an increase in the rate of dissolution. In order to 
detect the presence of any HPO4
2-
 in the suspected CDHA it is recommended an 
additional characterisation technique would be necessary, for example FTIR. 
SEM micrographs confirmed the single domain morphology for as-synthesised and 
sintered AP, CSPCS and SS samples. In comparison, globular and polygonal particles 
observed in sintered USPCS samples demonstrated a higher degree of densification. 
Particles synthesised by the AP methods were the only products less than 1μm in size; 
however notably a degree of bulk agglomeration was observed. 
In conclusion, despite the advantageous short reaction times of the reported SPCS 
processes due to the volatile and spontaneous nature of particle formation neither 
method is deemed feasible. Both the AP and SS methods are expected to adhere to the 
listed criteria after optimisation of influential reaction conditions, such as pH and 
reaction temperature. However, the SS method is considered unsuitable for further 
investigation due to the limited ability to control crystallinity and scale up this process. 
To reiterate, the degree of crystallinity of HA is deemed to be a critical factor due to 
its reported influence on the adhesion of osteoblasts [281]. Therefore, the AP method 
was selected for further investigation. 
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Table 3.5: Feasibility of selected HA synthesis methods according to product and efficiency criteria 
a
experimentally measured, 
b
not experimentally assessed
Synthesis 
technique 
Product criteria Efficiency criteria 
As-synthesised 
phase matched 
to HA?
a 
Average 
particle 
size 
<1μm?a 
Crystallinity control
b 
Ionic substitutions
b
 Scalability
b
 
Reaction 
temperature 
(°C) 
Processing 
time 
(hrs) 
AP 
Yes  
No secondary 
phases 
identified 
Yes 
Yes 
Reaction parameters 
such as temperature and 
solute concentration can 
be controlled throughout 
precipitation 
Yes 
Numerous reports of 
incorporation of 
various substitutions 
within the literature 
High 
Commonly used 
industrially 
RT 15 
USPCS 
No  
Secondary 
phases present 
No 
Limited 
Largely determined by 
combustion reaction and 
post heat treatment 
Difficult 
Volatile dispersion of 
molecules within 
initial solution could 
result in 
inhomogeneous 
distribution of 
additional ions in final 
product 
Low 
Dependent on size of 
crucibles and furnace. 
Foreseen difficulty in 
processing larger batches 
due to instantaneous 
ignition. Potential for 
reactants to remain 
unreacted 
500 1.5 
CSPCS No 450 5 
SS 
Yes 
No secondary 
phases 
identified 
No 
Limited 
Determined primarily by 
solvothermal treatment 
temperature and time 
Yes 
Successful reports 
within the literature 
Low 
Largest autoclave available 
50mL corresponding to a 
HA batch size  <1g 
160 26 
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4. Precipitation of hydroxyapatite – 
influence of reaction conditions 
4.1 Introduction 
The feasibility to produce phase pure HA with a particle size less than 1μm, 
controllable crystallinity, and an ability to alter stoichiometry by aqueous precipitation 
(AP), self-propagating combustion synthesis (SPCS), and solvothermal synthesis (SS) 
methods was experimentally assessed in Chapter 3. Results established that the AP 
method satisfied these product criteria most closely. Additionally, the ability to 
produce substantial quantities at relatively low temperatures is another notable 
advantage of AP methods (Tables 2.6 and 3.5). This technique was therefore selected 
for further investigation and this chapter explores the influence of various reaction 
conditions on material properties and the biological performance of HA. 
Generally it is accepted in the literature that the value of pH during synthesis affects 
the phase purity of precipitated CaPs [57, 282]. As summarised in Table 2.7, 
numerous authors have investigated the influence of other reaction conditions, such as 
temperature, reagent concentration, addition rate, ageing time, and heat treatment on 
pure, carbonated, and substituted calcium apatites [15, 60, 167, 209, 283-288].  
This chapter presents an experimental analysis of the single factor influence of pH, 
temperature, and solute concentration on the following properties of HA: (1) phase 
purity, (2) degree of crystallinity, (3) particle size and morphology, (4) thermal 
stability, (5) stoichiometry, (6) surface area, and (7) surface charge. Acellular and 
cellular assessments of bioactivity, cytocompatibility as well as the degree of cell 
proliferation were also performed, respectively. 
4.2 Materials and methods 
Analar grade reagents were purchased from Sigma Aldrich (UK) and used without 
further purification unless otherwise stated. 
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4.2.1 Aqueous precipitation (AP) 
Stock solutions containing Ca
2+
 and PO4
3-
 were obtained separately by dissolving 
0.05M of Ca(NO3)2·4H2O and 0.03M of (NH4)2HPO4 into 50mL of DI water, 
respectively. The solution containing PO4
3-
 was added dropwise to the Ca
2+
 solution 
while being stirred at 400rpm and RT. During addition the pH was controlled to 
11±0.1 using an appropriate amount of aqueous NH4OH. After addition, the combined 
solution was stirred for a further 1.5hrs at RT, and solution pH and temperature were 
recorded throughout. 
The precipitate formed was removed from the mother solution and centrifuged four 
times at 4000rpm for 10mins in a solution of DI water. In between each cycle the 
supernatant was removed and fresh DI water was added. Washing and filtering was 
then performed using DI water and a Bucker flask, respectively. The washed 
precipitate was oven dried at 60°C overnight and ground into a fine powder using a 
pestle and mortar. 
In order to determine the individual influence of pH, temperature, and solute 
concentration a single factor test method was used, i.e. only one reaction parameter 
was changed for each sample produced. Variations to the procedure reported above are 
summarised in Table 4.1.  
 
Table 4.1: Summary of varied pH, temperature and solute concentration conditions 
a
control sample 
 
4.2.2 In-vitro test methods 
Preparation of as-synthesised powders (AP07 – AP12) for acellular and cellular in-
vitro testing is described in this section.  
Sample 
Investigated 
parameter 
Parameter 
value 
Comment 
AP05 
pH 
8 
pH adjusted before addition of P 
solution and not controlled during 
AP06 9 
AP07 10 
AP08 11 
pH adjusted at start and end of addition 
of P solution 
AP09
a
 11 pH controlled during addition of P 
solution AP10 10 
AP11 
Solute 
concentration 
0.1M Ca 
reagent 
Stoichiometric amount (0.06M) of P 
reagent was used 
AP12 Temperature 70°C 
The solution was heated on a magnetic 
hot plate during addition and stirring 
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4.2.2.1 Pellet preparation 
In-vitro tests were performed on pellets formed from 0.25±0.02g of as-synthesised 
powder. Samples were pressed into cylindrical pellets (diameter 10mm) using a 
Simplemet 2 press (Buehler, UK) in combination with a self-manufactured hardened 
steel die and punch set (Figure 4.1). A uniaxial force of 800N was used to compress 
the powder, using the process illustrated in Figure 4.2. Pellets were consolidated by 
heating to 600°C with a ramping up and down rate of 1°C/min and dwell time of 1hr 
in an air atmosphere.  
 
 
Figure 4.1: Steel die and punch set used to prepare pellets 
(a) Top view and (b) side view arrangement in order of application 
 
Figure 4.2: Preparation of pellets used for in-vitro tests  
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4.2.2.2 Simulated body fluid test  
As a prerequisite to cellular in-vitro tests the bioactivity of substrates was evaluated by 
examining the ability of apatite to form on the surface of prepared pellets while 
immersed in simulated body fluid (SBF), which exhibits ion concentrations nearly 
equal to those of human blood plasma. SBF was prepared by the method reported by 
Kokubo et al. [289], in accordance to ISO 23317:2007. During preparation the 
solution was stirred continuously at 200rpm and the temperature was maintained at 
36.5±1.5°C. 4 pellets for each sample were placed individually into glass specimen 
bottles and immersed in SBF so the entire surface was covered. To avoid evaporation 
of the solution plastic caps were secured on specimen bottles, which were then placed 
into an incubator at 37°C until required. A single pellet of each sample was removed, 
dried, and analysed after 1, 7, 14, and 28 days of immersion.  
4.2.2.3 Live/dead staining 
MC3T3 osteoblast precursor cells were seeded on to pellets to determine the effect of 
different substrates on cell viability up to 7 days. Prior to cell culture pellets were 
sterilised with ethanol (70%, Fisher Scientific, UK) and left overnight under UV light. 
Well plates were coated with 1.5mL of Sylgard type 184 silicone elastomer (Dow 
Corning Corporation, US) and left to polymerise for a week before use to provide a 
non-cell-adhesive surface. Aliquots (50μm) containing 2x104 cells/well were seeded 
directly on top of the HA pellets in 24-multiwell plates and allowed to adhere for 4hrs. 
After this time 2mL of DMEM, which was supplemented with 10% fetal bovine 
serum, 2.4% L-glutamine, 2.4% HEPES buffer, and 1% penicillin/streptomycin, was 
added to each well and cultures were incubated in 5% CO2 atmosphere maintained at 
37°C.  The viability of cells seeded on the surface of HA pellets were analysed using a 
Live/Dead
®
 Viability/Cytotoxicity Kit after culturing for 1, 3, 5, and 7 days. Live and 
nonviable apoptotic cells were stained with calcein-AM (1mg/mL, Molecular Probes, 
UK) and propidium iodide (1mg/mL, Invitrogen, UK), respectively in the dark. 
Calcein-AM is a green florescent dye that is cell-permeant and converts into intense 
fluorescent calcein by the activity of an intracellular esterase, an enzyme found in live 
cells [290]. Propidium iodide is membrane impermeant and is excluded from viable 
cells. It binds to DNA by intercalating between base pairs. 
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4.2.2.4 MTT assay  
The viability of cells seeded on to the surface of HA pellets was analysed using an 
MTT assay after culturing for 1, 3, 5, and 7 days. Mitochondria of viable cells reduce 
the yellow MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to 
formazan, which was dissolved by acidic isopropanol after removal of culture 
medium. Cleavage of MTT occurs only by active mitochondria and therefore the 
amount of formazan generated is directly proportional to the cell number and 
activation thus this assay can be used to quantitatively assess cell survival and 
proliferation [291]. 
4.2.2.5 Hoechst assay 
Cell proliferation on various substrates was also analysed at designated times (1, 3, 5 
and 7 days) using a Hoechst 33258 dye that stains DNA. Samples were collected at the 
appropriate times and washed with PBS. Seeded cells were trypsinized (dissociated) 
from the surface of substrates and stored at -80°C until the end of the experimental 
period. All detached cells, from different culture times, were thawed to RT and 100μL 
of distilled water was added per sample. This solution was incubated at 37°C for 1hr 
and then stored at -80°C for 20mins and thawed to RT again. 100μL of aqueous 
Hoechst 33258 in TNE buffer solution was then added to each sample. 
4.2.2.6 Florescence staining to visualise cellular internalisation  
A stock solution of 5mg Fluorescein-5-Maleimide (Life Technologies, UK) in 1mL of 
PBS was prepared. 1mg of HA particles was suspended in 500μL of PBS and 
sonicated for 5mins before adding 400μL of Fluoresceine stock solution. The HA-
Fluoresceine mixture was left to react on a thermoblock mixer at 37°C and 1400rpm 
for 2hrs. The stained particles were finally washed 5 times with PBS. 
MC3T3 osteoblast precursor cells were seeded at a density of 3x10
4
cells per quadrant 
in a 4-segmented live cell imaging dish (Greiner-Bio One Ltd, UK) and incubated 
overnight at 37°C in supplemented DMEM media. 1mg of HA-dye stock was 
resuspended in 1mL of supplemented cell culture media and diluted into aliquots of 
2.4μg/mL. 500μL of supplemented media and 500μL of the diluted HA-dye solution 
was added to each quadrant of the imaging dish thus giving a final particle 
concentration of 1.2μg/mL. Imaging was performed after 24hrs. 
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4.3 Material characterisation 
4.3.1 X-ray diffraction (XRD) 
XRD was performed (section 3.3.1) on as-synthesised powders. Samples AP07 – 
AP10 calcined at 600 and 900°C using a ramp up/down rate of 1°C/min and a dwell 
time of 1hr were also analysed. Data was collected over the range 2θ = 5 – 60° using a 
step size of 0.02° and a count time of 15s. Line broadening analysis was performed as 
previously described using Equation 3.1. The crystalline fraction (Xc) of as-
synthesised powders was evaluated using Equation 4.1: 
 
       
        
    
                                                                                             (4.1) 
where      is the intensity of (300) diffraction peak, and          is the intensity of the 
hollow between (112) and (300) diffraction peaks of HA, which completely disappears 
in non-crystalline samples. 
4.3.2 Fourier transform infrared spectroscopy (FTIR) 
Spectra of finely ground as-synthesised and calcined (AP07-AP10) powders were 
recorded in Attenuated Total Reflectance (ATR) mode using a Spectrum One FTIR 
Spectrometer. Specimens were placed onto the sample stage and IR spectra were 
collect between 550 and 4000cm
-1
 with a 4cm
-1
 resolution averaged over 8 scans using 
Spectrum software. 
4.3.3 Scanning electron microscopy (SEM) 
SEM was performed on as-synthesised powders using the method described in section 
3.3.2.  
4.3.4 Transmission electron microscopy (TEM) 
TEM was performed on sample AP07 using a Jeol 2100 LaB6 instrument, operating at 
200kV. The specimen was dispersed ultrasonically in ethanol and deposited dropwise 
onto 3mm lacey carbon grids (Agar, UK).  
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4.3.5 Differential thermal and thermogravimetry analysis (DTA-
TGA) 
Simultaneous DTA-TGA analysis was performed using the method reported in section 
3.3.3.  
4.3.6 Energy dispersive spectroscopy (EDS) 
The influence of pH on the Ca:P ratio was determined from elemental analysis 
performed on a Zeiss Supra55 FEGSEM fitted with a X-max 50mm
2
 energy dispersive 
spectroscope (Oxford Instruments, UK). Preparation of samples was described in 
section 3.3.2 and involved the use of a carbon tab, as well as gold coating hence the 
presence of these elements in typical spectra. Three measurements from different 
locations were obtained and an average value calculated. 
4.3.7 X-ray fluorescence (XRF) 
The elemental compositions of samples AP07 – AP10 were determined by XRF (S8 
TIGER, Bruker Corp, UK). Samples were prepared by mixing 0.5g of HA powder 
with 0.1g of wax and pressed into pellets. Results were presented as elemental analysis 
and used to calculate the Ca:P ratio of each sample. 
4.3.8 BET surface area measurements 
Micromeritics ASAP 2020 surface area and porosity analyser was used to determine 
the surface area of dried powders using the nitrogen adsorption method [292]. Samples 
were prepared by heating to 30°C at 1°C/min and evacuated until the pressure reached 
10μmm Hg. Specimens were dwelled under these conditions for 10mins.  
Nitrogen adsorption data was collected at relative pressures between 0.06 and 0.2, plus 
a single point at saturation pressure (~1). Free space values were measured using 
helium prior to analysis. The adsorption took place in a liquid nitrogen bath; saturation 
pressure (P0) was measured at intervals and this was used to calculate the temperature 
of the bath.  A value of 0.162nm
2
 was used for the area occupied by an adsorbed 
nitrogen molecule and a non-ideality factor for nitrogen of 5.7 x 10
-5
 was used. BET 
analysis was carried out on data between relative pressures of 0.06 and 0.2. 
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4.3.9 Zeta potential (ZP) 
Malvern instruments Zetasizer ZS (Malvern, UK) was used to measure particle 
electrophoretic mobility in DI water and DMEM. Dilute suspensions of particles in the 
media of interest were prepared at approximately 0.1wt% and loaded into plastic 
disposable zeta cells. Changes in light intensity fluctuations upon an applied electric 
field on the zeta cells were measured and employed by the Zetasizer to calculate ZP. 
Prior to measurement, the cell was agitated in an ultrasonic bath and equilibrated at 
25°C for 2mins.  
4.3.10 SBF test 
Any growth of apatite on the surface of pellets immersed in SBF was visualised by 
SEM, as described in section 3.3.2. The roughness of the surface of gold coated pellets 
was profiled using white light interferometry performed on a NT2000 interferometer 
(Wyco, UK). Average roughness (Ra) was calculated using Equation 4.2: 
 
   
 |  | |  | |  |   |  | 
 
                                                                            (4.2) 
where Z = profile height, and N = number of data points. 
4.3.11  Live/dead staining 
A fluorescence microscope fitted with a mercury lamp (Carl Zeiss Ltd, UK) was used 
to visualise live (green) and dead (red) cell cultures on the surface of pellets at 
magnifications of x20. 
4.3.12 MTT assay 
The absorbance of coloured solutions was quantified by measuring at a wavelength of 
620nm using a microplate reader (BIO-TEK, US), which gave an indication of the cell 
number at each time point. 
4.3.13 Hoechst assay 
Fluorescence measurements were carried out using a microplate reader (BIO-TEK, 
US) with excitation at 360nm and detection at 460nm.  
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4.3.14 Cellular internalisation 
Fluorescein stained samples were imaged with a Zeiss LSM 710 ConfoCor 3 confocal 
system (Carl Zeiss Ltd, U.K.) attached to a Zeiss Axio Observer.Z1 inverted 
microscope and equipped with a Zeiss EC Plan-Neofluar x63 NA = 1.40 oil objective 
lens, 488nm laser diode, 458nm/488nm beam splitter and a 34-channel spectral 
detector, which was used to divert fluorescence between 500nm and 650nm to a 
photomultiplier tube detector. Bright field images were obtained simultaneously with 
the fluorescence images by detecting the transmitted excitation laser light with a 
second photomultiplier detector [293]. 
4.3.15 Statistical analysis 
It is desired to ascertain whether cell proliferation occurs within the MTT and Hoechst 
assays. The standard method in the literature is to investigate the variance between and 
within days 1 and 7 with an analysis of variance (ANOVA) test, for example [294]. A 
one-way ANOVA was performed, where statistical significance is tested for by 
comparing the ratio of variance between days 1 and 7 and the variance within days 1 
and 7 to the F-distribution. 
A modified ANOVA test was also used in this thesis (Appendix A). Instead of 
calculating variance from the mean of day 1 and day 7, linear regression was 
performed for either days 1 – 3 or alternatively days 1 – 5. Thus the variances were 
calculated from the straight line fit and the lag cell growth phase was effectively 
stripped back from the experimental data. It is important to note that since experiment 
error was random it was therefore assumed that measurements are normally distributed 
about the true cell number. 
The F ratios calculated via ANOVA and modified ANOVA analyses were compared 
with critical F values (Fcrit) to determine any statistical significance. The level of 
significance was set at p < 0.05 (Table 4.2) 
 
Table 4.2: Fcrit values for data sets collected for MTT and Hoechst assays 
fb = between group degrees of freedom,  fw = within group degrees of freedom 
Assay Fcrit(fb, fw) Fcrit value (p < 0.05) 
MTT Fcrit(1, 10) 4.965 
Hoechst Fcrit(1, 4) 7.709 
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4.4 Results 
4.4.1 Development of solution pH 
Monitoring the uncontrolled reaction of Ca(NO3)2·4H2O (0.05M) and (NH4)2HPO4 
(0.03M) at RT demonstrated the acidity of the starting solution containing Ca and the 
final suspension (Figure 4.3). A summary of the solution pH at key reaction stages is 
presented in Table 4.3 for samples AP07 – AP12. 
 
Figure 4.3: Uncontrolled reaction of Ca(NO3)2·4H2O and (NH4)2HPO4 at RT 
 
 
Table 4.3: Development of solution pH 
Sample 
Solution pH 
Start of 
addition 
End of 
addition 
Removal from 
mother solution 
AP07 10.03 9.14 5.60 
AP08 11.00 10.72 10.94 
AP09 11.05 10.99 10.78 
AP10 10.00 10.00 9.87 
AP11 11.10 11.01 10.95 
AP12 11.01 11.00 10.38 
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4.4.2 Crystal structure 
Formation of HA was indicated in samples AP07 – AP12 by the characteristic peak 
occurring at 2θ = 31.77° and verified by matching to the JCPDS pattern for HA (09-
432). AP07 exhibited a higher intensity between 2θ = 28 – 30°, which suggests a trace 
amount of DCPD (09-0077) (Figure 4.4). The influence of temperature and solute 
concentration is shown in Figure 4.5 with AP09 depicted as a reference. 
The different 2θ positions of characteristic peaks observed for samples produced at a 
starting pH < 10 (AP05 and AP06) were matched to reference patterns for DCPD (09-
0077) and DCPA (09-0080) (Figure 4.6). 
 
Figure 4.4: Influence of pH value (>10) and control on crystal structure of as-synthesised HA 
(a) AP07, (b) AP10, (c) AP08, and (d) AP09 
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Figure 4.5: Influence of solute concentration and temperature on crystal structure of as-
synthesised HA (a) AP09, (b) AP11, and (c) AP12 
 
 
Figure 4.6: Influence of pH on CaP phase formation of as-synthesised (a) AP05, and (b) AP06 
 
Formation of β-calcium pyrophosphate (β-Ca2P2O7) is known to occur between 250 
and 700°C according to Equation 2.4 if any HPO4
2-
 is present, i.e. CDHA. However, 
XRD patterns of samples AP07 – AP10 heated to 600°C did not demonstrate any β-
Ca2P2O7 (09-346) formation, which suggests no or trace amounts of non-apatitic 
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HPO4
2-
 in as-synthesised materials (Figure 4.7) nor did AP11 – AP12 (Figure 4.8). 
Notably, detection of β-Ca2P2O7 was difficult due to the superposition of its peaks with 
HA ones. 
 
Figure 4.7: Influence of pH on the crystal structure of HA heated to 600°C 
(a) AP07, (b) AP10, (c) AP08, and (d) AP09 
 
XRD analysis of samples heated to 900°C confirmed the presence of β-TCP. This 
phase is known to form between 700 and 800°C from P2O7
4-
, as a by-product of the 
condensation of HPO4
2-
 (Figure 4.9). The intensity of characteristic β-TCP peaks were 
significantly less and characteristic HA peaks were of a relatively higher intensity in 
AP07 as well as AP12 compared with other samples. A noticeable peak attributed to 
β-Ca2P2O7 at 28.9° was also observed in these samples. 
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Figure 4.8: Influence of solute concentration and temperature on the crystal structure of HA 
heated to 600°C (a) AP09, (b) AP11, and (c) AP12 
 
 
Figure 4.9: XRD patterns of (a) AP07, (b) AP10, (c) AP08, and (d) AP09 heated to 900°C 
 
Line broadening analysis indicated no discernible increase in crystallite size between 
as-synthesised and powders heated to 600°C (Table 4.4). Heating to 900°C resulted in 
a significant increase in crystallite size of more than 200%. Equation 4.1 could not be 
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applied to as-synthesised powders since the hollow between the (112) (32.196°) and 
(300) (32.902°) peaks was not observed (Figures 4.4 and 4.5). XRD patterns of 
samples heated at 600°C demonstrate the hollow between the peaks of interest in 
samples AP07 and AP12 suggesting an increase in crystallinity. 
4.4.3 Molecular structure 
The samples with XRD patterns matching with HA (AP07 – AP12) were further 
analysed by FTIR and the major band assignments for HA and CHA are summarised 
in Table 4.5. OH
-
 and absorbed H2O bands between 2500 and 3750cm
-1
 were very 
weak in all samples and this is suggested to be due to the relatively short ageing time, 
1.5hrs (Figures 4.10 and 4.11). A weak band at approximately 875cm
-1 
was observed 
in all samples, which has been reported to correspond to CO3
-
. However, this 
attribution was made here since no introduction of carbonate was made during 
synthesis. Instead, this peak was assigned to HPO4
2-
, which can be incorporated into 
non-stoichiometric HA, i.e. CDHA.  
 
Table 4.4: Influence of pH, temperature, and solute concentration on phase and XRD peak 
broadening 
Sample 
Calcination 
temperature (°C) 
XRD peaks 
matched to 
Crystallite 
size (nm) 
AP05 
As-synthesised DCPD, DCPA 
83 
AP06 80 
AP07 
As-synthesised 
HA 
24 
600 27 
900 
HA, β-Ca2P2O7, 
β-TCP 
54 
AP08 
As-synthesised 
HA 
21 
600 23 
900 HA, β-TCP 64 
AP09 
As-synthesised 
HA 
20 
600 24 
900 HA, β-TCP 63 
AP10 
As-synthesised 
HA 
22 
600 22 
900 HA, β-TCP 65 
AP11 
As-synthesised 
HA 
22 
600 23 
900 HA, β-TCP 83 
AP12 
As-synthesised 
HA 
21 
600 24 
900 
HA, β-Ca2P2O7, 
β-TCP 
45 
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Notably, peaks within the region of 1300 – 1600cm-1 were exhibited in AP07, which 
could be misinterpreted as CO3
- 
but due to the previous explanation this peak was 
attributed to PO stretch associated with DCPD [295]. 
 
Table 4.5: IR band assignments reported for HA and CHA [296, 297] 
Assignments Reported vibrational  
frequencies (cm
-1
) 
PO4 bend (ν4) 566, 574, 600-604 
Structural OH 632-635, 3565-3571 
CO3
- 
group 873-875 
PO4 stretch (ν1) 961-963 
PO4 bend (ν3) 1030-1038, 1090-1098 
CO3
-
 group (ν3) 1418-1420, 1480-1487 
Absorbed H2O 1635-1640, 2500-3750 
Soluble CO2 (ν3) 2331-2335, 2360 
 
 
Figure 4.10: Influence of pH on FTIR spectra (a) AP07, (b) AP10, (c) AP08, and (d) AP09 
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Figure 4.11: Influence of temperature and solute concentration on FTIR spectra 
(a) AP09, (b) AP11, and (c) AP12 
 
FTIR analysis of samples AP07 – AP10 heated to 600°C revealed the disappearance of 
the band at 875cm
-1 
attributed to HPO4
2-
 (Figure 4.12). There is no evidence of 
structural OH
- 
bands between 2500 and 3750cm
-1 
in all samples and at 635cm
-1
 in 
AP08 – AP10. In contrast, a band at 635cm-1 was present in spectra for AP07. 
 
Figure 4.12: FTIR spectra of powders heated to 600°C 
(a) AP07, (b) AP10, (c) AP08, and (d) AP09 
 
IR spectra of samples AP11 and AP12 demonstrated a difference in intensity and 
broadening of PO4
3-
 bands (Figure 4.13). 
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Figure 4.13: FTIR spectra of powders heated to 600°C (a) AP09, (b) AP11, and (c) AP12 
 
AP07 – AP10 exhibited IR spectra typical of β-TCP when heated to 900°C (Figure 
4.14). The appearance of the peak at approximately 3700cm
-1
 is associated with O-H 
stretching within HA and this band was notably absent for the sample AP07. 
 
 
Figure 4.14: FTIR spectra of powders heated to 900°C 
(a) AP07, (b) AP10, (c) AP08, and (d) AP09 
 
4.4.4 Microstructural development  
SEM micrographs revealed the polygonal morphology of particles of AP05 and AP06 
compared with the typically globular morphology of all other samples (Figure 4.15). 
This difference was attributed to the phase change exhibited in these samples by XRD 
analysis (Figure 4.6).  
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Figure 4.15: Influence of pH, temperature, and solute concentration on typical particle 
morphology (a) AP05, (b) AP06, (c) AP07, (d) AP08, (e) AP09, (f) AP10, (g) AP11, and (h) AP12 
 
Bulk agglomeration occurred and a significant decrease in particle size was observed 
for samples AP07 – AP12 compared with AP05 – AP06 (Table 4.7). TEM 
micrographs revealed a needle-like morphology of AP07 crystallites with an average 
length and width of 32.8±10.1nm and 5.7±1.2nm, respectively (Figure 4.16)  
Chapter 4: Precipitation of hydroxyapatite – influence of reaction conditions 
113 
 
Table 4.6: Influence of pH, temperature, and solute concentration on average particle and 
agglomerate size (n=3) 
Sample 
Average Size (μm) 
Particles Agglomerates 
AP05 12.7±0.8 17.9±3.4 
AP06 15.6±7.7 21.2±3.0 
AP07 2.1±0.8 38.4±2.6 
AP08 3.2±1.0 34.2±2.4 
AP09 2.7±0.5 24.6±4.3 
AP10 4.0±1.7 35.5±6.9 
AP11 3.6±0.6 31.7±4.2 
AP12 7.6±1.9 31.7±2.9 
 
 
Figure 4.16: Typical crystallite morphology of (a) AP07 100nm scale bar, and (b) AP07 20nm 
scale bar observed by TEM 
 
4.4.5 Thermal behaviour 
Samples AP07 – AP12 were analysed by simultaneous DTA-TGA between 30 and 
1300°C. Differentiation of TGA data (DTG) enabled distinctive regions of weight loss 
to be identified and attributed to previously reported reactions (Table 4.7). Figures 
4.17 – 4.20 demonstrate the different combinations of DTG peaks exhibited, which 
were attributed to loss of water due to the occurrence of the reactions described by 
Equations 2.4 and 2.5. 
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Table 4.7: Summary of DTG analysis 
Temperature 
region (°C) 
Peak 
/gradual 
DTA peak 
Present in 
samples 
Attribution 
30 – 200 Peak 
Endothermic 
AP07 – AP12 N/A 
200 – 300 Peak AP07, AP10 
Dehydration of DCPD 
to DCPA and 
subsequent 
condensation to P2O7
4-
 
(Equations 2.3 and 2.4) 
250 – 700 
Gradual 
No peak 
observed 
AP08, AP09, 
AP11, AP12 
Dehydration of HPO4
2- 
 
in CDHA to P2O7
4-
 
(Equation 2.4) 
300 – 700 AP07, AP10 
Dehydration of HPO4
2- 
 
to P2O7
4-
 (Equation 2.4) 
700 – 800 Peak Endothermic AP08 – AP11 
Reaction of β-Ca2P2O7 
(see above) and HA to 
form β-TCP (Equation 
2.5) 
 
 
Figure 4.17: Thermal behaviour of AP07 
(DTA = dashed red line, TGA = solid black line, DTG = solid blue line) 
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Figure 4.18: Thermal behaviour of AP09 
(DTA = dashed red line, TGA = solid black line, DTG = solid blue line) 
 
Figure 4.19: Thermal behaviour of AP10 
(DTA = dashed red line, TGA = solid black line, DTG = solid blue line)  
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Figure 4.20: Thermal behaviour of AP12 
(DTA = dashed red line, TGA = solid black line, DTG = solid blue line) 
 
The amount of water loss within temperature regions associated with the reactions 
described by Equations 2.3 – 2.5 was determined by integrating the DTG curve with 
respect to temperature (Table 4.8). These results were used in combination with 
Equations 2.3 – 2.5 to determine the amount of non-apatitic HPO4
2-
 and P2O7
4-
 sourced 
from DCPD or CDHA, and the amount of HA and TCP residue at 800°C (Table 4.9). 
 
Table 4.8: Influence of pH, temperature, and solute concentration on the amount of water lost 
between temperature regions associated with Equations 2.3 – 2.5 
a
temperature region adjusted to 300 – 700°C, bpeak area between 700 to 800°C analysed, and 
c
no DTG peak identified 
 
Temperature 
region 
Water loss (wt%) 
AP07 AP08 AP09 AP10 AP11 AP12 
200 – 300 8.67 N/A 2.81 N/A 
250 – 700 4.07a 2.40 1.98 3.73a 2.26 0.48 
700 – 800b 0.59c 0.77 0.71 0.91 0.68 0.02c 
30 – 800 17.78 8.45 8.26 12.90 8.71 4.94 
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Table 4.9: Influence of pH, temperature, and solute concentration on chemical composition calculated from DTG analysis using Equations 2.3 – 2.5 
a
temperature region adjusted to 300 – 700°C, bpeak area between 700 to 800°C analysed
Temperature region 
(°C) 
Ion/phase Source 
Weight (wt%) 
AP07 AP08 AP09 AP10 AP11 AP12 
200 – 300 HPO4
2-
 DCPD 18.48 N/A N/A 5.99 N/A N/A 
250 – 700 
HPO4
2-
 
CDHA 
43.37
a 
25.62 21.09 39.74
a
 24.08 5.12 
P2O7
4-
 39.30 23.21 19.11 36.01 21.82 4.64 
700 – 800b 
P2O7
4-
 5.67 7.42 6.82 8.75 6.54 0.21 
TCP 30.35 39.72 36.46 46.82 35.00 1.12 
HA 51.87 51.83 55.27 40.28 56.29 93.93 
HA + TCP residue (mg) 8.20 11.47 8.49 13.28 11.59 8.40 
TGA residue at 800°C 8.20 11.47 8.49 13.28 11.59 8.40 
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4.4.6 Elemental analysis 
The influence of pH on the Ca:P ratio of samples AP07 – AP10 was determined by 
EDS and XRF (Table 4.10). EDS results indicate a non-stoichiometric Ca:P ratio and 
suggest samples are calcium-rich HA. In contrast XRF data suggests samples are 
CDHA. 
 
Table 4.10: Infleunce of pH on Ca:P ratio calculated from EDS and XRF analysis 
Sample Ca:P ratio calculated from EDS Ca:P ratio calculated from XRF 
AP07 2.03±0.02 1.66 
AP08 2.16±0.04 1.56 
AP09 2.17±0.03 1.52 
AP10 2.11±0.02 1.57 
 
4.4.7 Surface area 
The surface area of AP07 was found to be significantly lower than samples AP08 – 
AP12. Furthermore, AP12 was observed to be significantly higher than all other 
samples (Table 4.11). 
 
Table 4.11: Influence of pH, temperature and solute concentration on the surface area of as-
synthesised powders 
Sample Surface area (m
2
/g) 
AP07 72.7±0.1 
AP08 100±0.2 
AP09 106.7±0.2 
AP10 104.1±0.2 
AP11 111.1±0.2 
AP12 132.3±0.7 
 
4.4.8 Surface charge 
The ZP of as-synthesised samples AP07 – AP10, and AP12 were measured in DI 
water (Table 4.12). A positive ZP was observed as a result of a relatively low 
uncontrolled pH value during addition of the PO4 solution (AP07) and an increase in 
reaction temperature (AP12). Due to the influence of surface charge on cell adhesion 
the difference in the sign of ZP recorded for AP07 and AP12 is expected to alter the 
relative morphology of any adhering cells. 
Samples AP07 and AP09 were dispersed in cell culture medium (DMEM) and ZP was 
measured every 30mins over a 60hr period, and after approximately 7 days (Figure 
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4.21). Over the initial 60hrs no significant difference in ZP was observed. However, 
after 7 days AP07 was shown to exhibit a less negative ZP value compared with AP09. 
Linear regression of data demonstrated the same value for gradient but opposite sign, 
i.e. ZP measurements were increasingly less negative for AP07 and more negative for 
AP09 over time. 
 
Table 4.12: Influence of pH, temperature, and solute concentration on ZP of as-synthesised 
particles measured in DI water at 25°C 
Sample ZP (mV) 
AP07 0.525 
AP08 -16.8 
AP09 -21.3 
AP10 -19.1 
AP12 2.98 
 
 
Figure 4.21: ZP measurements over time for samples AP07 and AP09 in DMEM at 37°C 
 
4.4.9 SBF test 
Prior to immersion in SBF (i.e. day 0) the surface of pellets formed by pressing 
powders was visualised by SEM (Figure 4.22) and the surface roughness characterised 
quantitatively by white light interferometry (Figure 4.23). AP07, AP08, and AP12 
were observed to exhibit a lower surface roughness at day 0 compared with other 
samples. A peak in the degree of surface roughness was observed at day 7 or 14. 
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Figure 4.22: Pellet surface prior to immersion in SBF visualised by SEM 
(a) AP07, (b) AP08, (c) AP09, (d) AP10, (e) AP11, and (f) AP12 
 
 
Figure 4.23: Surface roughness (Ra) of pellets immersed in SBF for up to 28 days 
 
SEM images of pellets immersed in SBF demonstrated the growth of a layer on the 
surface of pellets from day 7 (Figure 4.24 a – dotted blue circle). Typically needle-like 
particles were observed within this coating (Figure 4.24 b – solid purple circle). After 
immersion in SBF all samples were shown to exhibit some degradation as indicated by 
the presence of globular fragments on the surface of substrates (Figure 4.24 a – dashed 
red circle), which are suggested to alter surface roughness. 
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Figure 4.24: Typical morphology of surface apatite (a) AP10 day 7 (dotted blue circle = apatite 
layer, dashed red circle = pellet surface), and (b) AP12 day 14 (solid purple circle = needle-like 
morphology of apatite) 
 
4.4.10 Live/dead assay 
Fluorescence micrographs demonstrated the viability (green) of MC3T3 osteoblast 
precursor cells seeded on samples AP08 – AP11 from days 1 – 7 (Figure 4.25). The 
extent of dead cells (red) observed were minimal and therefore can be associated to the 
preparation method. The density of live cells on these samples was clearly shown to 
increase over time and the typical morphology changed from rounded (day 1) to 
elongated (day 7). These factors are all conducive to the conclusion that these 
substrates are cytocompatible with osteoblast cells, and support adhesion, spreading, 
and proliferation. 
In contrast, a higher number of cells was observed to be non-viable on AP12 at day 1 
and from day 3 onwards the vast majority of osteoblasts were non-viable. The 
morphology of seeded osteoblasts was found to be rounded, which is typical of 
apoptotic cells (Figure 4.25). Seeding of cells on AP07 was revealed to result in the 
death of the cell population at day 1, indicating the cytotoxic effect of this sample on 
MC3T3 cells. Therefore AP07 was not included in further cell culture studies. 
4.4.11 MTT assay 
The metabolic activity of live MC3T3 cells seeded on to substrates and tissue culture 
plastic (TP) was quantitatively measured by MTT assay (Figure 4.26). Results suggest 
that the control of pH (AP09 – AP11) compared with adjustment (AP08) greatly 
improves the ability of HA substrates to support osteoblast proliferation over the 
culture period (Table 4.13). However, it seems that this marked effect is dominated by 
the influence of an increase in synthesis temperature (AP12). An increase in solute 
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concentration enhanced the relative proliferative rate and the number of metabolically 
active cells seeded on AP11, which was notably higher at days 5 and 7 compared with 
other samples. In contrast, a marked reduction was observed at days 5 and 7 for AP12 
compared with other samples prepared under controlled or adjusted pH conditions. 
 
Figure 4.25: Influence of pH, temperature, and solute concentration on the viability of MC3T3 
osteoblast precursor cells seeded on substrates (green = live, red = dead) 
 
ANOVA analysis revealed that osteoblasts seeded on substrates and TP exhibited a 
significant increase in the number of metabolically active cells at day 7 compared with 
day 1 (Table 4.14). Analysis of significance via the modified ANOVA method was not 
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conducted on AP08 using a linear trend from days 1 – 3 because regression lines 
exhibited a negative gradient. In contrast to the standard test, statistical significance 
was not demonstrated using the modified ANOVA test for AP10 or AP12 at day 7 
using either trend line. No samples were revealed to exhibit a significant increase in 
metabolic activity at day 5 compared with day 1 (Table 4.14). 
 
Figure 4.26: Influence of pH, temperature, and solute concentration on the metabolic activity of 
MC3T3 cells 
 
 
Table 4.13: Influence of pH, temperature, and solute concentration on the proliferative rate of 
MC3T3 cells assessed by MTT assay between 1 and 7 days 
Sample Proliferative rate (%) 
AP08 46.3 
AP09 82.8 
AP10 68.7 
AP11 140.7 
AP12 11.9 
TP 279.2 
  
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1.1
1.2
1 3 5 7
A
v
er
a
g
e 
A
b
so
rb
a
n
ce
 
Culture Time (days)  
AP08
AP09
AP10
AP11
AP12
TP
Chapter 4: Precipitation of hydroxyapatite – influence of reaction conditions 
124 
 
Table 4.14: Statistical analysis of MTT assay samples AP08 – AP12 
Fcrit=4.965 when p<0.05, * = statistically significant 
Sample 
ANOVA test Modified ANOVA test 
Day 7 F ratio 
Day 7 F ratio Day 5 F ratio 
Trend 1-3 Trend 1-5 Trend 1-3 
AP08 50.215* N/A 0.632 N/A 
AP09 96.317* 7.237* 6.842* 0.212 
AP10 44.015* 2.935 3.662 -0.704 
AP11 1043.828* 12.817* 10.697* 0.217 
AP12 40.316* 4.481 2.428 1.679 
TP 767.697* -18.333 -5.764 -2.765 
 
4.4.12 Hoechst assay 
An increase in the average fluorescence measured using a Hoechst 33258 dye that 
stains DNA was observed for MC3T3 precursor osteoblasts seeded on samples AP08 – 
AP11 between day 1 and 7 of culture, which corresponds to an increase in cell number 
and indicates that these substrates support proliferation (Figure 4.27). AP08 
demonstrated a significantly lower proliferative rate compared with AP09 – AP11 
(Table 4.15), which may be due to the large experimental variation as indicated by the 
standard deviation error bars (Figure 4.27). The cell number observed at day 7 for 
AP10 was shown to be significantly higher compared with other HA substrates. In 
contrast to other specimens, results indicate that AP12 did not support proliferation 
since a decrease in cell number was observed at day 7 compared with day 1. 
 
Figure 4.27: Proliferation of MC3T3 cells on substrates prepared under different pH, solute 
concentration, and temperatures assessed by Hoechst assay   
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Table 4.15: Influence of pH, temperature, and solute concentration on the proliferative rate of 
MC3T3 cells assessed by Hoechst assay between 1 and 7 days 
Sample 
Proliferative rate (%) 
Day 1-7 
AP08 42.3 
AP09 431.4 
AP10 626.0 
AP11 256.0 
AP12 -21.5 
TP 477.2 
 
ANOVA testing revealed statistically significant growth between days 1 and 7 for all 
samples except AP08 (Table 4.16) and this is attributed to the large variation in 
experimental data (Figure 4.27). The modified ANOVA method distinguished AP12 
as non-significant and the calculated negative F ratios reflect the decrease in cell 
number between days 1 – 5, and 1 – 3. F ratios calculated for day 5 using the modified 
ANOVA method did not indicate any statistically significant differences compared 
with day 1 data, suggesting that the exponential cell growth phase occurs after day 5. 
The negative values obtained for AP08 and AP11 indicate that the experimental cell 
number at day 5 was less than the projected value, calculated linearly from day 1 and 3 
data. These observations suggest that the lag cell growth phase occurs up to day 5 
(Appendix A). 
 
Table 4.16: Statistical analysis of Hoechst assay 
Fcrit=7.709, where p<0.05, * = statistically significant 
Sample 
ANOVA test Modified ANOVA test 
Day 7 F ratio 
Day 7 F ratio Day 5 F ratio 
Trend 1-3 Trend 1-5 Trend 1-3 
AP08 2.887 4.896 7.654 -2.237 
AP09 106.892* 14.895* 12.780* 0.508 
AP10 507.364* 25.684* 15.947* 0.557 
AP11 102.197* 8.855* 11.667* -2.011 
AP12 11.822* -0.786 -0.547 0.297 
TP 14.656* -2.927 -1.299 -1.253 
 
4.4.13 Cellular internalisation 
Combined bright field and confocal fluorescence images of MC3T3 cells exposed to 
AP07 – AP10 powders for 24hrs revealed the internalisation of particles (Figure 4.28). 
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Aggregation of internalised AP07 and AP08 particles was detected in multiple cells 
and the typical morphology of osteoblasts was more rounded compared to elongated 
MC3T3 cells containing AP09 and AP10. 
 
Figure 4.28: Combined bright field and fluorescence images of MC3T3 cells exposed to particle of 
(a – c) AP07, (d – f) AP08, (g – i) AP09, and (j – l) AP10. Images in columns 1 and 2 are slices 
from a confocal z stack taken through the middle of the cell, and column 3 at the top of the cell  
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4.5 Discussion 
The attributions made from DTA-TGA analysis revealed a number of endothermic 
weight loss regions, which were ascribed to the chemical reactions described by 
Equations 2.3 – 2.5 (Table 4.7). Notably, for samples AP07 and AP10, which were 
both prepared at pH 10, a rapid endothermic loss of weight between 200 and 300°C 
was demonstrated by DTG and upon closer inspection it appears that the onset of this 
peak begins at approximately 175°C. Thus these losses were attributed to the 
dehydration of DCPD to DCPA and subsequent condensation to β-Ca2P2O7, which 
have been reported to occur at 180°C and 320 – 340°C, respectively [217]. Despite 
these water losses inferring 18 and 6% content of non-apatitic HPO4
2- 
ions due to 
DCPD within AP07 and AP10 (Table 4.9), respectively no obvious traces of this phase 
were identified in XRD patterns of as-synthesised samples (Figure 4.4). A trace 
amount of DCPD appeared to be present in AP07 but due to the close proximity to 
characteristic HA peaks this attribution cannot be made with confidence. In contrast, 
noticeable peaks in IR spectra, previously associated with DCPD [295], were observed 
in AP07 but not for AP10 (Figure 4.10). At the lowest pH recorded during 
precipitation of AP07 (5.60) the solubility of HA and DCPD are relatively close 
(Figure 2.7), hence it is plausible that this secondary phase could form. Since it is 
likely that FTIR would detect the HPO4
2-
 concentration attributed to dehydration of 
DCPD calculated for AP10 (6%) this suggests AP07 and AP10 were formed via 
different mechanisms, which is likely due to the observed differences in pH 
development (Table 4.3). When comparing the DTG plots the major variance between 
these two samples is the absence of a DTG peak between 700 and 800°C for AP07. 
Elliott reported that CDHA prepared via the hydrolysis of DCPA would demonstrate 
weight loss between 250 – 300°C [17]. The combination of weight loss within this 
region and between 700 – 800°C as well as no presence of DCPD in FTIR or XRD 
patterns suggests AP10 is a CDHA formed via an intermediate DCPA phase. It has 
been reported that unstable precursor phases can form prior to HA and the 
composition of this phase is dependent on pH [196-199]. However, the solubility 
isotherms for different CaP phases (Figure 2.7) validates that HA is the most stable 
phase over the bulk solution pH range (9.83 – 10.09) recorded during the precipitation 
of AP10, and formation of DCPA under these conditions is unlikely. It should 
however be noted that local pH (i.e. the pH at nucleation sites) might not be equal to 
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the measured bulk value due to the vast potential number of different ionic species 
present within the solution. Thus it is plausible that final crystallites of AP10 formed 
via a transitional DCPA phase. 
Interestingly, AP12 did not exhibit DTG peaks between either 200 – 300°C or 700 – 
800°C, which explains the calculated lower weight loss (Table 4.8). According to 
Equations 2.3 – 2.5 these observations infer under these conditions that precipitates do 
not contain DCPD, form via an intermediate DCPA phase or contain large amounts of 
non-apatitic HPO4
2-
. XRD analysis revealed no presence of secondary phases up to 
600°C and notably, compared with AP09 and AP11, (112) and (300) HA peaks were 
not superimposed when samples were heated to 600°C. Since this was not 
accompanied with a significant change in the broadening of the (200) peak (i.e. a 
change in crystallite size) this observation suggests a relatively higher crystalline 
fraction in AP12. Since no DTG peak was shown between 700 – 800°C for either 
AP07 or AP12 and β-Ca2P2O7 was detected in XRD patterns of samples heated to 
900°C this suggests that the reaction represented by Equation 2.5 was uncompleted or 
did not occur. In the case of AP12 is it likely this phase transformation did not take 
place since a relatively low content of non-apatitic HPO4
2-
 was calculated from 
thermal analysis (Table 4.9) Therefore it is suggested that AP12 exhibits a Ca:P ratio 
closer to stoichiometric HA compared to CDHA samples prepared at lower 
temperatures under the same pH conditions, for example AP09. 
AP08 and AP09 were both prepared at pH 11 and exhibited DTG peaks within the 
same temperature regions, <250°C and 700 – 800°C, with a gradual weight loss 
observed between (Figure 4.18). The absence of rapid weight loss between 200 – 
300°C infers neither sample contains DCPD or formed via a DCPA transition phase. 
XRD and FTIR results support these assertions since no secondary phases were 
identified in as-synthesised or heated (600°C) HA powders. FTIR bands associated 
with non-apatitic HPO4
2- 
were detected in as-synthesised samples and the intensity of 
PO4
3-
 and apatitic OH
-
 peaks were sharper and more intense in heated (600 and 900°C) 
AP09 compared with AP08. These observations along with the lower weight loss 
recorded by TGA indicate AP09 is more crystalline and/or contains less HPO4
2-
 than 
AP08. Thus, the analysis of samples AP05 – AP10 by XRD, FTIR, and DTA-TGA 
indicate that it is not merely the starting value of pH that determines the precipitated 
CaP phase but also stoichiometry is affected by the development of pH throughout 
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synthesis. Control of pH at 10 during addition led to a reduction in the formation of 
other phases as evidenced by the comparison of AP07 and AP10, and control of pH at 
11 resulted in a lower non-apatitic HPO4
2-
 content. This is explained in terms of the 
sensitivity of ionic species (e.g. Figure 2.10), and the ranging solubility of CaP phases 
according to pH (Figure 2.7). 
The influence of doubling the concentration of initial Ca (0.1M) and PO4 (0.06M) 
reagents was also considered (AP11). As-synthesised AP09 and AP11 exhibited XRD 
patterns typical of precipitated HA. No discernible difference was observed in the 
degree of XRD peak broadening between as-synthesised and heated AP09 and AP11 
specimens, indicating a similar nanosized crystallite and crystalline fraction. A band at 
875cm
-1
 was detected in FTIR spectra of as-synthesised AP09 and AP11, which was 
attributed to HPO4
2-
 content, indicating the samples contain CDHA. In comparison to 
AP09, typical PO4
3-
 and OH
-
 bands in AP11 heated to 600°C were noticeably broader 
and less intense. Differences in the broadening infer a variation in the number and 
strength of intermolecular interactions and this is common in any sample containing 
hydrogen bonding. Weaker intermolecular interactions translate to a lower number of 
chemical environments and narrower IR bands. Hence these spectra suggest stronger 
or a higher number of PO4
3-
 and OH
- 
interactions within AP11 and this may be linked 
to the higher content of HPO4
2-
 calculated from TGA analysis (Table 4.9). Since no 
discernible difference was observed in the size of crystallites it is suggested both 
reactions generated the same amount of nucleation sites. Therefore the variation in 
non-apatitic content at a higher solute concentration can be attributed to the solution 
becoming closer to the relative supersaturation levels of both HPO4
2-
 and PO4
3-
 (e.g. 
Figure 2.10). 
Samples AP07 – AP12 exhibited rapid weight loss below 200°C (DTG) and this is 
attributed to loss of absorbed water since DTA analysis revealed a corresponding 
endotherm. However, FTIR results contradict this attribution due to the absence of 
bands associated with unbonded OH
-
. It has been proposed that the surface of freshly 
precipitated apatites comprises of a non-apatitic hydrated layer containing a number of 
relatively mobile ionic species, which is responsible for the high reactivity of 
nanocrystalline apatites [2, 58]. Since no change in the crystal or molecular structure 
was observed at 600°C for samples that exhibited a single DTG peak below this 
temperature at less than 200°C (AP08, AP09, AP11, and AP12) this weight loss is 
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associated with the removal of water from the hydrated layer [11, 58]. This structural 
model and the relatively short ageing time (1.5hrs) clarify the high degree of 
broadening exhibited in XRD patterns, the presence of non-apatitic HPO4
2- 
(i.e. a non-
stoichiometric Ca:P ratio) and the absence of OH
-
 bands in FTIR spectra [59]. 
A marked difference in the morphology of particles prepared below pH 10 was 
associated with the phase change confirmed by XRD (Figure 4.6). No significant 
difference in particle morphology was observed by SEM between samples AP07 – 
AP12. Increase in the size of agglomerates for AP07 – AP12 compared with AP05 and 
AP06 is attributed to the higher energy associated with smaller crystallites (Table 4.4). 
Needle-like morphology has been reported within the literature for precipitated HA 
crystallites and is synonymous to apatite crystals found in hard tissues, including bone 
[191, 298]. Despite not being stoichiometric HA, TEM micrographs of AP07 (Figure 
4.16) demonstrated this typical morphology and illustrated crystallites within the 
nanoregime, which correlates with the line broadening analysis that confirmed 
nanosized crystallites for all sample (Table 4.4). Evidently, nanosized crystallites can 
enhance the proliferation and adhesion of bone cells and therefore the ability to 
precipitate nHA is considered advantageous [8, 9]. 
Due to the inevitable agglomeration associated with wet preparation methods typical 
surface areas exhibited for HA are reported to be between 20 and 60m
2
/g [299]. In 
comparison, the surface areas of samples presented in this thesis are notably higher 
(Table 4.11). Variation between samples is attributed to the influence of pH (AP07), 
solute concentration (AP11), and temperature (AP12) on solution supersaturation, 
which determines the number of nucleation sites. Specifically higher pH, solute 
concentration, or temperature leads to faster stabilisation since relative supersaturation 
is increased and therefore smaller crystallites are formed, which corresponds to a 
larger surface area. Partial evaporation of water due to a higher synthesis temperature 
of 70°C appears to have the most marked effect on supersaturation since AP12 
exhibited the largest surface area (Table 4.11). It is promising that all samples had a 
relatively high surface area since this will improve sintering kinetics and subsequently 
increase the mechanical properties of scaffolds fabricated from such materials [13]. It 
is also advocated that these samples are likely to enhance osteointegration and 
osteoconduction since a higher surface area provides more fixation points for 
osteoblasts to adhere [108, 109]. 
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CaPs present a challenge for elemental X-ray analysis due to the high absorption of 
low energy X-rays in the HA matrix, highlighting the importance of an accurate 
absorption correction and the potential sensitivity of spectra to roughness effects 
[300]. SEM micrographs and the relatively high surface area exhibited by samples 
infer a high surface roughness. This may explain why EDS measurements of Ca:P 
ratios are substantially higher than what is advocated by FTIR and DTA-TGA 
analysis, since these results suggest powders are CDHA, i.e. Ca:P ratio < 1.67. In 
contrast, XRF analysis which was performed on pressed pellets with wax, revealed 
Ca:P ratios consistent with other characterisation methods that indicate all samples are 
CDHA. This explains the presence of β-TCP in samples AP08 – AP10 after heating 
(Figure 4.9). AP07 was shown to exhibit a ratio close to stoichiometry, 1.66, which 
complements XRD and DTA-TGA analysis that revealed a relatively lower β-TCP 
content. 
Notably, the ZP of as-synthesised samples was negative, except for AP07 and AP12 
(Table 4.12). The change in sign confirms the acidity of AP07, which is attributed to 
the presence of DCPD within this sample. Interestingly a positive ZP was also 
recorded for as-synthesised AP12 but no secondary phases were detected by XRD or 
FTIR. This suggests an excess of Ca
2+
 or H
+
, which is explained in terms of an 
increase in the concentration of calcium per unit volume due to increased evaporation 
of water at a higher synthesis temperature of 70°C. This may have resulted in the 
solution approaching supersaturation of additional cationic species, such as [CaOH]
+
 
or [CaH2PO4]
+
. Analysis of the ZP of AP07 and AP09 in DMEM revealed a negative 
value over a 60hr period, which is explained by the buffering effect of ionic salts 
within the culture medium. However, a positive trend (i.e. decreasing negative value) 
for AP07 indicates a reduction in colloidal stability over time. This is attributed to the 
aforementioned acidity of this sample due to the presence of DCPD. 
SBF testing was used as a prerequisite to cell culture and in the authors opinion the 
needle-like morphology of the observed surface coating (Figure 4.24) demonstrates a 
positive result of bioactivity since it is typical of apatite grown in SBF [301]. In an 
effort to distinguish between the degree of apatite precipitation, the surface roughness 
of pellets was measured using white light interferometry. Average roughness was 
shown to peak between 7 and 14 days, which was not expected since a surface coating 
was observed on samples up to day 28. Therefore suggesting measurements of surface 
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roughness do not directly infer the degree of apatite precipitation. This is explained by 
the dissolution of pellets over the test period, as well as the sensitivity and variability 
of the SBF solution to any changes in the concentration of ionic species, in particular 
those containing Ca. Thus, no conclusions can be drawn with certainty from 
interferometry analysis. 
XRD, FTIR, DTA-TGA, XRF and ZP results highlighted a number of distinctive 
differences in the composition of samples. It was expected that these variations would 
influence the interaction of cells with the prepared substrates but it was not expected 
that AP07 and AP12 would be cytotoxic.  Since cells were only found to be non-viable 
on AP07 at day 1 the source of cytotoxicity is likely to be due to the presence of acidic 
DCPD, which was identified by FTIR, DTA-TGA, and ZP measurements. In contrast, 
no DCPD or any other secondary phases were identified by XRD, FTIR or DTA-TGA 
in AP12. However, ZP measurements indicated an excess of surface cations (i.e. 
acidity), which may explain the death of cells after day 3 of culture. MTT assay results 
demonstrated a lower proliferative rate for AP12 compared with AP08 – AP11 and for 
the same sample cell number measured using Hoechst dye to stain DNA was shown to 
decrease over the culture period. However, ANOVA testing confirmed a statistically 
significant increase in metabolic activity of live cells (Table 4.14) and cell number 
(Table 4.16) between days 1 and 7, which contradicts the results of the live/dead 
assay. This can be explained since the standard ANOVA test does not include all the 
data, meaning days 3 and 5 are effectively ignored and some information is thereby 
lost. In, contrast the modified ANOVA method takes into account this data, which 
explains why this test effectively pulls out this sample as non-significant for MTT 
results, i.e. the observed increase between days 1 and 7 could have occurred by 
chance. The negative F ratio for Hoechst assay data of AP12 calculated using the 
modified ANOVA test indicates that the experimental value at day 7 is lower than the 
projected cell number at day 7, which is based on the lag growth phase (Appendix A). 
MTT and Hoechst assays both demonstrated a lower proliferative rate of MC3T3 cells 
on AP08 compared with AP09 – AP11. Since no obvious compositional difference 
was identified using XRD, FTIR, DTA-TGA or ZP measurements attention was 
focused on the development of pH during precipitation. This revealed that the range of 
pH values recorded for AP08 was greater than AP09 – AP11 (Table 4.3), inferring that 
the relative supersaturation of different ionic species in solution was less controlled. 
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Thus, it is probable that the solution became close to the supersaturation level of a 
greater number of ionic species due to the lack of control of pH during crystallisation, 
which may have resulted in trace incorporations of other phases in the final product. 
Comparison of the proliferative rates of AP08 – AP11 for MTT and Hoechst assays 
suggests that the degree of variation of solution pH has a greater effect on cell number 
than metabolic activity. However, it is important to note the larger degree of variation 
in the fluorescence of Hoechst dye for AP08 (Figure 4.27), thus it is not possible to 
accurately draw this conclusion from the presented data.  
ANOVA testing of MTT data for samples AP08 – AP11 confirmed the significance of 
growth between days 1 and 7. In contrast, the modified method distinguished samples 
AP08, AP10, and AP12 as non-significant when the within group variances were 
compared to the linear regression of day 1 – 5 data (i.e. the proliferation at day 7 is not 
significantly different from the projected day 7 value). This suggests, assuming that 
only lag growth occurred between days 1 and 5 that these samples support osteoblast 
proliferation to a lesser degree than AP09 and AP11, meaning that cells seeded on 
these substrates will take longer to reach confluency. If this is the case, this supports 
the assertion that higher pH variability influences material composition to a degree 
that negatively impacts the metabolic activity of cells, as per the discussion above 
concerning AP08. The results presented here also advocate that forming CDHA via an 
intermediate DCPA phase reduces the potential of the substrate to support cell 
proliferation (AP10). 
Recently, the potential of nHA as a vehicle for drug delivery has been explored since 
such particles can be uptaken by cells and have been shown to exhibit good 
intracellular release kinetics [302]. It is known that size, shape, and surface charge are 
key parameters that influence receptor-mediated cellular uptake [303]. Since ZP 
measurements and SEM studies presented here demonstrated a variation in the sign as 
well as degree of surface charge, and a range of globular particle sizes, respectively 
osteoblast uptake of fluorescein stained AP07 – AP10 particles was investigated 
(Figure 4.28). No distinct change in the affinity for cells was observed between AP07 
that exhibited a positive ZP, and negatively charged CDHA particles (AP08 – AP10). 
Agglomeration of internalised particles was shown, in particular for samples AP07 and 
AP08 that were prepared in uncontrolled pH conditions. The morphology of cells 
containing agglomerates of these particles were typically more round compared with 
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MC3T3 cells that internalised AP09 or AP10, which were shown to exhibit an 
elongated shape. SEM analysis revealed a smaller average size for AP07 particles 
compared with AP08 – AP10, thus it appears that the process of internalisation or 
intracellular behaviour is affected by compositional differences that were shown to 
alter ZP charge. Chen et al. concluded that positively charged HA nanoparticles were 
more easily uptaken by MC3T3 precursor osteoblasts, this was attributed to the 
attractive interaction between the positively charged particles with the negative cell 
membrane [303]. The average size of AP08 particles was between the sizes 
demonstrated for AP09 and AP10 therefore the observed intracellular agglomeration 
of this sample cannot be attributed to the size of particles prior to internalisation. The 
ZP of AP08 was notably less negative compared with AP09 and AP10. Motskin et al. 
reported enhanced internalisation of less negatively charged rod-shaped particles 
compare with colloid nanoparticles of HA [304]. Thus, these results advocate that the 
degree and sign of particle charge influence the process of internalisation. Increased 
uptake of particles that release Ca
2+
, such as HA, has been correlated to toxicity since 
release can interfere with intracellular homeostasis of Ca
2+
, which is known to regulate 
cellular functions such as proliferation and apoptosis [304]. This may explain the 
elongated morphology of cells that exhibited fewer agglomerates of AP09 and AP10 
particles since this shape is indicative of potential cellular adhesion, spreading and 
proliferation [305, 306]. 
4.6 Conclusions 
The results presented in this chapter highlight the compositional variability of CaP 
phases under different pH, solute concentrations, and temperature conditions. 
Numerous authors have highlighted the effects of pH and temperature on a number of 
powder properties, such as phase and thermal stability (Table 2.7), and the material 
characterisations presented in this thesis demonstrate the knowledge that is established 
within the literature. Thus, the novelty of this work is attributed to the associations 
made between variations in material composition due to different preparation 
conditions and the effect of these changes on the biological performance of substrates. 
Results of in-vitro cellular proliferation studies established that pH and temperature 
conditions used during synthesis affect material composition to an extent that may 
determine the viability and proliferative rate of MC3T3 cells. This was explained by 
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the influence of these reaction parameters on the concentration of different molecular 
species within solution and this was shown to translate to the chemical composition of 
the precipitate. Development of a precipitate containing DCPD or excess cations, 
which created a positive ZP, resulted in substrates that were cytotoxic to MC3T3 cells 
(AP07 and AP12). Differences in the degree of proliferation of cells seeded on 
substrates, which were demonstrated to exhibit similar chemical compositions by 
XRD, FTIR, and DTA-TGA as well as a negative surface charge (AP08 – AP11), was 
explained in terms of the degree of variation of pH during synthesis. It was found that 
a greater degree of variation reduced the proliferative rate of osteoblasts measured by 
metabolic activity and DNA staining using Hoechst 33258 dye. Thus, these results 
advocate that it is vital to consider the absolute value of pH as well as temperature, 
and that it is advantageous to control the development of solution pH throughout 
synthesis in order to develop a substrate that is cytocompatible and supports a higher 
degree of cell proliferation. Variation in the degree and sign of surface charge as a 
result of preparation of CDHA under different pH conditions was shown to influence 
the cellular uptake process of AP07 – AP10. 
In summary, the ability of samples AP08 – AP11, that were all suggested to be CDHA 
by FTIR, DTA-TGA and XRF, to support the proliferation of MC3T3 osteoblast 
precursor cells was evidenced by the increase in cell number as measured by MTT and 
Hoechst assays between 1 and 7 days of culture. The relatively higher proliferative 
rates calculated for samples AP09 and AP11 should be noted and are considered 
promising since cell proliferation is the first step in the development of bone tissue: 
proliferation occurs for the first 10 – 12 days of culture, followed by ECM synthesis, 
maturation, and finally mineralisation [307]. Scaffolds fabricated from such materials 
are expected to exhibit enhanced osteogenesis and osteoinductivity. 
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5. Precipitation of hydroxyapatite – 
influence of solvent system 
5.1 Introduction 
There are a number of reaction conditions that affect the crystallisation process of HA, 
which comprises of nucleation and crystal growth mechanisms. The previous chapter 
highlighted the variability of HA composition under different pH, temperature, and 
solute concentrations leading to the conclusion that these parameters ultimately define 
the cytocompatibility and ability of the substrate to support osteoblast proliferation. 
Other authors have investigated the influence of a number of additional reaction 
parameters (Table 2.7), including the effect of different solvent systems [166]. 
Broadly, solvents can be described as either polar or non-polar. The degree of polarity 
is generally indicated by the dielectric constant, which is defined as a comparison of 
the ability of the solvent to reduce electric field strength surrounding an immersed 
charged particle, with the field strength of the charged particle in a vacuum. This term 
is also sometimes referred to as static relative permittivity. Generally, a solvent is 
considered to be non-polar if it exhibits a dielectric constant below 15.  
The influence of replacing water, the most common solvent used in the precipitation of 
HA, with two non-polar solvents, namely Toluene and/or Ethanolamine was 
experimentally investigated to determine the effect on key properties of HA: (1) phase 
purity, (2) degree of crystallinity, (3) particle size and morphology, (4) thermal 
stability, (5) stoichiometry, (6) surface area, and (7) surface charge. Corresponding 
effects of material characteristics on the bioactivity, cytocompatibility, and the ability 
of HA substrates to support the proliferation of MC3T3 cells was assessed using an 
acellular SBF test, and cellular MTT and Hoechst assays, respectively. 
5.2 Materials and methods 
Analar grade reagents were purchased from Sigma Aldrich (UK) and used without 
further purification unless otherwise stated. The procedure outlined in section 4.2.1 
was modified to incorporate the use of Toluene and Ethanolamine as follows. 
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5.2.1 Aqueous precipitation (AP) 
To investigate the influence of Toluene (C6H5CH3), 30mL was added to 20mL of DI 
water to form a 60Toluene:40water solution to which 0.05M of Ca(NO3)2·4H2O was 
added. When Ethanolamine (C2H7NO) was used it was added to the Ca
2+
 containing 
solution under stirring conditions (400rpm) before the adjustment of pH. The 
remainder of the procedure was kept as described in section 4.2.1. Samples produced 
using this modified method were compared to a control HA sample, namely AP09, 
which was precipitated under the same pH and temperature conditions in DI water 
(Table 5.1). 
 
Table 5.1: Summary of varied solvent conditions 
Sample Solvent system 
AP09 (control) DI water 
AP13 5wt% Ethanolamine 
AP14 60% Toluene 
AP15 
5wt% Ethanolamine, 
60% Toluene 
 
Toluene was selected to investigate as an alternative solvent since it is non-polar and 
therefore it is expected to influence the crystallinity of precipitates. Toluene exhibits a 
lower dielectric constant of 2.38 at 25°C compared to 80.1 for water at 20°C. 
Ethanolamine was selected for its properties of alkalinity and volatility, suggesting 
that the solvent would help to maintain a basic environment and be easily removed 
after synthesis. 
5.2.2  In-vitro test methods 
The methods described in section 4.2.2 for pellet preparation, SBF testing, dead/live 
staining, as well as MTT and Hoechst assays were followed. 
5.3 Materials characterisation 
Sample prepared in different solvent systems were characterised by: XRD, FTIR, 
SEM, DTA-TGA, EDS, BET, ZP, SBF, live/dead staining, as well as MTT and 
Hoechst assays using the methods described in section 4.3. XRD was performed on as-
synthesised and powders calcined at 600°C using a ramp up/down rate of 1°C/min, 
and a dwell time of 1hr. ZP was analysed in DI water at 25°C. Statistical analysis of 
Chapter 5: Precipitation of hydroxyapatite – influence of solvent system 
139 
 
data collected from MTT and Hoechst assays was performed using the ANOVA and 
modified ANOVA tests as described in section 4.3.14 (Appendix A). 
5.4 Results 
5.4.1 Development of solution pH in different solvent systems 
No discernible difference in the development of solution pH was observed between 
samples (Table 5.2). Notably, less NH4OH was required to control pH when 
Ethanolamine was added to the solvent system since it is a basic solvent. 
 
Table 5.2: Development of solution pH in different solvent systems 
Sample 
Solution pH 
Start of 
addition 
End of 
addition 
Removal from 
mother solution 
AP09 11.05 10.99 10.78 
AP13 10.99 11.00 10.80 
AP14 11.09 11.00 10.83 
AP15 11.09 11.00 10.86 
 
5.4.2 Crystal structure 
As-synthesised and calcined (600°C) samples were matched to HA alone (Figures 5.1 
and 5.2). Notably a higher degree of peak broadening in as-synthesised samples 
prepared in solvent systems containing Toluene (AP14 and AP15) was observed. In 
contrast, the hollow between the (112) and (300) HA peaks was observed for calcined 
AP14 but not in other heated samples and this is indicative of a higher crystalline 
fraction. No distinguishable difference in the degree of peak broadening between as-
synthesised and heated AP09 or AP13 was demonstrated.  
Line broadening analysis showed only a minimal variation in the size of as-
synthesised crystallites (Table 5.3). Less than 23% increase was calculated between 
the size of as-synthesised and calcined crystallites of AP09, AP13, and AP15. 
However, a relatively high increase of 41% was revealed for AP14.  
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Figure 5.1: Influence of solvent system on as-synthesised crystal structure of (a) AP09, (b) AP13, 
(c) AP14, and (d) AP15 
 
 
Figure 5.2: Influence of solvent system on the crystal structure of samples heated to 600°C 
(a) AP09, (b) AP13, (c) AP14, and (d) AP15 
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Table 5.3: Influence of solvent system on phase and XRD peak broadening 
Sample 
Calcination 
temperature (°C) 
XRD peaks 
matched to 
Crystallite 
 size (nm) 
AP09 
As-synthesised 
HA 
20 
600 24 
AP13 
As-synthesised 20 
600 20 
AP14 
As-synthesised 22 
600 31 
AP15 
As-synthesised 22 
600 27 
 
5.4.3 Molecular structure 
The major assignments for HA are summarised in Table 4.5. Strong characteristic 
bands corresponding to PO4
3-
 were demonstrated in all samples (Figure 5.3). Weak 
structural OH
-
 bands between 632 and 635cm
-1
 were assigned. Similarly to those 
samples reported in Chapter 4, OH
-
 and absorbed H2O bandings 2500 – 3750cm
-1
 
exhibited negligible intensity relative to PO4
3-
 bands. This is suggested to be due to the 
relatively short ageing time of 1.5hrs. Weak bands at 875cm
-1
 associated with non-
apatitic HPO4
2- 
were also revealed. 
IR analysis of samples heated to 600°C revealed the disappearance of the band 
attributed to HPO4
2- 
at 875cm
-1
 (Figure 5.4). A significant reduction in the relative 
intensity of PO4
3- 
bands was observed in AP14. 
 
Figure 5.3: Influence of solvent system on molecular structure of as-synthesised samples 
(a) AP09, (b) AP13, (c) AP14, and (d) AP15 
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Figure 5.4: Influence of solvent system on molecular structure of samples heated to 600°C 
(a) AP09, (b) AP13, (c) AP14, and (d) AP15 
 
5.4.4 Microstructural development 
Typical micrographs revealed globular particles (Figure 5.5) and bulk agglomeration 
throughout samples (Table 5.4). The surfaces of particles were observed to exhibit 
numerous irregularities, which infers surface roughness. 
Figure 5.5: Influence of solvent system on typical particle morphology 
(a) AP09, (b) AP13, (c) AP14, and (d) AP15  
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Table 5.4: Influence of solvent system on average particle and agglomerate size (n=3) 
Sample 
Average Size (μm) 
Particles Agglomerates 
AP09 2.7±0.5 24.6±4.3 
AP13 2.2±0.5 39.1±5.7 
AP14 2.0±0.2 24.2±5.2 
AP15 2.1±0.6 26.6±6.2 
 
5.4.5 Thermal behaviour 
Gradual weight loss between 250 and 700°C was observed and attributed to the 
dehydration of HPO4
2-
, present in CDHA, to P2O7
4-
 according to Equation 2.4 (Table 
4.7). Between 700 and 800°C rapid weight loss associated with an endotherm was 
demonstrated, which is likely to be due to the transformation of β-Ca2P2O7 to HA and 
β-TCP (Equation 2.5). These reactions are illustrated in Figures 5.6 – 5.8. These water 
losses were calculated from TGA data (Table 5.5) and used in combination with 
Equations 2.3 – 2.5 to determine HPO4
2-
 and P2O7
4-
 content (Table 5.6). 
 
 Figure 5.6: Thermal behaviour of AP13 
(DTA = dashed red line, TGA = solid black line, DTG = solid blue line)  
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Figure 5.7: Thermal behaviour of AP14 
(DTA = dashed red line, TGA = solid black line, DTG = solid blue line) 
 
Figure 5.8: Thermal behaviour of AP15 
(DTA = dashed red line, TGA = solid black line, DTG = solid blue line) 
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Table 5.5: Influence of solvent system on the amount of water lost between temperature regions 
associated with Equations 2.3 – 2.5 
a
peak area between 700 to 800°C analysed 
Temperature 
region (°C) 
Water loss (wt%) 
AP09 AP13 AP14 AP15 
250 – 700 1.98 1.809 2.047 2.839 
700 – 800a 0.71 0.7213 0.4575 0.7827 
30 – 800 8.26 8.335 8.756 9.255 
 
 
Table 5.6: Influence of solvent system on chemical composition calculated from DTG analysis 
using Equations 2.3 – 2.5 
a
peak area between 700 to 800°C analysed 
Temperature  
region (°C) 
Ion/phase Source 
Weight (wt%) 
AP09 AP13 AP14 AP15 
250 – 700 
HPO4 
CDHA 
21.09 19.28 21.81 30.25 
P2O7 19.11 17.47 19.76 27.41 
700 – 800a 
P2O7 6.82 6.96 4.42 7.56 
TCP 36.46 37.26 23.63 40.43 
HA 55.27 54.41 67.61 50.32 
HA + TCP residue (mg) 8.49 13.27 17.99 10.06 
TGA residue at 800 8.49 13.27 17.99 10.06 
 
5.4.6 Elemental analysis 
EDS was used to determine the influence of the solvent system on the Ca:P ratio 
(Table 5.7). These results indicated that samples were non-stoichiometric and calcium-
rich HA since the experimental Ca:P ratio was greater than the stoichiometric ratio, 
1.67. 
 
Table 5.7: Influence of solvent system on Ca:P ratio measured by EDS (n=3) 
Sample Ca:P ratio 
AP09 2.17±0.03 
AP13 2.13±0.03 
AP14 2.14±0.16 
AP15 2.11±0.01 
 
5.4.7 Surface area 
Precipitation in a 60:40 Toluene water system (AP14) was found to increase the 
surface area by nearly 20% compared with particles prepared in DI water (AP09), and 
a mixture of DI water and ethanolamine (AP13). A smaller increase of <5%, compared 
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with AP09, was observed when both Toluene and Ethanolamine were used (AP15) 
(Table 5.8). 
 
Table 5.8: Influence of solvent system on the surface area of as-synthesised powders  
Sample Surface area (m
2
/g) 
AP09 106.7±0.2 
AP13 106.2±0.4 
AP14 126.1±0.6 
AP15 110.2±0.5 
 
5.4.8 Surface charge 
Three measurements of electrophoretic light scattering were taken in DI water at 25°C 
to obtain an average ZP value (Table 5.9). Precipitation in DI water was shown to 
result in a relative increase in colloidal stability, i.e. a larger ZP value. Generally 
speaking a ZP <±20mV indicates that the colloids are liable to flocculation, such as 
AP13 – AP15. 
 
Table 5.9: Influence of solvent system on ZP measured in DI water at 25°C 
Sample 
ZP 
(mV) 
AP09 -21.3 
AP13 -5.22 
AP14 -5.21 
AP15 -2.85 
  
5.4.9 SBF test 
Figure 5.9 demonstrates the typical surface of substrates before immersion in SBF. 
After 7 days SEM micrographs revealed the presence of a surface layer (Figure 5.10 a) 
and in some areas spheroidal nodules as well as needle-like particles were observed 
(Figures 5.10 b and c). It has been reported in the literature that apatite grown in SBF 
typically exhibits the morphology described above [301]. Thus these results suggest 
that substrates are bioactive. 
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Figure 5.9: Surface of pellets prior to immersion in SBF  
(a) AP09, (b) AP13, (c) AP14, and (d) AP15 
 
5.4.10 Live/dead assay 
The majority of MC3T3 cells were observed to be viable between 1 and 7 days of 
culture on samples AP13 – AP15 (Figure 5.11). Very few dead cells were seen and 
therefore can be attributed to the sensitivity of the culture process. An increase in the 
density of cells was visually observed over the culture period and the morphology was 
revealed to change from rounded (days 1 – 5) to elongated at day 7. These results 
suggest all substrates are cytocompatible and support adhesion, spreading, and 
proliferation.  
5.4.11 MTT assay 
An increase in the metabolic activity of MC3T3 cells was observed between days 1 
and 7 (Figure 5.12). Proliferative rates were calculated over the culture period (Table 
5.9) and the data suggests that substrates supported the proliferation of osteoblast 
precursor cells, which is consistent with the qualitative assessments drawn from 
fluorescence micrographs of cell viability staining (Figure 5.11). 
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Figure 5.10: Influence of solvent system on the morphology of surface apatite after SBF 
immersion (a) AP13 day 7 surface layer, (b) AP14 day 14 needle-like surface particles, and (c) 
AP15 day 7 spheroidal surface particles 
 
Figure 5.11: Influence of solvent system on the viability of MC3T3 cells seeded on substrates 
(green = live, red = dead)  
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Figure 5.12: Influence of solvent system on metabolic activity of MC3T3 osteoblast precursor cells 
 
Notably, powders produced in a solvent system containing Ethanolamine exhibited a 
lower proliferative rate compared with AP09, which was prepared in DI water (Table 
5.10). In contrast, the proliferative rate more than doubled when precipitates were 
synthesised in a mixed Toluene and water system (AP14) compared with water alone 
(AP09). 
Statistical analysis using the standard ANOVA method established that all samples 
exhibited an F ratio greater than the critical value, which suggests that a significant 
increase in cell number occurred between day 1 and 7 (Table 5.11). Day 7 F ratios 
calculated from linear regression of day 1 and 3 data demonstrated statistical 
significance for all samples except AP13. In contrast, when the same ratio was 
calculated from a linear trend line of day 1 – 5 data the modified ANOVA method 
distinguished AP15 as non-significant. Proliferation at day 5 was not shown to be 
significant compared with projected day 5 data. The negative day 5 F ratios for AP13 
and AP14 calculated using the modified ANOVA method is explained in terms of 
experimental values being lower than those projected from day 1 and 3 data. Thus 
suggesting lag cell growth occurs up to day 5.  
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Table 5.10: Influence of solvent system on the proliferative rate of MC3T3 cells assessed by MTT 
assay between 1 and 7 days 
Sample Proliferative rate (%) 
AP09 82.8 
AP13 24.6 
AP14 193.5 
AP15 67.4 
TP 279.2 
 
 
Table 5.11: Statistical analysis of MTT assay performed on samples AP13 – AP15 
Fcrit = 4.965 where p<0.05, * = statistically significant 
Sample 
ANOVA test Modified ANOVA test 
Day 7 F ratio 
Day 7 F ratio Day 5 F ratio 
Trend 1-3 Trend 1-5 Trend 1-3 
AP09 96.317* 7.237* 6.842* 0.212 
AP13 29.069* 1.860 5.575* -3.656 
AP14 388.765* 22.217* 17.924* -0.747 
AP15 297.140* 9.549* 4.583 0.561 
TP 767.697* -18.333 -5.764 -2.765 
 
5.4.12 Hoechst assay 
An increase in the number of cells between days 1 and 7 was demonstrated for all 
samples (Figure 5.13), thus suggesting substrates supported proliferation. In 
comparison to the proliferative rate for AP09, a smaller increase in cell number was 
calculated for AP13 as well as AP14, and a greater increase for AP15 was shown 
(Table 5.12). The proliferation of cells between day 1 and 7 was confirmed to be 
statistically significant for all samples using the ANOVA test (Table 5.13). In contrast, 
the modified ANOVA method revealed that the day 7 F ratios for AP13 and AP14 
were non-significant when experimental values were compared with a linear trend 
calculated from day 1 – 3 data. However, when linear regression was performed on 
day 1 – 5 data the modified method suggests a significant increase in cell number for 
all samples at day 7. The day 5 F ratio for AP15 was also found to be above the Fcrit 
value and is therefore deemed statistically significant. 
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Figure 5.13: Proliferation of MC3T3 cells on substrates prepared in different solvent systems 
assessed by Hoechst assay 
 
 
Table 5.12: Influence of solvent system on the proliferative rate of MC3T3 cells assessed by 
Hoechst assay between 1 and 7 days 
Sample Proliferative rate (%) 
AP09 495.7 
AP13 431.0 
AP14 467.7 
AP15 538.9 
TP 477.2 
 
 
Table 5.13: Statistical analysis of Hoechst assay AP13 – AP15 
Fcrit = 7.709 where p<0.05, * = statistically significant 
Sample 
ANOVA Modified ANOVA 
Day 7 F ratio 
Day 7 F ratio Day 5 F ratio 
Trend 1-3 Trend 1-5 Trend 1-3 
AP09 106.892* 14.895* 12.780* 0.508 
AP13 137.446* 1.860 47.302* 4.005 
AP14 16.937* 6.182 8.696* -1.950 
AP15 162.713* 44.683* 8.478* 9.676* 
TP 14.656* -2.927 -1.299 -1.253 
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5.5 Discussion 
XRD patterns of AP13 – AP15 were matched to HA and no secondary phases were 
identified. Corresponding FTIR spectra revealed the presence of non-apatitic HPO4
2-
, 
which indicates as-synthesised samples are CDHA. This attribution was supported by 
DTA-TGA analysis that demonstrated gradual weight loss between 250 and 700°C, 
which is ascribed to the dehydration of HPO4
2-
 to P2O7
4-
 according to Equation 2.4. 
Further evidence was provided by the subsequent rapid endothermic weight reduction 
observed 700 – 800°C known to be due to the transformation of β-Ca2P2O7 to HA and 
β-TCP (Equation 2.5). Since all samples behaved similarly under heating, and FTIR 
spectra as well as XRD patterns were comparable it is concluded that variation of the 
solvent system did not alter the predominant CaP phase formed. 
As-synthesised AP14 and AP15 samples exhibited a notably higher degree of 
broadening of characteristic XRD peaks (Figure 5.1) suggesting that the use of 
Toluene influences the crystallisation process. This is explained in terms of a 
reduction in the polarity of the solvent system causing an increase in the rate of 
precipitation of polar molecules since the relative supersaturation level is lower. Hence 
the lower dielectric constant of Toluene resulted in faster precipitation of crystallites, 
which explains the increase in broadness of characteristic XRD peaks. Assuming a 
faster rate of precipitation, this may explain the smaller particle size (Table 5.4) and 
larger surface area (Table 5.8) exhibited by AP14 and AP15 compared with AP09.  
In contrast, XRD patterns of samples heated to 600°C exhibited no apparent difference 
in the degree of peak broadening. This observation suggests that in addition to the 
aforementioned difference in the degree of crystallinity of as-synthesised materials, 
samples prepared in different solvent systems may also exhibit a variation in chemical 
composition. Simply, Le Chatelier’s principle states that disruption of a dynamic 
equilibrium will result in the system countering this by shifting the position of the 
equilibrium backwards [308]. The large numbers of ionic species within the reported 
solutions make the equilibrium rather complex (e.g. Figure 2.10). Attention has been 
focused on the dynamic equilibrium between PO4
3-
 and HPO4
2-
 since FTIR and DTA-
TGA demonstrated presence of both of these ions (Equation 5.1). Notably, addition of 
Ethanolamine, since it is an alkali solvent, resulted in less NH4OH being required to 
control pH, i.e. a decrease in the amount of OH
-
 or a relative increase in H
+
 within the 
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system. Thus the equilibrium is shifted to reduce HPO4
2-
 to counteract this change, 
which explains the relatively low concentration of this ion calculated for AP13 
compared with AP09 (Table 5.6). In the case of AP14, the addition of Toluene 
decreases the relative concentration of H
+
 since it is a non-polar solvent and thus the 
equilibrium is shifted in the opposite direction, which explains the increase in the 
amount of HPO4
2-
 content for this sample (Table 5.6). When Ethanolamine and 
Toluene are used in combination DTA-TGA results suggest the effect of Toluene is 
dominant since an increase in HPO4
2-
 content was calculated for AP15 relative to 
AP09. Compositional differences (i.e. HPO4 content) between AP09 and AP13 
compared with AP14 and AP15 are suggested to explain the difference in the rate of 
crystallisation evidenced by XRD patterns of heated samples (Figure 5.2). 
 
[    
  ]    [   
  ]   [  ]                    (5.1) 
 
A significant reduction in the intensity and increased broadness of FTIR bands 
associated with PO4
3-
 was observed in calcined AP14 compared with other samples 
(Figure 5.4). The broader peaks indicate stronger or a greater number of PO4
3-
 
intermolecular interactions, suggesting that a larger number or smaller critical 
nucleation size was generated in the formation of precipitates prepared in a mixed 
Toluene and DI water system. This is associated with the faster stabilisation of 
crystallites due to the lower dielectric constant of Toluene. As mentioned previously 
this may also explain why AP14 exhibited a higher surface area (Table 5.8). It is 
important to note that all samples exhibited a surface area greater than what is 
typically cited for HA in the literature, 20 – 60m2/g [299]. 
No marked difference in particle morphology was observed for samples AP13 – AP15 
or for the samples analysed in Chapter 4 (AP07 – AP12). Thus it is suggested that 
particle morphology is dependent on the crystal structure of the precipitate. This is 
evidenced by the different morphologies observed for samples AP05 and AP06 that 
were predominantly matched to different CaP phases, DCPD and DCPA, by XRD 
analysis. A 60% increase in the average agglomerate size, compared with AP09, was 
observed for AP13 but in contrast less variation (<20%) in the size of particles was 
demonstrated. Therefore it is likely the degree of agglomeration is linked not only to 
particle size but also to the degree of grinding achieved when the dried powders are 
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crushed using a pestle and mortar. Since each powder was ground for the same period 
of time this suggests the dried filter cake for AP13 was more resistant to compressive 
force, which may be due to smaller crystallites creating more grain boundaries. 
Application of the Scherrer equation (Equation 3.1) confirmed crystallites of all 
samples were within the nanoregime (Table 5.3). 
Similar to the samples analysed in Chapter 4, the Ca:P ratio of AP13 – AP15 
calculated using EDS were substantially above the stoichiometric ratio of 1.67 for HA. 
Since EDS analysis was performed on powdered samples that were observed by SEM 
to exhibit numerous irregularities and a relatively high surface area, it is likely that this 
infers significant surface roughness which may have distorted X-ray scattering. This 
might explain why the calculated Ca:P ratios do not confer with FTIR and DTA-TGA 
data that clearly suggest powders are CDHA. 
Samples AP13 – AP15 all exhibited a negative ZP in DI water at pH 7.4, i.e. a 
negative surface charge. Particularly, a decrease in the value of ZP was observed for 
AP13, AP14, and AP15 compared to AP09, which indicates a reduction in the stability 
of dispersed particles. Colloidal stability is dependent on the balance of repulsive and 
attractive forces between particles that approach each other within the dispersion. If 
particles exhibit a mutual repulsion colloidal stability is maintained. However, if there 
are no or few repulsions the particles are susceptible to instability mechanisms, such as 
flocculation. Therefore, the lower ZP values of AP13 – AP15 compared with AP09 
indicate that these particles are more likely to flocculate in water. It is likely that the 
negative surface charge of AP09 is created by deprotonation of crystallites in the polar 
and OH
-
 rich water system. This would result in a degree of electrostatic stabilisation 
since deprotonation would create negatively charged particles. The ability of non-polar 
solvents to influence surface charge is significantly less and this explains why partial 
replacement of water with a non-polar solvent, such as Toluene results in a lower 
degree of electrostatic stabilisation of CDHA particles, i.e. a lower ZP value (AP14). 
Since addition of Ethanolamine resulted in less NH4OH being required to control pH 
during precipitation of AP13 the concentration of OH
-
 within the solvent system was 
reduced and hence also the degree of deprotonation. AP15 exhibited the lowest ZP 
value and this is due to the combined effects of Toluene and Ethanolamine, as 
described above. Particle flocculation during AP synthesis is reported as a common 
issue [3, 192, 193]. These results advocate that characterisation of ZP is an important 
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step in the understanding of such instability mechanisms and potential tweaking of the 
solvent system could reduce this unfavourable effect. 
Since the SBF test is relatively cheap and fast compared with cell culture this 
technique was once again used as an indication of substrate bioactivity prior to cell 
work. Formation of spheroidal nodules on the surface with a fine needle-like structure 
is suggested to infer bioactivity. A layer exhibiting this typical morphology was 
observed on all samples; however coverage was shown to be non-uniformly dispersed 
across the surface. In this context, it should be noted that the ability to infer in-vivo 
bioactivity from the formation of apatite in SBF is widely debated within the literature 
[289, 309, 310]. It is also reported that this test can result in false positive and false 
negative results due to potential changes in the supersaturation of the solution 
favouring possible apatite formation. Variability and difficulty in preparing the SBF 
solution are highlighted in the literature [309]. The author recognises that these issues 
infer that SBF results are likely to exhibit poor reproducibility as well as inconsistency 
and therefore since these results are refutable no conclusions are drawn from this test 
alone. 
Live/dead assay revealed that cells were viable on all substrates over the entire culture 
period (Figure 5.11). Micrographs qualitatively demonstrated an increase in cell 
density and a change in morphology from rounded to stretched and elongated at day 7, 
which is indicative of cell attachment and spreading. Hence it can be concluded that 
the effects of Toluene and/or Ethanolamine on the composition of substrates did not 
influence cytocompatibility. It may also be inferred that samples support the 
proliferation of osteoblast precursor cells and this assertion was quantitatively 
confirmed by MTT and Hoechst assays.  
Calculation of the proliferative rate of MC3T3 osteoblast precursor cells seeded on 
substrates revealed an increase in the number of metabolically active cells over 7 days. 
In comparison to the reference sample prepared in DI water (AP09), the increase in 
cell number between days 1 and 7 for AP13 and AP15 was 58 and 15% less, 
respectively. In contrast, the proliferative rate of cells on AP14 was more than double 
AP09 (Table 5.10), which may infer improved osteogenesis. AP14 exhibited a 
relatively high surface area and high degree of XRD peak broadening and therefore it 
may be considered sensible to assume that either or both of these powder properties 
influenced metabolic activity. Ribeiro et al., [311] proposed that osteoblast adhesion 
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and metabolic activity were affected by the surface morphology and roughness of 
sintered HA substrates. The authors demonstrated a higher level of viability and 
number of MC3T3 cells on substrates sintered at 1000°C compared to 725°C and 
attributed this to differences in surface morphology, including larger grain size, higher 
root mean square roughness, lower surface area and porosity. Unfortunately, the effect 
of sintering on the chemical composition and crystallinity of HA substrates was not 
considered in the study conducted by Ribeiro et al. [311] despite these properties being 
known influence on osteoblast differentiation. Numerous studies in the literature 
support the assertion that there is an inverse relationship between crystallinity and 
mineralisation [312, 313] as well as gene expression of osteonectin (a bone specific 
protein that is suggested to link bone mineral to collagen and initiate active 
mineralisation) [314], osteopontin (a prominent protein component of the mineralised 
extra cellular matrices of bones and teeth) [315], and alkaline phosphatase (ALP - an 
enzyme that dephosphorylates organic molecules and is linked to bone turnover and 
osteoblast activity) [316]. These observations were explained in terms of improved 
degradation of less crystalline HA and the ability of these surfaces to provide a 
dynamic zone for dissolution and re-precipitation [317]. Since the crystallinity of all 
heated samples appeared to be relatively similar the increased proliferation of 
metabolically active cells seeded on AP14 is not attributed to this factor. Instead, it is 
ascribed to the differences in surface properties, namely the higher surface area of 
AP14 particles, which is considered promising for osteointegration and 
osteoconduction [108, 109]. To confirm this, additional characterisations of key 
surface characteristics, such as surface area and roughness, of pellets are 
recommended in order to help understand the above observations. Aside from this, 
surface area is known to impact the sinterability of HA generally resulting in increased 
mechanical strength and thus the higher surface area exhibited by AP14 is considered 
a desirable property for load bearing applications. 
The increase in cell number observed by MTT assay was confirmed to be statistically 
significant for all samples using the ANOVA test. AP13, showing the lowest 
proliferative rate, was pulled out as non-significant by the modified ANOVA method 
when variances were compared to the linear line of best fit calculated from day 1 – 3 
data. An observable decrease in cell number at day 5 for AP13 explains why the F 
ratio for this sample was confirmed as statistically significant when the trend line was 
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calculated from day 1 – 5 data and negative at day 5 compared with linear regression 
of days 1 – 3 (Table 5.11). The day 7 F ratio for AP15 was calculated to be less than 
Fcrit when day 1 – 5 data was used for the modified ANOVA test and is attributed to 
the relatively large variation in experimental value (Figure 5.12). The modified 
ANOVA test identified samples that exhibited a lower proliferative rate than AP09 as 
non-significant whereas these samples were not distinguished using the standard 
method. This distinction highlights the importance of considering the whole data set 
(i.e. all time points) as otherwise potentially important information may essentially be 
overlooked. 
In contrast, the proliferative rate calculated for Hoechst assay results demonstrated a 
larger increase in cell number when MC3T3 cells were seeded onto AP15. Compared 
with AP09, samples prepared with Ethanolamine (AP13) and Toluene (AP14) alone 
exhibited a lower increase in cell number between days 1 and 7. Compared to AP09, 
AP13 and AP14, properties of AP15 that are notable include the greater concentration 
of non-apatitic HPO4
2-
 calculated from TGA analysis (30.25wt%) and the reduced 
colloidal stability measured in DI water. In comparison to the results presented in 
section 4.4.12 the highest increase in cell number was established on AP10, which also 
exhibited a relatively high content of HPO4
2-
 (39.74wt%). Concurrent analysis of these 
results suggests that a higher non-apatitic content may contribute to a higher increase 
in osteoblast proliferation as measured by DNA staining. This is explained in terms of 
the reduction in the Ca:P ratio with increasing HPO4
2-
 content, and this would improve 
dissolution, which can be favourable [317]. Statistical analysis using the modified 
ANOVA method revealed a non-significant increase for AP13 and AP14 at day 7 
compared with projected values based on day 1 – 3 data. However, the increase in cell 
number at day 7 compared to the linear regression of day 1 – 5 data advocates that 
proliferation was significant on all samples and this was also confirmed using the 
standard ANOVA test. This analysis suggests the lag cell growth phase occurs up to 
day 5 of culture for these samples. 
5.6 Conclusions 
In summary, variation in the dielectric constant of the solvent system used for 
precipitation was shown to influence the rate of crystallisation. This is explained by a 
decrease in the relative supersaturation of crystallites in a system containing non-polar 
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solvents. Hence the rate of precipitation in solvent systems containing Toluene (AP14 
and AP15) is likely to have been faster and this explains the higher degree of XRD 
peak broadening demonstrated for these samples. The above explanation was also used 
to conclude why AP14 and AP15 exhibited a relatively larger surface area. It is 
suggested that the substantial increase in surface area observed for AP14 explains the 
higher metabolic activity of MC3T3 cells seeded on this substrate after 7 days of 
culture. However, since the surface area of the pellet cannot directly be inferred from 
particle data further testing is recommended to quantify this properties as well as the 
surface roughness of substrates. 
FTIR and DTA-TGA analysis confirmed the presence of non-apatitic HPO4
2- 
within all 
samples suggesting precipitates are CDHA. Notably AP15 was shown to exhibit 
approximately 10% more non-apatitic content than other specimens. An increase in the 
number of cells at day 7 was linked to this higher HPO4
2-
 content. This relationship 
was also corroborated in section 4.4.12. 
Variation in the colloidal stability of powders prepared in different solvent systems 
was evidenced by ZP measurements and depending on the end use of the powder 
could be considered an important criterion. In relation to this project particle 
flocculation is considered a detrimental factor in a number of scaffold fabrication 
methods. In particular, the resolution and stability of parts fabricated via ALM 
methods that involve powders or colloids is directly linked with the flowability of 
stock material and any potential coagulation due to powder or dispersion instability 
would be unfavourable. 
In summary, the uses of Toluene and/or Ethanolamine in the solvent system for HA 
precipitation was not found to adversely affect the viability of cells seeded on the 
prepared CDHA substrates. The use of these solvents had mixed effects on 
composition and physical properties of substrates and this resulted in a varied degree 
of support for cell proliferation in comparison to CDHA prepared under the same 
conditions in DI water. In-vitro results for AP14 and AP15 are promising since a 
relative increase in the number of MC3T3 osteoblast precursor cells seeded on 
substrates over the 7 day culture period was demonstrated. Overall, these results 
highlight the potential application of alternative solvents to control and alter chemical 
as well as physical characteristics that play an important role in determining vital 
properties, including sinterability, mechanical strength, and biological performance. 
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6. Precipitation of hydroxyapatite – 
influence of divalent cation substitutions 
6.1 Introduction 
The reactivity of biological apatites, including bone mineral, depends on various 
parameters one of which is the existence of ionic substituents within the apatite 
structure [2]. Incorporation of numerous ionic species, generally in relatively small 
amounts (Table 2.1), exist in bone apatite and explain the different physical-chemical 
properties of this material compared with stoichiometric HA. Many of these dopants 
are known to elicit advantageous cellular responses. In an attempt to emulate the 
performance of native bone apatite researchers have investigated the influence of 
incorporating biologically relevant ions into synthetic HA. 
A number of reports have confirmed that substitution of Sr, Mg, or Zn can influence 
the crystallinity, solubility, surface charge, and physiological dissolution rate of 
synthetic CaPs [11]. Each of these divalent cations are known to play important roles 
in the biological responses of bone cells (section 2.9.1). Despite the synthesis of 
substituted HA attracting much interest in the biomedical research community to the 
best of the author’s knowledge Sr, Mg, or Zn substituted HA prepared under the same 
experimental conditions has not previously been reported. Preceding chapters have 
highlighted that changes in reaction conditions can greatly influence the physical, 
chemical, and crystal structure of precipitated apatite, which makes it difficult to 
determine the sole influence of substituents when comparing literature since variations 
in synthesis conditions, such as pH, temperature, and solute concentration, are 
common. Hence it is proposed that comparison of samples doped with Sr, Mg, or Zn 
prepared under the same experimental conditions is a more accurate assessment of the 
individual influence of these cations. This reasoning serves as justification for the 
experimental work presented in this chapter. A higher level of Mg doping was selected 
(10mol%) compared with Sr and Zn (2mol%) since a larger amount of this cation is 
known to be present in native bone apatite (Table 2.1). 
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6.2 Materials and methodology 
Analar grade reagents were purchased from Sigma Aldrich (UK) and used without 
further purification unless otherwise stated. 
6.2.1 Aqueous precipitation (AP) 
To form substituted HA the amount of Ca(NO3)2·4H2O used in the procedure outlined 
in section 4.2.1 was adjusted to reflect the incorporation of 2mol% Sr, 10mol% Mg, or 
2mol% Zn. An appropriate amount of strontium nitrate [Sr(NO3)2≥99%], magnesium 
nitrate [Mg(NO3)2≥99%], or zinc nitrate hexahydrate [Zn(NO3)2·6H2O ≥98%] was 
added to the Ca
2+
 containing solution and stirred until the reagents were fully 
dissolved. No further alterations were made to the precipitation process (section 4.2.1). 
Substituted HA samples were compared with a control HA sample (AP09) to ascertain 
the influence of the additional divalent cations (Table 6.1). 
 
Table 6.1: Summary of divalent cation substitutions 
Sample Substitution 
AP09 (control) N/A 
AP16 2mol% Sr 
AP17 10mol% Mg 
AP18 2mol% Zn 
 
6.2.2  In-vitro test methods 
The methods described in section 4.2.2 for pellet preparation, SBF testing, as well as 
live/dead, MTT and Hoechst assays were employed for samples AP16 – AP18. 
6.3 Materials characterisation 
HA substituted with Sr, Mg, or Zn were characterised by: XRD, FTIR, SEM, DTA-
TGA, XRF, BET, SBF, live/dead staining, as well as MTT and Hoechst assays using 
the methods described in section 4.3. XRD was performed on as-synthesised and 
powders calcined at 600°C using a ramp up/down rate of 1°C/min, and a dwell time of 
1hr. The amount and accuracy of cation substitutions was analysed by XRF. Statistical 
analysis of data collected from MTT and Hoechst assays was performed using the 
ANOVA and modified ANOVA tests as described in section 4.3.14 (Appendix A). 
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6.4 Results 
6.4.1 Development of solution pH containing additional divalent 
cations 
A maximum variation of 0.06 was observed between the final solution pH of HA 
(AP09) and suspensions containing additional divalent cations (Table 6.2). 
 
Table 6.2: Development of solution pH containing additional divalent cations 
Sample 
Cation 
substitution 
Solution pH 
Start of 
addition 
End of 
addition 
Removal from 
mother solution 
AP09 N/A 11.05 10.99 10.78 
AP16 Sr 11.10 11.00 10.84 
AP17 Mg 11.07 11.00 10.81 
AP18 Zn 11.00 10.99 10.82 
 
6.4.2 Crystal structure 
As-synthesised samples were matched to the standard JCPDS pattern for HA and 
notably an increase in the broadening of characteristic peaks was observed for AP16 – 
AP18 compared with AP09, which suggests these samples are less crystalline (Figure 
6.1). Calcined samples were matched to HA alone, except AP17 that was confirmed to 
be a biphasic mixture of HA and β-TCP (Figure 6.2). No distinguishable difference in 
the degree of HA peak broadening between as-synthesised and calcined samples was 
observed. However, an increase in the size of crystallites was confirmed by line 
broadening analysis (Table 6.3). 
Positions of characteristic XRD peaks were identified and any shifts observed between 
samples AP16 – AP18 compared with AP09 were recorded (Table 6.4). In general, a 
shift of peaks to lower angles was demonstrated for AP16 and, in contrast to higher 
angles for AP17 and AP18.  
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Figure 6.1: Influence of cations on as-synthesised crystal structure 
(a) AP09, (b) Sr AP16, (c) Mg AP17, and (d) Zn AP18 
 
 
Figure 6.2: Influence of cations on the crystal structure of samples heated to 600°C 
(a) AP09, (b) Sr AP16, (c) Mg AP17, and (d) Zn AP18 
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Table 6.3: Influence of cations on phase and XRD peak broadening 
Sample 
Cation 
substitution 
Calcination 
temperature (°C) 
XRD peaks 
matched to 
Crystallite 
size (nm) 
AP09 N/A 
As-synthesised 
HA 
20 
600 24 
AP16 Sr 
As-synthesised 
HA 
19 
600 21 
AP17 Mg 
As-synthesised HA 11 
600 β-TCP 35 
AP18 Zn 
As-synthesised 
HA 
19 
600 30 
 
 
Table 6.4: Influence of cations on the position of characteristic XRD peaks compared with AP09 
and HA reference pattern (09-432) 
Peak 
HA 
reference (°) 
2θ peak position (°) 2θ peak shift (°) 
AP09 AP16 AP17 AP18 AP16 AP17 AP18 
(002) 25.879 25.874 25.823 25.893 25.874 -0.051 0.019 0.054 
(102) 28.126 28.129 28.121 28.157 28.122 -0.007 0.028 0.002 
(200) 28.966 28.936 28.986 28.970 28.961 -0.280 0.027 0.047 
(211) 31.773 31.798 31.762 31.788 31.777 -0.012 0.014 0.043 
(112) 32.196 32.199 32.200 32.193 32.185 -0.001 0.021 0.015 
(300) 32.902 32.910 32.920 32.911 32.907 -0.006 0.014 0.250 
(202) 34.048 34.044 34.045 34.089 34.048 -0.051 0.048 0.022 
(001) 35.480 35.523 35.427 35.491 35.495 -0.054 0.009 0.018 
 
6.4.3 Molecular structure 
IR band assignments for HA are summarised in Table 4.5. Major bands associated 
with PO4
3-
 and HPO4
2-
 were observed in all as-synthesised samples (Figure 6.3). A 
band that is associated with structural OH
-
 was also demonstrated between 632 and 
635cm
-1
. 
Corresponding analysis of samples heated at 600°C revealed the absence of a band at 
875cm
-1
, which was attributed to non-apatitic HPO4
2-
 (Figure 6.4). A reduction in the 
intensity of all major PO4
3-
 frequencies was observed for AP16 – AP18 and in addition 
the shoulder associated with PO4
3-
 (ν3) at 1090cm
-1
 was unobservable for AP17 and 
AP18. 
6.4.4 Microstructural development 
Typical particles exhibited a globular morphology and a significant variation in size 
due to agglomeration (Figure 6.5). Measurements were taken of what appeared to be 
individual particles (i.e. material fractions that were dispersed), and agglomerates to 
obtain average sizes (Table 6.5). Compared with AP09, samples prepared with Sr and 
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Zn exhibited larger than average particle and agglomerate sizes. In contrast, an 
approximate reduction of 40% and 20% was demonstrated between the average 
particle and agglomerate sizes of AP17 and AP09, respectively. 
 
Figure 6.3: Influence of cations on molecular structure of as-synthesised samples 
(a) AP09, (b) Sr AP16, (c) Mg AP17, and (d) Zn AP18 
 
 
 
Figure 6.4: Influence of cations on the molecular structure of samples heated to 600°C 
(a) AP09, (b) Sr AP16, (c) Mg AP17, and (d) Zn AP18 
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Figure 6.5: Influence of cations on typical particle morphology 
(a) AP09, (b) Sr AP16, (c) Mg AP17, and (d) Zn AP18 
 
 
Table 6.5: Influence of cations on the average particle and agglomerate sizes (n=3) 
Sample 
Cation 
substitution 
Average size (μm) 
Particles Agglomerates 
AP09 N/A 2.7±0.5 24.6±4.3 
AP16 Sr 4.9±0.9 40.5±3.7 
AP17 Mg 1.6±0.4 19.9±4.2 
AP18 Zn 3.3±0.4 29.5±5.1 
 
6.4.5 Thermal behaviour 
The thermal behaviour of samples AP16 – AP18 were analysed by simultaneous DTA-
TGA and the results are shown in Figures 6.6 – 6.8. A gradual loss of weight was 
observed between 250 and 700°C, which is attributed to the dehydration of HPO4
2-
, 
present within CDHA, to P2O7
4-
 according to Equation 2.4. An increase in the weight 
loss within this temperature region was demonstrated for AP16 – AP18 compared with 
AP09 (Table 6.6). 
Differentiation of TGA data (DTG) revealed a distinct rapid weight loss region 
between 700 and 800°C for all samples except AP17. Reactions within this 
temperature region can be associated to the transformation of β-Ca2P2O7 to HA and β-
TCP as described by Equation 2.5. Water losses calculated from TGA data were used 
in combination with Equations 2.4 and 2.5 to determine HPO4
2-
, P2O7
4-
, as well as HA 
and TCP content (Table 6.7).  
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Figure 6.6: Thermal behaviour of AP16 (Sr) 
(DTA = dashed red line, TGA = solid black line, DTG = solid blue line) 
 
Figure 6.7: Thermal behaviour of AP17 (Mg) 
(DTA = dashed red line, TGA = solid black line, DTG = solid blue line) 
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Figure 6.8: Thermal behaviour of AP18 (Zn) 
(DTA = dashed red line, TGA = solid black line, DTG = solid blue line) 
 
 
Table 6.6: Influence of cations on the amount of water lost between temperature regions 
associated with Equations 2.4 and 2.5 
a
peak area between 700 - 800°C 
Temperature 
region (°C) 
Water loss (wt%) 
AP09 AP16 AP17 AP18 
250 – 700 1.98 2.64 3.45 2.48 
700 – 800a 0.71 0.72 0.31 0.74 
30 – 800 8.26 9.28 15.13 9.07 
 
 
Table 6.7: Influence of cations on chemical composition calculated from DTG analysis using 
Equations 2.4 and 2.5 
a
peak area between 700 - 800°C 
Temperature 
region (°C) 
Ion/phase Source 
Weight (wt%) 
AP09 AP16 AP17 AP18 
250 – 700 
HPO4 
CDHA 
21.09 28.16 36.72 26.45 
P2O7 19.11 25.52 33.27 23.96 
700 – 800a 
P2O7 6.82 6.90 2.98 7.18 
TCP 36.46 36.93 15.95 38.43 
HA 55.27 53.79 68.92 52.50 
HA + TCP residue (mg) 8.49 11.45 6.92 13.92 
TGA residue at 800°C (mg) 8.49 11.45 6.92 13.92 
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6.4.6 Elemental analysis 
XRF was used to identify the presence of additional cations within as-synthesised 
powders. The accuracy of cation substitution, defined as the experimental amount 
detected divided by the theoretical substitution, was calculated (Table 6.8). The 
detected amount of Sr substitution (AP16) was notably the most accurate and over 
80% higher than the accuracies calculated for Mg (AP17) or Zn (AP18) doping. 
 
Table 6.8: Accuracy of cation substitution levels measured by XRF 
a
Defined as experimental value divided by theoretical substitution level, 
b
Mx cation substitution 
Sample 
Cation 
substitution (%) 
Cation 
accuracy (%)
a
 
Ca:P Ca+Mx
b
:P 
AP16 1.86 (Sr) 93 1.48 1.53 
AP17 1.03 (Mg) 10.3 1.48 1.53 
AP18 0.24 (Zn) 12 1.56 1.57 
 
6.4.7 Surface area 
Substitution of all the investigated divalent cations was found to increase the measured 
surface area compared with AP09, which was prepared under the same reaction 
conditions (Table 6.9). Notably, AP17 exhibited a surface area 60% larger than AP09. 
 
Table 6.9: Influence of cation substitutions on the surface area of as-synthesised powders 
Sample Cation substitution Surface area (m
2
/g) 
AP09 N/A 106.7±0.2 
AP16 Sr 110.6±0.3 
AP17 Mg 170.8±0.8 
AP18 Zn 117.1±0.2 
 
6.4.8 SBF test 
The surface of pellets were visualised via SEM prior to immersion in SBF (Figure 
6.9). Typically, micron sized ridges were observed, which are expected to infer surface 
roughness. Immersion in SBF solution resulted in the formation of a surface coating 
after 7 days (Figure 6.10 a and b). This coating did not cover the entirety of the surface 
but instead was shown to be randomly dispersed. After 28 days a change in the pellet 
morphology was visualised suggesting that a degree of surface degradation occurred 
(Figure 6.10 c).   
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Figure 6.9: Surface of pellets containing cations prior to immersion in SBF 
(a) AP09, (b) Sr AP16, (c) Mg AP17, and (d) Zn AP18 
 
 
Figure 6.10: Influence of cations on the morphology of surface apatite grown in SBF (a) AP16 day 
7, (b) AP18 day 14, and (c) AP16 day 28 (solid blue circle pellet surface, dashed red circle surface 
coating) 
 
6.4.9 Live/dead assay 
Fluorescence micrographs demonstrated the viability of MC3T3 cells seeded on 
substrates prepared with additional cations, which indicates cytocompatibility (Figure 
6.11). An increase in the density of cells was visually observed as well as a change in 
morphology from rounded to elongated, which indicates that substrates supported 
adhesion, spreading and proliferation of MC3T3 osteoblast precursor cells.  
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Figure 6.11: Influence of cations on the viability of MC3T3 cells seeded on substrates (green = 
live, red = dead) 
6.4.10 MTT assay 
An increase in the number of metabolically active cells was observed on substrates 
over the culture period (Figure 6.12). Proliferative rates between 1 and 7 days were 
calculated and in particular, compared with AP09, samples substituted with theoretical 
concentrations of 10mol% Mg (AP17), and 2mol% Zn (AP18) exhibited an increase of 
80 and 40% metabolically active cells, respectively (Table 6.10). In contrast, AP09 
and AP16 demonstrated comparable proliferative rates. These results support live/dead 
fluorescence micrographs since they advocate that substrates are cytocompatible and 
support the proliferation of cells. 
Standard ANOVA testing established that the increase in cell number between day 1 
and 7 was statistically significant for substrates (Table 6.11). This assessment was 
reflected when between group variances were compared to within group variances 
calculated from the linear regression of experimental data for days 1 – 3. Notably, a 
negative day 7 F ratio was calculated for AP17 when a linear trend line between days 
1 and 5 was used, which is due to the significant increase in the number of cells at day 
5 skewing the lag growth phase rate. Compared with other samples AP17 exhibited a 
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much higher proliferative rate between days 3 and 5. Specifically, AP17 was the only 
sample that showed a statistically significant increase in the number of metabolically 
active cells at day 5, which suggests that the exponential cell growth phase began 
between days 3 and 5. 
Figure 6.12: Influence of cations on metabolic activity of MC3T3 osteoblast precursor cells 
 
 
Table 6.10: Influence of cations on the proliferative rate of MC3T3 cells assessed by MTT assay 
between 1 and 7 days 
Sample Cation substitution Proliferative rate (%) 
AP09 N/A 82.8 
AP16 Sr 81.9 
AP17 Mg 161.9 
AP18 Zn 124.3 
 
 
Table 6.11: Statistical analysis of MTT assay AP16 – AP18 
Fcrit = 4.965 where p<0.05, * = statistically significant 
Sample 
Cation 
substitution 
ANOVA test Modified ANOVA test 
Day 7 F ratio 
Day 7 F ratio Day 5 F ratio 
Trend 1-3 Trend 1-5 Trend 1-3 
AP09 N/A 96.317* 7.237* 6.842* 0.212 
AP16 Sr 130.184* 6.975* 5.153* -0.383 
AP17 Mg 142.161* 9.780* -0.810 8.821* 
AP18 Zn 103.221* 12.208* 8.655* 0.720 
TP N/A 767.697* -18.333 -5.764 -2.765 
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6.4.11  Hoechst assay 
Results for the fluorescence of DNA stained with Hoechst 33258 supported those 
obtained from live/dead and MTT assays since an increase in the number of MC3T3 
cells was demonstrated between 1 and 7 days of culture (Figure 6.13). Calculated 
proliferative rates revealed a smaller increase in cell number between day 1 and 7 for 
substrates substituted with any of the investigated cations compared with the control 
HA sample prepared under the same experimental conditions (Table 6.12). 
 
Figure 6.13: Proliferation of MC3T3 cells on substrates substituted with divalent cations assessed 
by Hoechst assay 
 
 
Table 6.12: Influence of cations on the proliferative rate of MC3T3 cells assessed by Hoechst 
assay between 1 and 7 days of culture 
Sample Cation substitution Proliferative rate (%) 
AP09 N/A 495.7 
AP16 Sr 457.4 
AP17 Mg 450.0 
AP18 Zn 439.7 
 
ANOVA using the standard test demonstrated the statistical significance of the 
increase in cell number between days 1 and 7 for all substrates, except AP18 (Table 
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6.13). Using the modified method AP16 was pulled out as non-significant using a 
trend line from days 1 – 3. Furthermore, the day 7 F ratios for AP16 and AP18 
calculated from linear regression of day 1 – 5 were less than the Fcrit. Growth in cell 
number at day 5 was not statistically significant for any sample as determined by the 
modified ANOVA test. 
 
Table 6.13: Statistical analysis of Hoechst assay AP16 – AP18 
Fcrit = 7.709 where p<0.05, *statistically significant 
Sample 
Cation 
substitution 
ANOVA test Modified ANOVA test 
Day 7 F ratio 
Day 7 F ratio Day 5 F ratio 
Trend 1-3 Trend 1-5 Trend 1-3 
AP09 N/A 106.892* 14.895* 12.780* 0.508 
AP16 Sr 102.615* 6.247 -0.298 5.432 
AP17 Mg 7.839* 15.237* 14.433* -1.739 
AP18 Zn 7.154 13.897* 7.029 2.797 
TP N/A 14.656* -2.927 -1.299 -1.253 
 
6.5 Discussion 
The reactivity of apatites is dependent on their crystal structure and thus substitutions 
in HA can alter physicochemical properties such as dissolution [318]. It is known that 
Y
-
 monovalent ions found within the ion channels can be exchanged readily at high 
temperature without any crystal alteration, whereas substitutions for trivalent XO4
3- 
or 
bivalent Me
2+
 ions that constitute the apatite frame may result in reorganisation of the 
structure [2]. Notably, a larger degree of XRD peak broadening of as-synthesised 
AP16 – AP18 compared with AP09 was demonstrated (Figure 6.1). Advantageously 
line broadening analysis confirmed crystallites of all samples were nanosized (Table 
6.3). In particular, a 45% reduction in crystallite size was calculated for precipitates 
that theoretically contained 10mol% Mg compared with CDHA prepared under the 
same conditions (AP09). A number of authors, for example [319], have reported that 
Mg acts as an inhibitor of HA nucleation and subsequent crystallisation, which may 
explain the above observation as well as the increase in surface area measured for 
AP17 (Table 6.9). FTIR spectra of as-synthesised samples established the following 
trend for the sharpness of PO4
3- 
bands: AP09>AP16>AP18>AP17, which is consistent 
with the degree of peak broadening observed in XRD patterns and the above assertion 
that Mg inhibits the crystallisation process (Figure 6.3). 
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Relative to Ca
2+
 the ionic radii of Sr
2+
, Mg
2+
, and Zn
2+
 are 116, 75 and 65% the size, 
respectively. Shifts to lower diffraction angles were observed for Sr substituted 
samples (AP16), and in contrast characteristic peaks of Mg (AP17) and Zn (AP18) 
doped powders were shifted to higher angles (Table 6.4), which suggest expansion and 
contraction of the lattice parameters, respectively. This advocates that the additional 
cations partially replaced Ca
2+
 within the crystal structure. 
Comparison of XRD patterns of AP16 – AP18 heated to 600°C revealed the presence 
of relatively sharp peaks that matched with β-TCP in AP17 (Mg), which were not 
observed in any other samples (Figure 6.2). In addition to the aforementioned 
inhibitory effect of Mg on nucleation, it has been reported that incorporation of this 
cation in non-stoichiometric HA favours a thermal transformation to whitlockite 
[Ca9MgH(PO4)7] above 600°C [129]. It should be noted that it is possible to replace up 
to 15% of Ca
2+
 with Mg
2+
 without changing the β-TCP structure. Since whitlockite 
and β-TCP exhibit a similar crystal arrangement this explains why XRD peaks were 
matched to β-TCP [320]. Compared with AP09 the PO4
3-
 bands for AP17 exhibited a 
shape synonymous with β-TCP and specifically the intensity of these bands were 
greater for AP17 compared with AP16 (Sr) and AP18 (Zn) (Figure 6.4). 
Variation of the size of globular particles and agglomerates was evidenced by SEM 
micrographs (Figure 6.5). Specifically, particulates and agglomerates were 80 and 
65% larger for Sr substituted precipitates (AP16), respectively compared to AP09. In 
contrast, a 40 and 20% reduction was observed when Mg was used (AP17), 
respectively. These observations are consistent with the trend of ionic sizes, i.e. 
Sr
2+
>Ca
2+
>Mg
2+
. 
Incorporation of Mg was observed to influence the high temperature behaviour of the 
prepared apatites between 700 and 800°C (Figure 6.7). Specifically, a significant 
reduction in the area of the DTG peak within this temperature region was 
demonstrated and this is linked to the degradation of AP17 to whitlockite below 
600°C, as evidenced by XRD analysis. Thermal analysis suggests that the presence of 
any of the investigated cations led to an increase in the concentration of non-apatitic 
HPO4
2-
 compared with AP09 (Table 6.7). This is explained in terms of the additional 
cations altering the ionic species (i.e. decrease in Ca
2+
 concentration as a result of 
replacement with Sr, Mg, or Zn) within the initial solution and thus the relative 
degrees of supersaturation. Gradual weight loss between 250 and 700°C and the 
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presence of banding associated with non-apatitic HPO4
2-
 in FTIR spectra suggests 
substituted samples are CDHA and in the case of AP17 XRD results advocate this 
specimen is potentially Mg-TCP. 
Presence of Sr, Mg, or Zn was confirmed by XRF. Analysis clearly indicated a 
significantly greater accuracy for Sr substitution in comparison to Mg and Zn (Table 
6.8). Other studies have reported significantly higher substitutions of 10% Mg and 
20mol% Zn, therefore it cannot be concluded that the lower accuracy of these cations 
in AP17 and AP18 is due to the respective substitution limits for these elements [139, 
321]. Instead, these results are indicative that the process of Mg and Zn incorporation 
is relatively difficult. In comparison, the higher accuracy of Sr substitution can be 
linked to the ability of Sr
2+
 to replace Ca
2+
 in the HA structure over the whole range of 
composition (i.e. 0 – 100%) [11]. These results suggest that the difference in ionic size 
play an important role in determining the ease of substitution but it is recognised that it 
would be necessary to investigate a range of substitution levels to clarify any 
correlation. It should also be noted that these results do not differentiate between 
surface absorption or lattice substitution, and therefore it is possible that the detected 
levels of Sr, Mg, or Zn are merely present on the surface of particles. However, since 
all XRD patterns exhibited shifts consistent with relative ionic sizes this strongly 
suggests that there is at least a partial substitution of these cations in the lattice 
structure. The Ca+Mx:P ratios calculated from XRF results indicate all samples are 
CDHA (Table 6.8), which is consistent with FTIR and DTA-TGA analyses. 
The advantages of the SBF test have previously been discussed in section 5.5 and 
hence justify why this technique has been used again in this chapter as a prerequisite 
to cell culture. However, the morphology of the surface coating on samples AP16 – 
AP18 was not shown to exhibit the spheroidal nodules and fine needle-like structure 
known to be typical of SBF grown apatite [301]. The author does not consider this a 
false result of bioactivity but instead experimental confirmation of the sensitivity and 
variability of SBF, which are the underlying reasons why this test is debated within the 
literature. It is suggested that the noticeable surface degradation of substrates 
containing additional cations influenced the process of apatite precipitation in SBF. 
These effects were only noted for samples AP16 – AP18, which explains why SBF 
results for these samples are different than those presented in other chapters. 
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Live/dead assay confirmed the viability of cells seeded on samples shown to contain 
Sr, Mg, or Zn thus indicating that the presence or effect of these additional cations on 
substrates did not induce a cytotoxic response (Figure 6.11). MTT and Hoechst assays 
demonstrated the ability of these samples to support cell proliferation between 1 and 7 
days of culture. Specifically, compared to the control sample prepared under the same 
conditions (AP09), substrates containing Mg (AP17) and Zn (AP18) were shown to 
exhibit a relative increase of 80 and 40% metabolically active cells between days 1 
and 7, respectively (Table 6.10). These samples exhibited a greater degree of 
broadening of characteristic XRD peaks as well as FTIR bands associated with PO4
3-
, 
and a relatively large surface area compared to the control. Thus, it is proposed that 
these characteristics are responsible for the observed improvement in the ability of 
substrates to support cell proliferation. This assertion is supported by the literature 
since numerous authors have reported an inverse relationship between crystallinity and 
mineralisation, and an increase in the number of osteoblasts on rougher substrates 
(section 5.5). Therefore it seems that the inhibitory effect reported for Mg as well as 
Zn on the process of nucleation is beneficial to the ability of substrates to support the 
proliferation of osteoblast precursor cells, this is explained in terms of the improved 
dissolution associated with lower crystallinity [319]. As such, scaffolds made from 
these materials might exhibit improved osteointegration and osteoconduction. SEM 
micrographs of all substituted substrates after 28 days of immersion in SBF exhibited 
morphology indicative of surface degradation (Figure 6.10 c), this was not observed in 
other samples characterised in this thesis. It is recommended that future work include 
characterisation of substrate dissolution rates since this information could support 
these suggestions that are based on qualitative observations. Standard and modified 
ANOVA testing verified the statistical significance of the observed cell proliferation 
(Table 6.11). The different trend in growth measured for Mg containing substrates 
(AP17) was distinguished by the F ratios calculated using the modified method. This 
highlights the importance of considering the whole data set to ensure information is 
not lost. The notable difference in the proliferative trend of AP17 is suggested to be 
due to the higher HPO4
2-
 content (Table 6.7), which infers a greater degree of non-
stoichiometry and thus a faster dissolution rate. The negative F ratio calculated for 
AP17 based on the linear regression of day 1 – 5 suggests that the exponential growth 
phase of MC3T3 cells begins between days 3 and 5, whereas for other samples it 
appears this does not occur until after day 5. Thus it is expected that osteoblasts seeded 
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on this sample would reach confluency quicker. No discernible difference was 
demonstrated between the number of metabolically active cells measured on AP09 and 
substrates containing Sr (AP16). The density of osteoblast precursor cells on HA 
containing 10mol% Sr has been reported previously to significantly exceed a control 
sample of pure HA [18], which suggests a higher concentration of Sr may be required 
to induce advantageous biological effects. 
A difference in the degree of proliferation on substrates was revealed between MTT 
and Hoechst assays, which are to be expected since the two assays measure different 
cellular properties. In contrast, the proliferative rates calculated from DNA staining 
using Hoechst 33258 for samples AP16 – AP18 were on average 9.4% lower 
compared with AP09. In previous chapters Hoechst assay results revealed an improved 
proliferative rate was associated with an increase in HPO4
2-
 content, hence the results 
presented here call this association into question since AP16 – AP18 exhibited a 
greater concentration of acid phosphate ions compared with AP09. However, due to 
the large degree of experimental variability, in particular for substrates containing Mg 
(AP17) and Zn (AP18), average values of these data sets were skewed by anomalous 
results and thus cannot be used to discount previous assertions. In order to draw a 
cohesive overall conclusion it is recommended that a larger number of samples are 
tested in the future so that any outliers can be disregarded. Statistical analysis 
confirmed the observed proliferation as significant, except AP18 using the standard 
ANOVA method and this is associated with the larger variability of fluorescence 
recorded at day 7 for this sample. In contrast, when the observed lag growth phase rate 
was stripped back, using the modified ANOVA test, the day 7 F ratio for substrates 
containing Zn exceeded the Fcrit value. The non-significance of cells seeded onto Sr-
CDHA (AP16) at day 7 can be explained by the relatively large increase in cell 
number between days 3 and 5 compared to the increase between days 5 and 7. 
6.6 Conclusions 
Literature concerning substitutions in HA is vast and numerous biologically relevant 
cations and anions have been investigated in an attempt to match the reactivity of 
native bone apatite. In summary, the influence of substituting precipitates with 
theoretical amounts of 2mol% Sr, 10mol% Mg, or 2mol% Zn on critical physical, 
chemical and crystallographic properties, which are related to cytocompatibility and 
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the ability of substrates to support cell proliferation were investigated. Importantly, 
CDHA substituted with these divalent cations was synthesised under the same reaction 
conditions (pH, temperature, solute concentration, solvent system) in order to assess 
the single factor influence of Sr
2+
, Mg
2+
 or Zn
2+
. 
Shifts of characteristic XRD peaks of HA due to the addition of Sr, Mg or Zn were 
demonstrated and found to be consistent with the relative ionic sizes of these cations 
compared to Ca
2+
. These observations present evidence to suggest that the levels of 
substituents detected by XRF were at least partially incorporated into the apatite 
lattice. Thermal conversion of Mg substituted precipitates to whitlockite (exhibiting a 
similar structure to β-TCP) was corroborated by XRD patterns of samples heated to 
600°C. It is concluded that this cation inhibited the nucleation process resulting in a 
reduction in the average crystallite size, crystallinity, and a 60% increase in the surface 
area of precipitates. These chemical and physical properties translated to an 80% 
increase in the number of metabolically active MC3T3 cells after 7 days of culture 
compared to the control. The effect and incorporation of Zn was also shown to 
enhance cell proliferation by 40%. In contrast, no marked difference in the ability of 
Sr doped substrates to support cell proliferation compared to the control was observed. 
Use of the modified ANOVA test enabled samples that exhibited a different 
proliferation trend to be identified since this method considered the whole data set. In 
general, day 7 F ratios calculated using both the standard and modified ANOVA test 
(using the linear trend of day 1 – 3 data) exceeded the critical value and thus the 
proliferation observed can be concluded as statistically significant. 
Despite the low accuracy of Mg and Zn substitutions the results presented in this 
chapter suggest effects of these cations on composition and particle surface area 
translated to an enhanced ability of substrates to support cell proliferation. These 
features are considered promising since they could help improve in-vivo 
osteointegration and osteoconduction of scaffold structures. If these results are to be 
taken further a better understanding of the positioning of these cations in the lattice 
would be valuable. In order to optimise the substitution level a range of doping 
concentrations would need to be schematically investigated. 
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7. Feasibility study - fabrication of 
hydroxyapatite scaffolds 
7.1 Fabrication methodology selection 
Cancellous bone tissue exhibits a porous hierarchical structure that facilitates the 
migration, and proliferation of bone cells (Figure 2.1). Besides the synthesis of 
appropriate apatite biomaterials that mimic the chemical and crystallographic 
properties of bone, the structural attributes of bone tissue scaffolds such as pore size 
distribution as well as interconnectivity, porosity, and surface topography, are known 
to be vital factors that determine the success of the implant. 
A review of common conventional and ALM methods used to fabricate bone scaffolds 
in relation to the structural attributes listed above was outlined in Table 2.8. In 
summary, low interconnectivity and poor mechanical strength of structures produced 
via conventional methods was highlighted. The literature also exposes the limited 
reproducibility and risk of using organic solvents in conventional techniques, such as 
salt leaching. In contrast, ALM methodologies generally require higher capital 
investment. However, this cost can be justified since these techniques enable the user 
to define scaffold morphology resulting in improved reproducibility, which ultimately 
could determine the success of the implant. Many ALM systems also operate without 
using toxic organic solvents and powder based techniques have been shown to produce 
rough microporous surfaces favourable for bone cell attachment and fluid flow, which 
can improve dissolution [322]. 
In the present work, the feasibility of two methods was investigated: (1) yeast as a 
pore forming agent (YP), and (2) 3D printing (3DP). Firstly, yeast was utilised as a 
natural pore forming agent since it overcomes the risks associated with using organic 
solvents in conventional techniques. This method can be described as a non-aqueous 
salt leaching technique where the by-product of the reaction between yeast and sugar, 
namely CO2 was exploited, instead of a conventional salt, to form pores within the 
scaffold structure. Secondly, in comparison, the viability of using a commercial 
powder based 3DP system was also selected to evaluate since it is compatible with the 
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raw feedstock material form of HA, can be performed at RT, does not typically use 
any organic solvents, and printed parts inherently exhibit desirable physical features, 
such as surface roughness. 
This chapter presents an experimental assessment of the feasibility to fabricate HA 
scaffolds via these two methods, YP and 3DP, that mimic the physical porous 
structure of native bone tissue. Scaffolds prepared using both techniques were 
characterised to reveal a number of features known to be crucial to implant success 
(section 2.6.2), including porosity, pore size, and interconnectivity. Since 
reproducibility is known to be an inherent disadvantage of conventional methods the 
consistency and variation between fabricated scaffolds was also discussed. 
7.2 Materials and methodology 
Analar grade reagents were purchased from Sigma Aldrich (UK) and used without 
further purification unless otherwise stated. 
7.2.1 Method one - yeast as a pore forming agent (YP) 
The principles used in traditional bread making, viz. dough mixing, fermentation, and 
baking, were followed with the addition of HA as an initial constituent. High purity 
HA (>90%, Fluka, UK) with a median particle size (d50) of 5μm and a specific surface 
area of 72m
2
/g was used as a precursor material. Gluten derived from wheat (≥80% 
protein), wheat based starch [(C6H10O5)n], and dried active yeast (DAY) were used as 
active constituents for the bioceramic dough. CO2 was formed as a by-product of the 
reaction of sugar, from the starch constituent, and DAY. 
20g batches of bioceramic dough were formed with HA loading between 25 and 
80wt%. Dry dough components (HA, gluten, and starch) were homogenised in powder 
form using a ball mill (Glen Creston, UK). To form the bioceramic dough, 1g of DAY 
dissolved in lukewarm DI water was added in stages to the dry mixture that was then 
kneaded for 10mins, and left to ferment for 24hrs at RT covered with a moist cloth, 
which is referred to as proofing. Pre-firing of green bodies was performed at 600°C for 
1hr at a ramp up rate of 1°C/min to burn off the gluten and starch constituents. The 
remaining HA structures were then sintered up to 1300°C, held at this temperature for 
3hrs and then cooled to RT in an air atmosphere using a ramp up and down rate of 
1°C/min. Variables investigated included, the influence of the gluten to starch ratio 
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(1:3 – 2:3), degree of grinding of DAY (unground or ground), and the yeast content 
(0.5 – 2g) (Table 7.1). 
 
Table 7.1: Summary of the reaction conditions used to fabricate scaffold structures via YP 
method (G = ground, UG = unground) 
Sample HA loading (%) Gluten:Starch DAY content (g) DAY (G/UG) 
Y01 25 1:3 1 G 
Y02 25 1:3 1 UG 
Y03 50 1:3 0.5 UG 
Y04 50 1:3 1 UG 
Y05 50 1:3 2 UG 
Y06 60 1:3 1 UG 
Y07 60 2:3 1 UG 
Y08 70 1:3 1 UG 
 
7.2.2 Method two - 3DP 
Prior to printing scaffold structures, the printability of HA:PVOH (Moiwol 23-88, 
Clariant, UK) composite powders was assessed by fabricating rectangular blocks of 
various compositions (50 – 100wt% HA). Prior to use, supplied PVOH was ball 
milled, passed through a 200μm sieve, mechanically mixed with appropriate amounts 
of HA, and stored at RT. Optimum binder saturation levels for each composition were 
visually assessed by considering the influence on part stability. This initial assessment 
was used to select printable HA:PVOH compositions to fabricate 200% cylindrical 
scaffold structures (Figure 7.1). Any loose powder was removed from parts after 
printing using compressed air. 
Rectangular blocks and scaffolds were designed using Solidworks CAD software, and 
converted to stereolithography format prior to printing. Green body parts were printed 
using a ZPrinter 310 (ZCorp, US) 3D printer in combination with Zb60 binder (ZCorp, 
US). Layer thickness was defined as 0.1mm.  
7.3 Scaffold characterisation 
7.3.1 X-ray diffraction (XRD) 
XRD analysis was performed on as-received and sintered (1300°C) HA, as well as a 
50:50wt% composition of HA:PVOH. Phase identification was performed using the 
JCPDS database using the scan parameters previously described in section 4.3.1. 
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Figure 7.1: CAD design of 3DP cylindrical scaffolds (1mm pores, 10mm height and diameter) 
(a) External structure and (b) internal structure 
 
7.3.2 Differential thermal and thermogravimetry analysis (DTA-
TGA) 
Burn out of organic constituents (starch and gluten) used in the YP process was 
characterised by DTA-TGA (section 3.3.3) by heating 20mg of dry bioceramic dough 
from 30 to 800°C at a constant ramp rate of 1°C/min in flowing air. The thermal 
behaviour of as-received HA and ball milled PVOH powders used in the 3DP 
procedure were also analysed between 30 and 1300°C at a constant ramp rate of 
1°C/min in flowing air. 
7.3.3 Scanning electron microscopy (SEM) 
The method previously described (section 3.3.2) was used to image the surface 
topography, and microstructure of typical scaffolds. Micrographs were used to 
measure the average pore size (n=3) and qualitatively assess the degree of pore 
interconnectivity. Prior to analysis the constructs were attached to aluminium stubs 
using conducting silver paint and sputter coated with a thin layer of gold in an argon-
purged chamber for 90s. 
7.3.4 Computer tomography (CT) 
A CT scanner (Model XT H 320 LC, Nikon Metrology, UK) was used to capture the 
volume data of a typical YP construct and visualise the internal structure. 
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7.4 Results 
7.4.1 Characterisation of precursors used in YP and 3DP methods 
7.4.1.1 Crystal structure 
The phase purity of as-received and sintered HA (used in both YP and 3DP methods), 
as well as 50HA:50PVOH powders (used in only 3DP method) were analysed by 
XRD (Figure 7.2). Characteristic peaks of as-received HA and 50HA:50PVOH 
powders were matched to the JCPDS standard for HA (09-432) and DCPA (09-0080). 
Notably the peak intensity of the 50HA:50PVOH powder was reduced and a higher 
background observed. Sintering HA at 1300°C resulted in the formation of β-TCP (70-
2065), and α-TCP (29-359) phases (Figure 7.2 c). 
 
Figure 7.2: XRD pattern of (a) supplied HA, (b) 50HA:50PVOH, and (c) HA sintered to 1300°C 
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7.4.1.2 Thermal behaviour 
Simultaneous DTA-TGA analysis of supplied HA, used in both fabrication processes, 
was carried out from 30 to 1300°C and the remaining mass was calculated to be 
95.42wt% (Figure 7.3). Differentiation of the TGA curve (DTG) revealed the presence 
of three temperature regions where a significant change in the rate of weight loss was 
observed: (1) endothermic 350 – 450°C, (2) endothermic 700 – 800°C, and (3) 
exothermic 1100 – 1150°C. Gradual weight loss associated with an endotherm was 
also demonstrated below 350°C. 
 
Figure 7.3: Thermal behaviour of as-received HA used in YP and 3DP processes 
(DTA = dashed red line, TGA = solid black line, DTG = solid blue line) 
 
In comparison, simultaneous DTA-TGA analysis of ball milled PVOH revealed a 
residue of 0.45wt% at 1300°C (Figure 7.4), which is consistent with the maximum ash 
content (<0.5wt%) reported by the manufacturer. PVOH was heated above its thermal 
degradation temperature meaning cross linking of the polymer chain began to be 
disrupted, i.e. molecular deterioration. Onset of thermal degradation was observed to 
be approximately 185°C. Holland et al. attributed solid state thermal degradation of 
PVOH exclusively to the elimination of water [323] and this may account for the 
observed endothermic peak close to the degradation temperature (Figure 7.4). In 
contrast, the following were attributed to molten state degradation between 230 and 
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450°C: (1) elimination of water and chain scission, (2) formation of saturated and 
unsaturated volatile aldehydes, and (3) formation of saturated and unsaturated volatile 
ketones. The three exothermic DTA peaks exhibited between 245 and 450°C are 
attributed to molten state degradation of PVOH. The DTG peak at 260°C was 
associated to solid state degradation, and the other two regions of rapid weight loss, 
between 350 and 500°C, were attributed to removal of volatile aldehydes and ketones. 
 
Figure 7.4: Thermal behaviour of ball milled PVOH used in the 3DP process 
(DTA = dashed red line, TGA = solid black line, DTG = solid blue line) 
 
Burn out of the organic constituents, namely gluten and starch, from the bioceramic 
dough formed for sample Y02 was analysed by DTA-TGA (Figure 7.5). Three weight 
loss stages were observed between 30 and 800°C that corresponded to: (1) endotherm 
peaking at 80°C, (2) exotherm peaking at 340°C, and (3) exothermic reaction peaking 
at 460°C. These events are attributed to the removal of water, and the burn out of 
starch and gluten, respectively. A residue of 21.1wt% was calculated for Y02. When 
the weight loss observed for HA alone over this temperature regime (Figure 7.3) was 
taken into account (4.19wt%), this total 25.3wt%, corresponded approximately to the 
HA loading (25wt%) of Y02. This observation suggests that both organic constituents 
were completely removed from the dough. 
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Figure 7.5: Thermal behaviour of Y02 25wt% HA bioceramic dough formed in YP process 
 
7.4.2 Microstructural development of scaffolds 
7.4.2.1 Method one - YP scaffolds 
It is well known that the by-product of the reaction of yeast with sugar is CO2 and it is 
this process that was utilised to form the observed pores in YP scaffolds (Figure 7.6). 
It is proposed that this process is initiated firstly by evolution of CO2 from individual 
DAY granules that results in the formation of micropores. Over time, it seems this 
reaction propagates and CO2 it built up within the sample, which leads to the 
development of macropores. 
Micrographs of samples prepared with ground and unground DAY demonstrated a 
difference in the degree of micropores (Figures 7.6 f and g). Consequently, it is 
suggested that grinding of DAY fragments pellets to a degree, which resulted in a 
reduction of the amount of CO2 evolved from individual granules. This disrupts the 
previously described sequence of micropore formation. Less than 10% difference was 
observed in the average pore sizes of Y01 and Y02, which suggests that the 
development of macropores is not affected by granulation since bulk scale 
development of CO2 is not altered (Table 7.2). 
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Figure 7.6: Micrographs of scaffolds produced via YP method and sintered at 1300°C 
(a) Y03, (b) Y04, (c) Y05, (d) Y06, (e) Y07, (f)Y01, (g) Y02, (h) Y02, (i) Y04, (j) Y06, and (k) Y08 
Images taken from ‘micropore’ region (Figure 7.12) of a cross sectional slice 
 
Yeast content was observed to affect the size of pores (Table 7.2). An increase in yeast 
content from 0.5 – 1g resulted in an increase of average pore size of over 115% and 
further addition of yeast (2g) caused a 35% growth. This is attributed to a greater 
amount of CO2 evolution. Increasing the yeast content, within the ranges assessed, 
resulted in a roughly proportional increase in the average pore size, which is attributed 
to a higher proportion of sugar from starch reacting with DAY granules (Figure 7.7). 
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Table 7.2: Summary of the average pore size of YP scaffolds (n=3) 
Sample 
Investigated 
parameter 
Parameter value 
Average pore size 
(μm) 
Y01 
DAY G/UG 
G 15.8±1.3 
Y02 UG (micropores) 2.5±0.4 
Y02 UG and 25wt% HA 17.4±4.7 
Y03 
DAY content 
0.5g 13.8±2.4 
Y04 1.0g and 50wt% HA 29.9±5.8 
Y05 2.0g 40.5±13.2 
Y06 
Gluten:Starch 
1:3 and 60wt% HA 15.4±4.6 
Y07 2:3 10.1±2.8 
Y08 HA loading 70wt% HA 14.4±4.8 
 
 
Figure 7.7: Influence of DAY content on average pore size of YP scaffolds 
 
It appears that as gluten content was increased the scaffold structure became less 
networked (Figures 7.6 d and e). This is ascribed to the viscoelastic properties of 
typical proteins, such as gluten, which may have resulted in a higher firming rate i.e. 
lack of pore volume development caused by entanglements and crosslinking of 
hydrogen bonds between protein fibrils and starch.  
The development of porosity and pore size were shown to be dependent on the degree 
of HA loading (Figure 7.6 h – k). In particular, the observed decrease in average pore 
size of samples Y06 (60wt% HA) and Y08 (70wt% HA) advocate that the dough has a 
limited loading capacity, and above this the development of pores is restricted by HA 
content (Figure 7.8). 
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Figure 7.8: Influence of HA loading on the development of pores within YP scaffolds 
 
Typical 2D slices of YP constructs after pre-firing at 600°C confirmed the presence of 
both micro and macropores (Figure 7.9). In the majority of samples a denser outer 
region, referred to as ‘skin’, was demonstrated. This observation is analogous with the 
crust formed in traditional bread making and is thought to be due to a higher 
consolidation rate at extremities trapping CO2. The ‘skin’ layer is therefore suggested 
to have contributed to the coalescing of micropores in the inner regions of the sample. 
 
 
Figure 7.9: Typical 3D distribution of pores in YP constructs  
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7.4.2.2 Method two - 3D printed parts 
The stability of 3D printed blocks of various HA:PVOH compositions were visually 
assessed, and the large degree of variability observed highlights the importance of 
selecting an optimum precursor composition (Figure 7.10). These results suggest that 
the minimum PVOH content required to bind printed layers together was 20wt%, 
since blocks with less than this value could not be handled. Above this minimum 
PVOH content all tested compositions (50, 70, and 80wt% HA) exhibited a sufficient 
flowability to recoat the build bed without compromising bed stability, and interlayer 
bonding was strong enough to enable parts to be handled. Therefore these 
compositions were deemed printable. Blocks printed from the 50HA:50PVOH 
precursor were notably distorted along the axis perpendicular to the direction of 
spreading, which was attributed to excessive wetting due to the relatively high 
polymer content. 
 
Figure 7.10: Stability of 3D printed blocks  
(a) 50HA 100% saturation, (b) 70HA 194% saturation, (c) HA80 194% saturation, (d) HA90 
194% saturation, and (e) 100HA 194% saturation   
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The surface topography of blocks fabricated from printable precursor compositions 
was assessed via SEM (Figure 7.11). Two distinctly different particle morphologies 
and sizes were observed within the surface layer of parts that were attributed to HA 
and PVOH particles. It appeared that smaller HA particles were bonded to the surface 
of larger PVOH particles, creating a rough surface topography. Surface pores were 
demonstrated in all green bodies suggesting a degree of microporosity is inherently 
produced during printing, which is attributed to a packing efficiency less than 1 due to 
interparticulate voids within spread powder layers. 
 
Figure 7.11: Surface topography of 3D printed blocks (a – c) 50wt% HA 100% saturation, (d – f) 
70wt% HA 194% saturation, and (g – i) 80wt% HA 194% saturation 
 
Scaffold structures were produced from precursors compositions that were deemed 
printable (50, 70, 80wt% HA). Remarkably, scaffolds printed from these 
compositions, except 50HA:50PVOH, were found to be structurally unstable and 
difficult to handle without causing damage. Fragility of these constructs is attributed to 
insufficient bonding between powder layers. In contrast, green scaffolds printed from 
the 50HA:50PVOH precursor powder were easy to handle and could not be crushed 
by hand (Figure 7.12 a and b). Visualisation of typical green structures validated that 
designed pore channels were not occluded (Figure 7.12 c), and scaffold struts revealed 
the layer by layer manufacturing method employed (Figure 7.12 d). A similar 
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microporous surface topography to block parts was demonstrated (Figure 7.12 e and 
f). Measurements of pore width and length, as well as strut width of six different 
samples was used to calculate the reproducibility ratio of green parts, which is defined 
as experimental size divided by the corresponding user defined CAD dimension 
(Table 7.3). 
Figure 7.12: 50wt% HA green scaffolds produced via 3DP  
(a) Side view, (b) top view, (c) designed pore channel, (d) strut, and (e - f) surface morphology 
 
 
Table 7.3: Reproducibility of 50wt% HA scaffolds produced via 3DP (n=6) 
Feature 
Average 
(μm) 
Reproducibility 
ratio 
Pore width 2035±507 101±26 
Pore length 1893±538 94.7±27 
Strut width 1723±290 86.1±15 
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7.5 Discussion 
XRD analysis of as-received commercial HA powder, used in both fabrication 
processes, matched to standard patterns of HA and DCPA (Figure 7.2). This result was 
confirmed by DTA-TGA analysis that revealed weight losses within the temperature 
region (320 – 340°C), which is associated to the transformation of DCPA to β-
Ca2P2O7 (Equation 2.4). Further weight loss between 700 – 800°C suggests the 
commercial powder is CDHA since degradation products of this phase are known to 
transform to HA and β-TCP within that temperature range (Equation 2.5). This 
assertion is supported by the presence of β-TCP in the XRD pattern of sintered HA 
(Figure 7.2 c). Presence of DCPA infers that during synthesis key reaction parameters, 
such as pH and temperature, were not controlled to a high degree. The exotherm 
demonstrated between 1100 and 1150°C for HA was attributed to the transformation 
of β-TCP to α-TCP, which is known to occur at approximately1125°C (Figure 2.9). 
The thermal behaviour of a typical bioceramic dough composition formed during the 
YP process, and PVOH used in the 3DP system were primarily assessed to determine 
the burn out behaviour of organic constituents. This may be considered as an 
important prerequisite to the design of heat treatment protocols to remove organics 
from HA green bodies. The residue after heating bioceramic dough up to 800°C was 
shown to be approximately equal to the HA loading of samples, which suggests 
organics were completely removed from the structure. Heating beyond the thermal 
degradation temperature of PVOH revealed the thermal events involved in its 
molecular deterioration, which were attributed to reported solid and molten state 
degradation processes [323]. In order to maintain the structural integrity of sintered 3D 
printed scaffolds it will be vital that the gases evolved during PVOH degradation do 
not become trapped within the structure. It is proposed that the inherent micron sized 
interparticulate voids associated with a packing efficiency less than 1 could help to 
facilitate gaseous removal (Figures 7.11 and 7.12). However, the author recognises 
that the effectiveness of the observed surface microporosity to enable gas evolution is 
greatly dependent on 3D interconnectivity of these pores. 
Printing of rectangular blocks proved to be a time efficient way to determine which 
HA:PVOH compositions were printable. Initial visual assessment of samples 
suggested the minimum content of PVOH required to bond powdered layers together 
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was 20wt% therefore suggesting that 50, 70 and 80wt% HA precursors could be 
deemed as printable. However, of these initial three compositions stable and easy to 
handle scaffolds could be fabricated only from the 50HA:50PVOH precursor powder. 
SEM micrographs of the surface of green parts exhibited an inherent surface 
roughness due to numerous topographical irregularities, which was attributed to the 
packing efficiency of composite powders. This observation has been reported in the 
literature as advantageous for fluid flow, resultant remodelling and dissolution [322], 
which could improve osteoconductive and osteointegrative properties of the scaffold. 
It is also important to note the microporosity caused by interparticulate voids, since 
this structural attribute has been reported to facilitate attachment points for osteoblasts 
and vital to capillary ingrowth [88]. 
Interconnectivity is known to be a structural property required of bone tissue scaffolds 
since it is necessary to ensure blood cell invasion, cell migration, and mass transport 
[103]. A notable inherent advantage of ALM techniques, such as 3DP, is the user can 
design the scaffold construct so that this critical structural demand is met on a bulk 
scale. However, it is also important to consider whether the inherent microporosity 
formed in these 3D printed scaffolds are connected, this could be achieved by CT 
scanning structures. Previously, other authors have reported that de-powdering 3D 
printed parts is difficult and therefore loose powder can remain within the structure, 
which could lead to occlusion of pores. Micrographs of designed pore channels 
established that this was not the case in this study (Figure 7.12). 
2D slices of CT scans of YP scaffolds demonstrated three areas within structures that 
exhibited different pore sizes and limited interconnectivity (Figure 7.9). SEM analysis 
of the size of micropores within YP constructs revealed a relatively small range (Table 
7.2). It is suggested that the formation of a relatively dense ‘skin’ layer at the 
extremities during pre-firing is responsible for the inhomogeneous distribution of 
pores since it may have trapped evolving CO2 within the structure thus causing a 
build-up in the inner areas, which explains the larger pores within this region. Since 
the residue of DTA-TGA analysis of the bioceramic dough corresponded 
approximately to HA content it seems that the ‘skin’ layer did not prevent the removal 
of organic constituents. Microstructural development of YP scaffolds was shown to 
depend on: (1) yeast content, (2) gluten content, and (3) HA loading. Specifically the 
formation of micropores (2 – 3μm) was linked to the evolution of CO2 from individual 
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DAY pellets. YP scaffolds were observed to exhibit surface and bulk porosity, 
however the interconnectivity of pores were shown to be limited (Figure 7.6) and their 
distribution inhomogeneous (Figure 7.9). Inhomogeneity is suggested to be due to 
variation in the thickness (1 – 2mm) of the ‘skin’ layer trapping evolving CO2 to 
different degrees, resulting in poor reproducibility. To understand this process further 
it would be necessary to assess the kinetics and quantity of CO2 production and 
perhaps this knowledge could be used to improve sample consistency. 
Overall, a comparison of experimental and CAD dimensions is evidence that the 3DP 
process enabled accurate translation of the designed model to the green scaffold (Table 
7.3). It should be noted that since the resolution of 3DP is partially dependent on the 
maximum particle size of stock materials, in this case 200 μm, reproducibility is likely 
to be reduced if scaffold features were scaled down. In comparison, the pore size and 
distribution as well as interconnectivity of YP constructs were demonstrated to vary as 
a result of changing any of the investigated experimental variables. These properties 
are suggested to determine the ease of CO2 evolution, thus sample consistency and 
reproducibility is dependent on the ability to accurately control these effects. The high 
degree of variability of pore size and distribution, as well as interconnectivity was 
highlighted in this study. These are typical inherent disadvantages reported for 
conventional methods that result in poor reproducibility due to lack of control over 
pore development. 
7.6 Conclusions 
The feasibility of fabricating porous bone tissue scaffolds by two different fabrication 
processes, namely YP and 3DP, was experimentally assessed in this chapter. The YP 
process developed in this work demonstrates the possibilities of adapting conventional 
methods, such as salt leaching, to use alternative natural pore forming agents that do 
not require the use of common toxic organic solvents. Furthermore, the potential to 
fabricate user defined constructs with a rough surface topography, known to be 
favourable for bone cell attachment, via 3DP has also been highlighted. It is important 
to note that the reported intrinsic advantages of ALM techniques, such as improved 
reproducibility relative to conventional methods, were evidenced experimentally. 
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Reported disadvantages of conventional fabrication techniques, such as poor 
interconnectivity, were highlighted by the characterisations performed on YP 
scaffolds. To improve this method it would be necessary to develop a better 
understanding of the evolution of CO2 and its influence on microstructural 
development. In order to ensure sample consistency and improve reproducibility it 
would be necessary to formulate a mechanism to appropriately control CO2 release 
and thus pore size distribution. 
Scaffolds produced via the 3DP method were observed to exhibit an inherently 
irregular surface topography and microporosity that are both desirable characteristics, 
since these features could correlate to improved attachment of bone cells and structural 
infiltration. These results are a promising foundation to the fabrication of a scaffold 
that exhibits physical properties considered as advantageous, as well as critical to the 
success of bone implants, thus justifying the selection of this technique for further 
investigation. 
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8. 3D printing of hydroxyapatite 
scaffolds 
8.1 Introduction 
The feasibility of fabricating 3D porous scaffolds from compositions of HA:PVOH, 
suitable for use as a component of the tissue engineering strategy was assessed in 
Chapter 7. This preliminary study highlighted the potential of 3DP to produce 
constructs that exhibit key structural criteria, such as surface roughness and porosity, 
which are known to be vital in determining the success of bone tissue scaffolds 
(section 2.6.2). This chapter expands on previous conclusions and assesses in more 
detail the experimental viability of printing scaffold structures suitable for use in bone 
tissue replacement from HA:PVOH precursors. 
Previous studies concerning 3DP of CaPs have notably highlighted the influence of a 
number of powder characteristics, such as particle size distribution, on parameters, 
namely flowability and wettability, that are advocated to be crucial in defining 
printability [266, 267]. Flowability, defined as the ability of the powdered raw 
material system to flow and recoat previous layers, is expected to strongly influence 
the resolution, mechanical stability, and packing efficiency of 3D printed scaffolds 
(section 2.16.2). Therefore, prior to printing a number of key precursor parameters 
were determined experimentally, including flowability, particle morphology and size 
distribution, as well as bulk and tapped density.  
In summary, this chapter demonstrates the influence of precursor characteristics, green 
part post-processing, and sintering protocols in relation to: (1) macro and 
microporosity, (2) pore size distribution, (3) pore interconnectivity, (4) surface 
topography, and (5) mechanical strength of green and sintered scaffolds. 
8.2 Materials and methodology 
Analar grade reagents were purchased from Sigma Aldrich (UK) and used without 
further purification unless otherwise stated. As previously described (section 7.2.2), 
prior to use as-received PVOH was ball milled to form a powder with particle sizes 
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<200μm. This was mechanically mixed with varying quantities of HA in an alumina 
crucible. Composite powders were sieved before use to break up any agglomeration 
formed during mixing or storage. 
Prior to printing, the flowability of HA:PVOH compositions were directly assessed 
using the methods described in section 8.3.1. A number of additional characterisations 
were performed to obtain a reference composition and assess properties known to 
affect flowability, for example particle morphology. 
A ZPrinter 310 3D printer in combination with a water based commercial binder 
(Zb60) was used to print 200% cylindrical scaffold structures (Figure 7.1) using 
powder compositions with a maximum HA content of 80wt%. Precursors were poured 
into the powder bed of the printer, arranged into a strip, and compacted before 
printing. The binder saturation level used was 194% and layer thickness was set to 
0.1mm. Green parts were left to dry for 1hr, as recommended by the printer 
manufacturer, before being removed from the build bed. The influences of a number 
of green part processing variations were investigated: (1) de-powdering method, (2) 
drying method, and (3) drying time. De-powdered constructs were finally sintered to 
remove PVOH. 
8.3 Scaffold characterisation  
For clarity, the characterisations performed have been split into the following sections: 
(1) precursor materials, (2) green-parts, and (3) sintered constructs. Green and sintered 
constructs were characterised to determine if scaffolds exhibited vital physical 
properties (section 2.6.2) namely: (1) porosity, (2) pore size and distribution, (3) 
interconnectivity, (4) surface topography, and (5) mechanical strength. 
8.3.1 Precursor characterisations 
Flowability of raw materials and composite powders were assessed by two different 
funnel methods. In addition, characteristic particle properties that have been reported 
to affect flowability were also experimentally assessed, including particle morphology, 
and particle size distribution. DTA-TGA analysis of HA:PVOH powders was 
performed as a prerequisite to designing heat treatment protocols, and FTIR was used 
to obtain reference compositions of precursors.  
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8.3.1.1 Precursor flowability 
A Pyrex funnel (60°, 10mm diameter orifice) was held upright 10±0.1cm above a level 
surface using a clamp, and clamp stand. 10±0.1g of as-received HA, milled PVOH, 
and composite powders were weighed and reproducibly poured into the funnel while 
its opening was blocked. The obstruction was removed and the time taken for the 
powder to pass through was manually recorded using a stopwatch (±0.01seconds). In 
order to calculate the angle of repose (R) the height and width of the formed powder 
pile was measured to an accuracy of ±0.1cm (Equation 8.1). This process was repeated 
thrice for each composition to obtain average values. 
         (
 
(
 
 
)
)                                                                                                      (8.1) 
Where R = Angle of repose, h = height of powder pile, and w = width of powder pile 
(Figure 8.1). 
 
Figure 8.1: Measurements to calculate angle of repose (R) 
(w = width, h = height)  
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8.3.1.2 Particle size distribution 
Dry particulate size and distribution data was measured by laser diffraction using a 
Mastersizer 2000 fitted with Scirocco 2000 dry dispersion unit (Malvern Instruments, 
UK). HA, PVOH, and composite powders were loaded into the dispersion unit and fed 
through the cell at 1 bar. The laser was aligned to the centre of the cell for optimum 
intensity and prior to each measurement, a background spectrum was collected to 
eliminate the presence of contaminants in the data set. Refractive indices from the 
instrument database for HA and PVOH were used to compile the software scattering 
model. The final result for each sample was formed from an average of 3 
measurements, each of 10s duration, and was transformed from volume average to 
number average. 
8.3.1.3 Bulk and tapped density 
The ratio of the mass to volume of an untapped (i.e. unsettled powder), which includes 
interparticle void volume, is defined as bulk density (  ). Hence,    is a measure of 
both the density of the powder and the spatial arrangement of powder particles 
(Equation 8.2). 
To measure    of as-received HA, milled PVOH, and composite powders 50±0.01g 
was weighed ( ) and poured into a dry 150mL graduated cylinder readable to 1mL. 
The powder was levelled without compacting, and the apparent volume (  ) was 
recorded to the nearest graduated unit in mL. Prior to testing each sample was passed 
through a 250μm sieve to break up any agglomerates. This process was repeated thrice 
to obtain an average. 
    
 
  
                                                                                                                      (8.2) 
Tapped density (  ) is commonly obtained by using a tapped density analyser, which 
mechanically taps a container comprising of a powder sample and any changes in 
volume are recorded until no further significant change occurs, i.e. until interparticle 
voids are filled. Since a tapped density analyser was not available and an absolute 
value was not required an ultrasound bath was used to reduce interparticulate voids. 
After observing    the cylinder was placed in an ultrasonic bath for 1, 2, and 5mins, 
corresponding volumes    ,   , and     were recorded to the nearest graduated unit. 
Each measurement was repeated three times to calculate an average. Reproducibility 
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of these results was ensured by ‘tapping’ a fixed mass of powder over a defined period 
of time while using the same ultrasound bath. 
Using these density measurements the Hausner ratio ( ) for each precursor powder 
was calculated (Equation 8.3). This ratio provides a measure of the propensity of a 
powder to be compressed, which can be used as a measure of the ability of the powder 
to settle, and to assess the relative importance of interparticle interactions. 
   
  
  
                                                                                                                       (8.3) 
Where     final tapped volume, in this study        . Free flowing powders should 
exhibit bulk and tapped densities close in value since interparticle interactions are less 
significant in such materials. 
8.3.1.4 Spreadability 
An indirect assessment of powder flowability and bed stability was obtained by 
observing the ability of each powder to be spread from the powder to build bed. 
HA:PVOH precursor materials were poured into the powder bed of the 3D printer, 
arranged into a strip, and reproducibly compacted. 5 layers of 0.1mm thickness were 
spread by the counter-rotating roller and photographs were taken before and after 
spreading, which were used to measure the maximum and minimum lengths of each 
bed profile. An average length was calculated from measurements taken in three 
locations: (1) and (2) 1cm from each edge of the bed, and (3) the centre point (Figure 
8.2). This was repeated for the build bed profile and a build:powder bed ratio was 
calculated. A qualitative assessment of the topography of spread powder layers was 
also obtained from photographs. 
 
Figure 8.2: Measurements to assess the spreadability of composite powders  
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8.3.1.5 Particle morphology of precursor materials 
The morphology and particle size of as-received HA, milled PVOH, and 
50HA:50PVOH powders were analysed by SEM (Zeiss Supra55 FEGSEM) at 20kV. 
Powders were dispersed onto double adhesive carbon tabs attached to an aluminium 
stub and sputter-coated with a thin layer of gold in an argon-purged chamber for 90s. 
8.3.1.6 Chemical composition of precursor materials  
As a prerequisite to determining the chemical composition of post-processed and 
sintered samples, precursors of different HA:PVOH ratios were assessed by FTIR 
using the method described in section 4.3.2.  
8.3.1.7 Thermal analysis 
Burn out of PVOH from HA:PVOH precursors was evaluated as a prerequisite to 
designing heat treatment protocols for scaffolds. Simultaneous DTA-TGA was 
performed using the method described in section 3.3.3.  
8.3.2 Green body characterisations 
8.3.2.1 De-powdering 
Post printing it is necessary to remove loose powder from the pore channels of 
scaffolds. The use of ultrasound treatment for up to 15mins, and compressed air were 
investigated as de-powdering methods. In order for a thin jet of air to be blown a 
syringe needle was attached to the end of an AS18K airbrush compressor (Absolute 
Airbrush, UK), as shown in Figure 8.3. The effectiveness of these techniques was 
visually assessed from images of constructs, and specifically the ability to remove 
loose powder from pore channels was noted. The amount of powder removed via 
ultrasound was determined by weighing scaffolds (±0.0001g) before and after 
treatment. This process was repeated three times to obtain an average value. 
Figure 8.3: Set up of compressed air method to de-powder scaffolds 
(a) Airbrush compressor, and (b - c) air brush nozzle with syringe needle attachment  
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8.3.2.2 Chemical composition 
The influence of drying scaffolds in a furnace or vacuum oven, on the chemical 
composition of HA:PVOH constructs was assessed by FTIR. Prior to using the method 
described in section 4.3.2 scaffolds were crushed using a pestle and mortar to obtain a 
fine powder.  
8.3.2.3 Surface topography and pore size  
SEM micrographs of pore channels, struts, and the surface of constructs were obtained 
using the method described in section 7.3.3. 
8.3.2.4 Mechanical Strength 
The yield and ultimate compressive strength of green bodies were measured using an 
5800R 100kN static tester (Instron, UK) with a 1kN load cell, and a cross head speed 
of 10mm/min. Prior to analysis the initial diameter and height of scaffolds were 
measured using a micrometre. Samples were then placed in the centre of the load cell 
(Figure 8.4a), the load cell position was adjusted (Figure 8.4b), and the gauge length 
zeroed. Yield strength and strain were determined from the load and corresponding 
extension observed before the onset of plastic deformation, i.e. the linear region of the 
stress-strain curve. 
 
Figure 8.4: Compressive strength testing set-up (a) positioning of sample within loading cell, and 
(b) adjustment of loading cell 
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8.3.3 Characterisation of sintered constructs 
A number of heat treatment protocols were used to burn out PVOH from green bodies 
and consolidate the remaining HA scaffold. Any effect of this process on construct 
stability, composition, size, and microstructure were considered using the methods 
described in this section. 
8.3.3.1 Stability of sintered scaffolds  
Scaffolds were visually assessed before and after sintering to determine if the heat 
treatment protocol had any detrimental effect on bulk stability. Formation of any 
defects or instability was noted and sintered parts were photographed. 
8.3.3.2 Chemical composition 
Sintered structures were ground using a pestle and mortar and their composition 
analysed by FTIR as described in section 4.3.2. 
8.3.3.3 Scaffold shrinkage 
The height and diameter of constructs were measured using a micrometre before and 
after heat treatment to determine bulk thermal shrinkage. 
8.3.3.4 Microstructure of sintered scaffolds 
To enable a comparison of green and sintered parts, the microstructure of heat-treated 
scaffolds was assessed by SEM as described in section 8.3.2.3. 
8.4 Results 
8.4.1 Precursor materials 
8.4.1.1 Flowability 
The results of the two funnel tests performed to assess the flowability of HA:PVOH 
precursor powders are summarised in Table 8.1. A decrease in both the angle of repose 
and the time taken to flow through the funnel was observed with decreasing HA 
content (Figure 8.5). These trends indicate improved flowability with increasing 
PVOH content. 
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Table 8.1: Flowability of HA:PVOH precursor powders using funnel tests (n=3) 
HA (wt%) 
Flow time Angle of repose 
Average  
time (s) 
Standard 
deviation 
Angle 
(°) 
Standard 
deviation 
100 4.71 0.24 38.66 0.29 
90 2.96 1.09 35.82 0.86 
80 2.92 0.26 35.60 0.77 
70 2.27 0.27 35.38 0.75 
60 1.98 0.24 27.30 0.65 
50 1.59 0.08 25.80 0.77 
0 
(100% PVOH) 
0.47 0.03 21.22 2.75 
 
 
Figure 8.5: Funnel test results for HA:PVOH precursor powders (n=3) 
 
8.4.1.2 Particle size distribution 
The particle size distribution for precursor powders containing 100, 90, 80, and 50wt% 
HA, as well as milled and unmilled PVOH were measured (Figure 8.6). All composite 
powders exhibited a bimodal distribution comprising of individual HA and PVOH 
fractions. Intensity was found to vary according to the relative proportion of HA and 
PVOH, i.e. as HA content was increased the intensity of the HA fraction increased and 
PVOH decreased. A shift in the PVOH distribution to a larger particle size for 
composite powders in comparison to the milled PVOH distribution was observed, 
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which is likely to be due to coagulation with HA particles. The relatively small 
fraction observed at approximately 1000μm for the milled PVOH precursor is 
suggested to be due to particles clumping together due to humidity. 
 
Figure 8.6: Particle size analysis of HA:PVOH precursor powders (ratios expressed as wt%) 
 
Percentile values (d10, d50, d90) for each powder distribution are shown in Table 8.2. 
The significant increase in the d90 value for milled PVOH compared with unmilled is 
linked with the aforementioned clumping behaviour due to humidity. 
 
Table 8.2: Particle size percentiles of HA:PVOH precursor powders 
Precursor powder 
Particle size percentile 
d10 
(μm) 
d50 
(μm) 
d90 
(μm) 
100wt% HA 2.76 8.45 19.27 
90wt% HA 3.12 10.5 222.86 
80wt% HA 2.84 11.61 268.86 
50wt% HA 5.76 144.75 362.38 
100wt% PVOH (milled)  71.32  159.85  811.97 
100wt% PVOH (unmilled) 133.76 293.79 543.43 
 
8.4.1.3 Bulk and tapped density 
An increase in density was observed for all HA:PVOH precursor powders with 
increasing ultrasound treatment time (Figure 8.7). A reduction in the rate of density 
increase was demonstrated between 1 and 2mins. After 2mins of ultrasound treatment 
most samples exhibited less change or plateaued. This suggests that the majority of the 
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impact of ultrasound treatment on interparticle voids occurs in the first minute of 
treatment. The corresponding average increase in density calculated between treatment 
times quantitatively confirmed the above observation (Table 8.3).  
The Hausner ratio was calculated from the observed densities and is proposed to be an 
indication of the ability of each precursor to settle. These results also reveal the 
relative effect of interparticle interactions on flowability (Table 8.3). PVOH powder 
was shown to be easiest to compact and is suggested to exhibit fewer interparticle 
interactions. A larger Hausner ratio was also calculated for as-received HA compared 
with composite precursors, which suggests particle interactions were more influential 
in HA:PVOH powders. These samples are therefore likely to be harder to compact or 
settle. 
 
Figure 8.7: Bulk and tapped density of HA:PVOH precursor powders 
 
 
Table 8.3: Change in density due to ultrasound treatment 
HA content (%) 
Average change in density (%) Hausner 
Ratio 0 – 1 min 1 – 2 mins 2 – 5 mins 
100 6.69 1.07 0.72 0.9210.02 
90 10.95 2.36 1.50 0.8680.01 
80 18.13 2.70 1.52 0.8120.02 
70 8.25 1.61 2.31 0.8890.02 
50 5.64 1.92 2.76 0.9040 
100% PVOH 0.90 0.30 0.61 0.9820 
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8.4.1.4 Spreadability 
A typical profile of HA:PVOH powder after 5 layers were spread from the powder to 
build bed is shown in Figure 8.8. Measurements of each bed (Figure 8.2) were used to 
calculate minimum, maximum, and average build:powder bed ratios for each 
composite precursor (Figure 8.9). Since the standard deviation of the average ratio 
overlaps the corresponding minimum and maximum values in the majority of cases, it 
is reasonable to assume that this range is representative of the whole bed. Furthermore, 
since build:powder bed ratios were observed to follow the same trend it is therefore 
recommended that only a comparison of average values is necessary. 
 
Figure 8.8: Illustration of typical powder distributions for 50wt% HA (a) powder and build beds, 
(b) powder bed topography, (c) comparison of powder and build bed topographies, and (d) build 
bed topography 
 
It was proposed that the build:power bed ratio would give a quantitative indication of 
the spreadability of each HA:PVOH powder, which could be associated to precursor 
flowability and bed stability. Since the majority of ratios were <1 (i.e. the build profile 
was narrower compared to the powder bed) it is suggested this indicates bed stability 
since any instability would likely be associated with widening. Visually no discernible 
difference in the topography of the build and powder beds was observed for 
50HA:50PVOH powder (Figure 8.8). In contrast, clumping of particles was seen for 
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all other powders, which is expected to reduce the mechanical stability of parts since 
disruption of the bed could lead to a larger void volume (Figure 8.10). 
 
Figure 8.9: Build to powder bed ratios of HA:PVOH precursors 
 
 
Figure 8.10: Typical clumping behaviour of 60wt% HA precursor (a) powder bed, (b) close up of 
powder bed, and (c) build bed 
 
8.4.1.5 Microstructure of precursor materials  
Typical SEM micrographs of HA, PVOH, and 50HA:50PVOH powders at low (x200) 
as well as high (x5000) magnifications are shown in Figure 8.11. HA powder (Figure 
8.11 b) exhibited a similar globular morphology and agglomeration behaviour to 
samples self-prepared by AP (Chapters 3 – 6). Higher magnification micrographs 
revealed the typical topography of HA particles, which in comparison to the slate like 
PVOH particles appeared to be relatively rough (Figures 8.11 b and f). The average 
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particle size of 50HA:50PVOH was found to be closer to the average of PVOH 
particles than HA (Table 8.4). Thus, it is suggested the mechanical mixing of stock 
HA and PVOH resulted in a degree of agglomeration between materials. This 
assertion is supported by typical micrographs that demonstrate the presence of HA 
particles on the surface of larger PVOH fragments (Figure 8.11 c and d). 
 
Figure 8.11: Typical micrographs of (a - b) HA, (c - d) 50HA:50PVOH, and (e - f) PVOH 
precursors  
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Table 8.4: Summary of typical microstructure observed for HA, 50HA:50PVOH, 
and PVOH precursors 
HA content 
(wt%) 
Average 
particle size 
(μm) 
Standard 
deviation 
(±μm) 
Typical morphology 
100 3.47 0.92 
Largely agglomerated rounded particles 
Relatively rough surface topography 
50 59.76 63.52 
Polygonal particles infiltrated with smaller 
rounded particles 
100 PVOH 70.92 28.50 
Dispersed slate like polygonal fragments 
Relatively smooth surface topography 
 
8.4.1.6 Chemical composition of precursor materials 
Individual FTIR spectra of HA and PVOH are shown in Figure 8.12. Corresponding 
plots of HA:PVOH precursors revealed a combination of HA and PVOH band 
assignments. An increase in the IR transmission of HA peaks was observed with an 
increase in the nominal content of HA (Figure 8.13). Vice versa a decrease in the 
intensity of PVOH bands was seen with increasing HA loading. 
 
Figure 8.12: FTIR spectra of HA and PVOH raw materials 
 
8.4.1.7 Thermal behaviour of precursors  
DTA and TGA results for HA:PVOH powders, obtained simultaneously between 30 
and 1300C, revealed that the majority of the observed weight loss occurred 185 – 
500°C (Figure 8.14). These results corroborate the corresponding analysis of PVOH 
(Figure 7.4), and therefore weight loss in this region is partially attributed to burn out 
of PVOH. The remaining weight loss is accredited to the degradation of DCPA to β-
Ca2P2O7 since DTA-TGA analysis of as-received HA confirmed an endothermic 
reaction within this temperature range. A monotonic relationship between the residue 
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of HA (i.e. the observed residue of HA:PVOH precursors plus weight loss observed 
for HA alone), and the HA content of precursor powders was demonstrated (Table 
8.5). DTA plots for HA:PVOH samples appear to be a combination of the 
corresponding data recorded for HA (Figure 7.3) and PVOH (Figure 7.4). However, it 
should be noted that with increasing HA content the onset of the endothermic reaction, 
which begins at approximately 800C for 50HA:50PVOH, is shifted to higher 
temperatures. For samples containing 80wt% and 90wt% HA this reaction was shown 
to occur over a larger temperature range up to approximately 1100C. 
 
Figure 8.13: FTIR spectra of HA:PVOH precursors (a) 90HA:10PVOH, (b) 80HA:20PVOH, 
(c) 70HA:30PVOH, (d) 60HA:40PVOH, and (e) 50HA:50PVOH 
 
8.4.2 Green body scaffolds 
8.4.2.1 Precursor viability 
The results presented for 3DP in section 7.4.3 established that precursors containing a 
maximum of 80wt% HA were printable and therefore scaffolds of various HA:PVOH 
ratios within this range were produced. The viability to print scaffolds from each 
composition was evaluated (Table 8.6). Scaffolds produced from 50 and 60wt% 
precursors were the only stable compositions and therefore only these structures were 
characterised.  
Figure 9.14: Thermal behaviour of HA:PVOH precursors 
Chapter 8: 3D printing of hydroxyapatite scaffolds 
216 
 
Figure 8.14: Thermal behaviour of HA:PVOH precursors 
 
 
Table 8.5: Summary of weight loss behaviour for HA:PVOH precursors 
HA 
content 
(wt%) 
Weight loss (wt%) 
Residue 
(wt%) 
Residue + HA 
weight loss (wt%) 30 – 184C 184 – 500C 500 – 1300C 
50 3.21 49.72 2.22 44.85 49.42 
60 2.38 37.28 1.76 58.57 63.14 
70 2.21 30.97 1.32 65.50 70.07 
80 1.69 21.34 1.41 75.56 80.13 
90 1.58 10.89 1.51 86.01 90.58 
 
 
Table 8.6: Printability of scaffold structures fabricated from HA:PVOH precursor powders 
HA content 
(wt%) 
Bonded 
layers 
Ease of 
handling 
Comment 
80 No 
N/A 
Layers were not bonded together leading to 
scaffold collapse 70 No 
60 Yes Difficult 
A number of printed scaffolds were damaged 
during removal from build bed 
Required drying before parts could be removed 
from the build bed without causing damage 
50 Yes Easy 
No damage observed as a result of handling 
Construct stable straight after printing 
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8.4.2.2 De-powdering methods 
The effectiveness of ultrasound and compressed air to remove loose powder from the 
surface and pore channels of 50wt% and 60wt% HA green scaffolds was evaluated. 
Figure 8.15 demonstrates the average amount of powder removed from green parts 
using ultrasound for up to 15mins. Corresponding images (Figure 8.16) illustrated the 
limited effectiveness of this method after 5mins and overall the technique was 
observed to remove loose powder only from the surface of scaffolds. Designed pore 
channels were shown to remain occluded regardless of treatment time. However, a 
notable advantage of this technique is that no damage of scaffolds occurred. 
 
Figure 8.15: Average amount of powder removed from 50wt% HA green scaffolds using 
ultrasound (n=3) 
 
 
Figure 8.16: Effectiveness of ultrasound treatment to remove loose powder from 50wt% HA 
green bodies 
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In comparison, the use of compressed air was observed to effectively remove powder 
from the surface as well as designed pore channels of green scaffolds (Figure 8.17). 
Attachment of a syringe needle to the airbrush nozzle enabled a fine jet of air to be 
directed to areas containing loose powder. This minimised the damage caused to parts 
during de-powdering. More damage was caused to relatively fragile parts since 
scaffolds had to be handled during de-powdering, i.e. 60HA:40PVOH. On average 
approximately 2mins to de-powder a single construct using this method was necessary. 
 
Figure 8.17: Effectiveness of compressed air to de-powder 50wt% HA green bodies (a) printed 
scaffold, (b) side view of de-powdered scaffold, and (c) top view of de-powdered scaffold 
 
8.4.2.3 Post-processing of green scaffolds 
The effect of drying de-powdered green scaffolds at 60°C in a furnace or vacuum 
oven, for 2 or 6hrs was investigated (Table 8.7). Images of dried green parts were used 
to identify any bulk changes to the scaffold structure (Figure 8.18). Notably, 60wt% 
HA parts were relatively more fragile than equivalent 50wt% scaffolds. External outer 
struts for samples 50F6Y, 50V6Y, 60F6Y and 60V6Y were observed to be damaged, 
which suggests these post-processing treatments reduced mechanical integrity, and as 
a result the ease of handling was poorer. 
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Table 8.7: Summary of 3D printed green body scaffolds 
 
The height and diameter, as well as weight of printed and post-processed green bodies 
were recorded. A larger variation was observed between the diameter and height of 
printed green bodies fabricated along the X-axis compared with those printed along 
the Y-axis (Figure 8.19). A reduction in the average height and diameter of all 
constructs was demonstrated between printed and dried samples. Generally, a decrease 
in sample weight was calculated for post-processed scaffolds compared with printed 
parts (Figure 8.20). 
 
HA content 
(wt%) 
Printing 
direction 
(axis) 
Post-processing 
method 
Post-processing 
time (hrs) 
Sample ID 
50 X 
N/A Printed N/A 50PX 
Furnace dried 
2 50F2X 
6 50F6X 
Vacuum dried 
2 50V2X 
6 50V6X 
50 Y 
N/A Printed N/A 50PY 
Furnace dried 
2 50F2Y 
6 50F6Y 
Vacuum dried 
2 50V2Y 
6 50V6Y 
60 X 
N/A Printed N/A 60PX 
Furnace dried 
2 60F2X 
6 60F6X 
Vacuum dried 
2 60V2X 
6 60V6X 
60 Y 
N/A Printed N/A 60PY 
Furnace dried 
2 60F2Y 
6 60F6Y 
Vacuum dried 
2 60V2Y 
6 60V6Y 
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Figure 8.18: Dried 50wt% HA green scaffolds 
(a) 50PX, (b) 50F2X, (c) 50F6X, (d) 50V2X, (e) 50V6X, (f) 50PY, (g) 50F2Y, (h) 50F6Y, (i) 50V2Y, and (j) 50V6Y 
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Figure 8.19: Influence of post-processing on size of 50wt% HA green body scaffolds 
 
 
Figure 8.20: Influence of post-processing on weight of 50wt% HA green body scaffolds 
 
Chemical composition 
In comparison to respective precursor powders, the intensity of PO4
3-
 bands were 
observed to increase for printed and dried green bodies (Figure 8.21). 
Correspondingly, only weak bands associated with PVOH were detected in precursor 
powders as well as dried green bodies. An increase in the O-H vibration intensity at 
635cm
-1
 for printed and post-processed samples may be attributed to the composition 
of the commercial binder being largely water. 
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Figure 8.21: Influence of drying methods on composition of X-axis 50wt% HA green bodies 
(a) 50HA:50PVOH precursor, (b) 50PX, (c) 50F2X, (d) 50F6X, (e) 50V2X, and (f) 50V6X  
 
Microstructural Development  
The average range (i.e. mean ± one standard deviation) calculated for the height of 
pore channels was shown to overlap for all printed and post-processed green scaffolds 
(Figure 8.22). This suggests that the investigated drying methods did not significantly 
influence the size of scaffold features that were defined in the initial CAD model. A 
comparison of the average pore channel height for samples 50PX and 50PY, as well as 
60PX and 60PY suggests that features perpendicular to the direction of spreading are 
distorted to some degree, since the X-axis dimension was smaller in both cases. 
The width of designed struts for samples 50F6X, 60F6Y, 60V2X, 50V6X, 50V6Y, 
60V6X, and 60V6Y were significantly (i.e. no overlap was exhibited between the 
range of mean ± one standard deviation) smaller compared with printed counterparts 
(Figure 8.23). This reduction suggests that a degree of construct shrinkage occurred as 
a result of the corresponding post-processing treatments. 
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Figure 8.22: Influence of post-processing methods on the height of designed pore channels of 3D 
printed green scaffolds 
 
 
Figure 8.23: Influence of post-processing methods on strut width of 3D printed green scaffolds 
(significant difference observed compared with: *50PX, **50PY, #60PX, and ##60PY)  
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Reductions observed in the size of surface pores presents further evidence that post-
processing treatments resulted in green part shrinkage (Figure 8.24). Surface pore size 
analysis suggests that vacuum drying for 2hrs has the most consistent marked effect 
since all samples exhibited a significant reduction compared with respective printed 
constructs. The average size of surface pores in 60wt% HA samples were 
demonstrated to be notably smaller in comparison to equivalent 50wt% HA scaffolds, 
which suggests that a larger fraction of smaller HA particles improves the packing 
efficiency of printed layers (Figure 8.6). The effect of drying processes on the average 
height of pore channels, width of struts, and size of surface pores is summarised in 
Table 8.8 
 
Figure 8.24: Influence of post-processing methods on average surface pore size of 3D printed 
green scaffolds (significant difference observed compared with: *50PX, **50PY, #60PX, and 
##60PY) 
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Table 8.8: Effect of drying processes on the microstructure of 3D printed green scaffolds (n=6) 
Sample 
Average size (μm) 
Strut width 
Surface 
pores 
Pore channel 
height 
50PX 1931±70 61.5±21.5 1480±102 
50F2X 1933±31 27.2±6.7 1660±171 
50F6X 1833±12 26.4±6.8 1543±104 
50V2X 1853±45 26.0±4.7 1583±124 
50V6X 1621±40 33.8±14.2 1590±95 
50PY 1916±88 53.8±16.2 1650±157 
50F2Y 1910±73 51.7±15.4 1520±145 
50F6Y 1960±90 50.2±13.3 1456±93 
50V2Y 1853±21 29.7±2.4 1753±40 
50V6Y 1758±41 43.8±3.8 1700±90 
60PX 1948±35 43±13.4 1660±99 
60F2X 1941±29 17.7±2.8 1627±110 
60F6X 1878±32 14.4±1.1 1737±81 
60V2X 1602±33 11.0±3.4 1687±15.3 
60V6X 1587±25 11.4±1.8 1677±76 
60PY 1930±66 39±10.5 1749±75 
60F2Y 1977±12 21.6±7.2 1610±52 
60F6Y 1736±20 35.5±4.9 1703±161 
60V2Y 1838±52 13.9±1.5 1657±45 
60V6Y 1736±47 20.1±6.2 1777±31 
 
Typical micrographs showed the morphology of the designed struts and pore channels, 
as well as the surface topography. Generally, pore channels were shown to be free of 
loose powder and exhibited rough edges, which was also observed to be the case for 
strut extremities. This observation is due to the relationship between printing 
resolution and the maximum particle size and morphology, since these properties infer 
the packing efficiency of respective powders. Visualisation of scaffold surfaces 
revealed the presence of micropores as well as numerous topographical irregularities. 
Characteristic micrographs of scaffold struts, surfaces, and designed pore channels are 
shown in Figures 8.25 for constructs produced from the 50wt% HA precursor and 
printed along the X-axis. 
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Figure 8.25: Micrographs of 50wt% HA green scaffolds printed along X-axis 
(a) 50PX strut, (b) 50PX surface, (c) 50PX pore channel, (d) 50F2X strut, (e) 50F2X surface, (f) 
50F2X pore channel, (g) 50F6X strut, (h) 50F6X surface, (i) 50F6X pore channel, (j) 50V2X strut, 
(k) 50V2X surface, (l) 50V2X pore channel, (m) 50V6X strut, (n) 50V6X surface, and (o) 50V6X 
pore channel 
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Mechanical strength 
The yield and ultimate compressive strengths of 50wt% HA scaffolds were 
remarkably higher than corresponding 60wt% HA samples (Figures 8.26 and 8.27). 
All drying processes were shown to improve the yield as well as ultimate compressive 
strength of X-axis samples compared with 50PX. However, this trend was not 
observed for all post-processed samples printed along the Y-axis, namely 50F2Y and 
50V2Y exhibited lower strength values. Notably, 50PY, 50F6Y, and 50V6Y green 
bodies yielded as well as failed at higher compressive loads in comparison to 
equivalent samples printed along the X-axis. Thus suggesting drying via either method 
for 6hrs was particularly advantageous to the development of compressive strength of 
green scaffolds printed along the Y-axis.  
In contrast, furnace and vacuum drying 50wt% HA constructs for 2hrs was observed 
to improve the yield and ultimate compressive strength of X-axis scaffolds but a 
reduction was seen for equivalent Y-axis samples compared with 50PX and 50PY, 
respectively. Analysis of the surface microstructure revealed larger pores in 50PX 
compared with 50PY but a relatively higher shrinkage rate was demonstrated after 
2hrs of either drying treatment (Table 8.8). 
 
Figure 8.26: Average compressive yield strength of 50 and 60wt% HA 3D printed green scaffolds 
(n= 3)  
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Figure 8.27: Average ultimate compressive strength of 50 and 60wt% HA green scaffolds (n= 3) 
 
The average degree of strain at the onset of plastic deformation, and failure were 
calculated to be higher in Y-axis samples compared with corresponding constructs 
printed along the X-axis (Figures 8.28 and 8.29). Loading parallel to the printing axis, 
(i.e. X-axis samples) was observed to result in a relatively brittle and catastrophic 
failure mechanism compared with the higher plastic deformation seen for Y-axis 
samples (Figure 8.30). Therefore the direction of printing was found to be a key 
determinant of the part failure mechanism. It is recognised that a more dynamic 
loading pattern is to be expected in-vivo compared with the uniaxial testing reported in 
this thesis. 
Drying treatments did not influence the yield or ultimate compressive strains 
developed in X-axis scaffolds. In comparison, post-processing treatments had a mildly 
positive influence on the yield strain of 60PX. It is plausible that PVOH particles 
became slightly molten at 60C, resulting in improved infiltration of the structure, 
which is likely to strengthen layer bonding once parts were cooled after drying 
treatments. Post-processing techniques generally had a positive effect on the yield 
strain of 50wt% HA scaffolds printed along the Y-axis but a reduction in the ultimate 
strain was observed. Contrastingly, the opposite trend was largely demonstrated for 
corresponding 60wt% HA constructs. 
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Figure 8.28: Average strain at onset of plastic deformation in 3D printed 50 and 60wt% HA green 
scaffolds under compressive loading (n= 3) 
 
 
Figure 8.29: Average compressive strain of 3D printed 50 and 60wt% green scaffolds at failure 
(n= 3) 
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Figure 8.30: Typical failure mechanisms of printed 50wt% HA scaffolds (a – d) catastrophic 
failure of 50PX, and (e – h) plastic failure of 50PY 
 
8.4.3 Sintered constructs 
8.4.3.1 Stability of sintered scaffolds  
TGA results revealed the majority of precursor weight loss occurred between 185 and 
500C. Heat treatment protocols (Table 8.9) were designed according to this 
information and the temperature (230C) reported as the onset of PVOH molten state 
degradation [323]. Initially the feasibility of each protocol was tested on 50PX and 
50PY samples. 
To begin with, a sintering temperature of 800C was investigated (HT1 – 3) and the 
most stable parts were found to be those heated at a rate of 1C/min using a single 
stage protocol (HT2), i.e. without soaking at 230C. However, these constructs were 
all difficult to handle and therefore in an effort to increase the consolidation of the HA 
construct a higher sintering temperature of 1300C was investigated.  
A reduction in the ramp rate from 10 to 1C/min was observed to improve the stability 
of the sintered scaffold (HT4 and HT5). However, a further reduction to 0.5C/min 
caused the structure to collapse between 250 and 800C (HT6). Since failure occurred 
above 230C it was concluded that the HA scaffolds were not consolidated fast 
enough after PVOH burn out. This attribution was confirmed by HT7, since a higher 
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ramp rate (1C/min) above 230C resulted in maintenance of mechanical integrity. A 
further improvement in mechanical strength was achieved when the dwell time at 
230C was removed and the ramp rate between 230 and 1300C was increased to 
2C/min (HT8), which is explained in terms of a reduction in time between PVOH 
burn out and HA consolidation. 
The effect of green body post-processing on the stability and structure of final sintered 
scaffolds was assessed using HT8 protocol (Figure 8.31). X-axis scaffolds were 
observed to exhibit some lateral expansion at the base of the structure, and the pore 
channels at the bottom of samples 50F2Y and 50F6Y were shown to be relatively 
smaller. Partial collapse of samples 50F2X and 50F6X occurred parallel to the 
direction of layer printing, which corresponds to the propagation of cracks along 
interlayer bonding that was shown to be the cause of failure in mechanical strength 
tests. Some instability was also noted for samples 50F2Y and 50F6Y. Overall, 50PX, 
50PY, 50V6X, and 50V6Y were the easiest to handle, no defects were observed, and 
bulk shrinkage appeared to be uniform. 
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Table 8.9: Heat treatment protocols employed on 50wt% HA scaffolds 
(T= temperature, R= ramp rate, D= dwell time) 
  
Protocol 
ID 
Heat treatment stages 
Comment T0 
(°C) 
R1 
(°C/min) 
T1 
(°C) 
D1 
(hrs) 
R2 
(°C/min) 
T2 
(°C) 
D2 
(hrs) 
R3 
(°C/min) 
T3 
(°C) 
HT1 
30 
1 230 1 1 800 1 1 30 
Failure of parts occurred parallel to direction of 
printing 
HT2 1 800 1 1 30 
N/A 
Scaffolds difficult to handle and some cracks 
observed 
Improvement in stability compared to HT1 
HT3 10 800 1 10 30 More cracks observed compared to HT2 
HT4 10 1300 1 10 30 
Improved stability compared to HT3 
Cracks observed parallel to direction of 
printing 
HT5 1 1300 1 1 30 
Some cracking and distortion of part shape 
observed 
Less shrinkage than HT4  
HT6 0.5 1300 1 0.5 30 
Scaffolds intact at 250C 
Structure collapsed before 800C 
HT7 0.5 230 1 1 1300 1 1 30 
No collapse of structure 
Few cracks observed 
HT8 0.5 230 0 2 1300 1 2 30 
Improved ease of handling compared with HT7 
Cracks observed only in some samples (Figure 
8.31) 
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Figure 8.31: Sintered scaffolds heat treated using HT8 protocol (a) 50PX, (b) 50F2X, (c) 50F6X, (d) 50V2X, (e) 50V6X, (f) 50PY, (g) 50F2Y, (h) 50F6Y, (i) 50V2X, 
and (j) 50V6Y 
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8.4.3.2 Chemical composition of sintered scaffolds  
Band/peak assignments corresponding to PVOH were not observed in 50wt% HA 
precursor powder after TGA analysis or X-axis scaffolds after sintering using protocol 
HT8 (Figure 8.32). In contrast, strong vibration bands corresponding to C-H alkyl 
groups were revealed in sintered Y-axis scaffolds (Figure 8.33), which signifies 
incomplete removal of PVOH. Furthermore, the appearance of bands between 1900 – 
2300cm
-1
 were attributed to stretching of CC in low molecular weight alkynes, which 
have been reported as thermal degradation products of PVOH [324]. O-H vibration 
was also demonstrated in sintered Y-axis scaffolds 3600 – 3750cm-1. Corresponding 
XRD patterns of as-supplied and sintered HA (1300°C) as well as 50 HA:50PVOH 
were illustrated in Figure 7.2. 
 
Figure 8.32: FTIR spectrum of 50wt% HA scaffolds printed along X-axis and sintered using HT8 
(a) 50wt% HA precursor post TGA analysis, (b) 50PX, (c) 50F2X, (d) 50F6X, (e) 50V2X, and (f) 
50V6X 
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Figure 8.33: FTIR spectrum of 50wt% HA scaffolds printed along Y-axis and sintered using HT8 
(a) 50wt% HA precursor post TGA analysis, (b) 50PY, (c) 50F2Y, (d) 50F6Y, (e) 50V2Y, and (f) 
50V6Y 
 
8.4.3.3 Shrinkage of sintered scaffolds 
Average shrinkage of scaffold height was found to be greater than corresponding 
diameter reductions for all sintered X (Figure 8.34) and Y-axis (Figure 8.35) 
constructs. A larger shrinkage in height was observed in all Y-axis samples compared 
with equivalent X-axis scaffolds. Overall, a more uniform shrinkage was observed for 
X-axis constructs, i.e. shrinkage of average height and diameters were closer in value. 
On average 55 and 54% weight loss was calculated for X and Y-axis samples, 
respectively. This corresponds approximately to the weight loss recorded for 50wt% 
HA precursor powder measured by TGA (55.15%), thus suggesting that PVOH 
content was removed from the construct. 
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Figure 8.34: Bulk shrinkage of X-axis 50wt% HA scaffolds sintered using HT8 (n=3) 
 
 
Figure 8.35: Bulk shrinkage of Y-axis 50wt% HA scaffolds sintered using HT8 (n=3) 
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8.4.3.4 Microstructure of sintered scaffolds 
The effect of sintering on scaffold microstructure, specifically the shrinkage of 
designed pore channels, struts, and surface pores was evaluated (Table 8.10). A 
number of trends in pore channel height and strut width were observed: (1) 50PX, 
50F2X and 50F6X shrank less than equivalent Y-axis samples, and (2) ranges (mean ± 
one standard deviation) for 50V2X and 50V2Y, as well as 50V6X and 50V6Y 
overlapped. The average surface pore size for sintered X-axis scaffolds was larger than 
corresponding Y-axis samples (Table 8.10). It is suggested that this observation 
explains why Y-axis constructs were demonstrated to contain residue of PVOH 
degradation products (Figure 8.33).  
Shrinkage of pore channels, struts, and surface pores due to HT8 are illustrated in 
Figures 8.36 – 8.38, respectively. Pores, designed channels and surface, as well as 
struts of Y-axis constructs were observed to shrink more compared with X-axis 
scaffolds. Shrinkage of surface pores was shown to be substantially greater than pore 
channel height or strut width. 
 
Table 8.10: Effect of HT8 protocol on microstructure of sintered 50wt% HA scaffolds 
Sample 
Average size (μm) 
Pore channel 
height 
Strut 
width 
Surface 
pores 
PX 1152±106 1587±41 3.2±1.0 
PY 907±39 1357±53 1.8±0.5 
F2X 1064±77 1498±41 3.0±1.6 
F2Y 830±43 1105±102 1.8±0.2 
F6X 1039±55 1161±116 3.2±1.2 
F6Y 877±71 1014±14 2.0±0.1 
V2X 1085±110 1181±53 2.3±0.5 
V2Y 1122±26 1238±46 1.6±0.6 
V6X 1015±36 1252±55 3.5±1.0 
V6Y 1144±12 1304±5 3.0±0.8 
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Figure 8.36: Shrinkage of pore channel height for sintered scaffolds compared with green bodies 
(n=3) 
 
 
Figure 8.37: Shrinkage of strut width for sintered scaffolds compared with green bodies (n=3)  
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Figure 8.38: Shrinkage of surface pores for sintered scaffolds compared with green bodies (n=3) 
 
Corresponding micrographs revealed the influence of HT8 on the surface topography 
of scaffolds. A degree of distortion of designed pore channels in X (Figure 8.39) and 
Y-axis (Figure 8.40) scaffolds was observed, indicating that uniform shrinkage did not 
occur. The surface topography of sintered constructs was shown to be distinctly 
different to green parts where larger PVOH particles were observed (Figure 8.25). In 
comparison, the surface of sintered scaffolds appeared to be consolidated HA particles 
arranged in a coralline like structure. Micropores (<5μm) were demonstrated within 
samples and it is suggested that this porosity is a result of consolidation of inherent 
surface pores observed in green scaffolds. Typically, the surface topography of 
sintered constructs appeared to be more regular than equivalent green parts, which is 
attributed to heat treatment causing consolidation of HA as well as removal of PVOH 
particulates. 
  
80%
85%
90%
95%
100%
Printed Furnace
2hrs
Furnace
6hrs
Vacuum
2hrs
Vacuum
6hrs
S
h
ri
n
k
a
g
e 
o
f 
S
u
rf
a
ce
 P
o
re
s 
(%
) 
Drying Methods 
X-axis
Y-axis
Chapter 8: 3D printing of hydroxyapatite scaffolds 
240 
 
Figure 8.39: Micrographs of 50wt% HA sintered scaffolds printed along X-axis (a) 50PX pore 
channel, (b) 50PX strut, (c) 50PX surface, (d) 50F2X pore channel, (e) 50F2X strut, (f) 50F2X 
surface, (g) 50F6X pore channel, (h) 50F6X strut, (i) 50F6X surface, (j) 50V2X pore channel, (k) 
50V2X strut, (l) 50V2X surface, (m) 50V6X pore channel, (n) 50V6X strut, and (o) 50V6X surface 
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Figure 8.40: Micrographs of 50wt% HA sintered scaffolds printed along Y-axis (a) 50PY pore 
channel, (b) 50PY strut, (c) 50PY surface, (d) 50F2Y pore channel, (e) 50F2Y strut, (f) 50F2Y 
surface, (g) 50F6Y pore channel, (h) 50F6Y strut, (i) 50F6Y surface, (j) 50V2Y pore channel, (k) 
50V2Y strut, (l) 50V2Y surface, (m) 50V6Y pore channel, (n) 50V6Y strut, and (o) 50V6Y surface 
 
8.5 Discussion 
Preliminary results presented in Chapter 7 established that HA:PVOH precursor 
powders with a maximum of 80wt% HA were printable. However, further printability 
assessments demonstrated the instability of 80HA:20PVOH and 70HA:30PVOH 
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scaffolds, which was attributed to poor interlayer bonding due to insufficient PVOH 
content (Table 8.6). Prior to printing the flowability of precursor powders was 
assessed by two funnel methods, and these results correlated with the observed 
printability, i.e. materials that recorded faster flow times and a lower angle of repose 
were more easily printed. This is explained in terms of improved powder flowability 
resulting in a higher degree of bed recoating, leading to less interparticulate voids, 
which contributes to stronger bonding between layers. Thus it is clear that precursor 
flowability contributes to mechanical stability and strength. 
Clumping of powders with 60wt% or more HA was observed during spreadability 
analysis (Figure 8.10), which was attributed to the higher fraction of smaller HA 
particles in these precursors (Figure 8.6). This observation may also be a contributing 
factor in determining printability, since spreading of clumped powders was shown to 
disrupt the surface topography of the build bed. As a result reduced packing 
efficiency, corresponding to a higher void volume is likely. The Hausner ratio presents 
an assessment of the relative effect of interparticle interactions on flowability. 
Calculation of this value revealed that 90, 80, and 70wt% HA precursors were harder 
to settle compared with 50HA:50PVOH and raw stock materials, which may have 
contributed to the observed clumping behaviour and instability of green parts. As part 
of future studies it could be of interest to investigate any influence of particle surface 
charge on the flowability of powders and if it can be used to reduce clumping of 
precursors. If this property is found to be influential it would be important to consider 
the solvent system in which HA is produced since the results of Chapter 5 highlighted 
the variability of ZP according to the degree of solvent polarity. 
Measurements of the width of powder and build beds were taken to assess 
spreadability, since these profiles were suggested to indicate powder flowability and 
bed stability. No significant differences were observed between precursors (Figure 
8.9) and trends of these results did no match direct flowability or density 
measurements, which presented cohesive attributions. For these reasons it is concluded 
that this method cannot be used as a means to quantitatively distinguish the 
spreadability of powders. In contrast, comparison of the surface topography of beds 
observed after spreading different precursors was useful. 
A notable difference in the average size of precursor powders was observed between 
SEM measurements (Table 8.4), and particle size analysis (Table 8.2). Thus, the 
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agglomeration behaviour of precursors, which was demonstrated in typical 
micrographs (Figure 8.11), is expected to be more prominent within the bulk sample 
than SEM analysis suggests. It is likely that the method used to prepared samples for 
SEM resulted in a reduction of agglomerates due to fine spreading of powders on 
stubs. If this is the case it can be concluded that agglomerates of HA and PVOH 
particles are only loosely bound together. This suggests that sieving powders prior to 
printing is a sufficient method to ensure the flowability of precursors is not 
compromised by any agglomeration that could occur as a result of mechanical mixing 
or storage. 
A reported disadvantage of 3DP is the ‘difficulty’ involved in removing unbound 
powder from green bodies (Table 2.9). The novel combination of a commercial 
airbrush nozzle and a syringe needle (Figure 8.3) used in this project was proven to be 
an effective and time efficient way to remove loose powder from pore channels, as 
well as the surface of green bodies. The success of this method was attributed to the 
fine jet of compressed air, which could be blown at a controlled rate (Figure 8.17). 
Micrographs of green scaffolds demonstrated that pore channels were not occluded, 
and no surface damage was apparent (Figure 8.25). It should be noted that the 
interconnection of designed pore channels helped to facilitate the removal of loose 
powder, and the ease of de-powdering is expected to be more difficult for intricate or 
relatively complex structures. 
The ease of handling green Y-axis 50 and 60wt% HA scaffolds was observed to 
reduce when structures were dried for 6hrs in a furnace or vacuum oven, which 
resulted in damage to external struts (Figure 8.18). In general, drying of scaffolds 
resulted in bulk shrinkage of height and diameter (Figure 8.19), as well as loss of 
weight (Figure 8.20). Notably a larger weight reduction was recorded for Y-axis 
samples compared with equivalent X-axis green bodies. Corresponding micrographs 
revealed no significant change in the height of pore channels due to post processing 
compared with printed constructs (Figure 8.25). This dimension was found to be 
smaller for printed X-axis samples compared with Y-axis constructs. Thus, it is 
suggested that the build bed is partially distorted as the counter-rotating roller spreads 
powder across and this affects dimensions parallel to the direction of spreading, which 
corresponds to the height of X-axis constructs. 
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Significant shrinkage of strut width occurred for samples 50F6X, 60F6Y, 60V2X, 
50V6X, 50V6Y, 60V6X, and 60V6Y, which was attributed to these drying treatments 
causing consolidation of the structure (Figure 8.23). It is unlikely that consolidation of 
HA would occur at such a low temperature and since shrinkage was accompanied by 
weight loss (Figure 8.20) it is therefore suggested that this observation is associated 
with partial decomposition of PVOH. TGA analysis of precursors demonstrated 2.5%, 
and <0.5% weight loss of PVOH and HA at 60°C, respectively. Since no 
corresponding DTA peaks were observed this weight loss can be attributed to loss of 
non-bound surface water. Weight losses caused by post-processing treatments were 
greater than TGA reductions, thus it is probable that some thermal degradation of 
PVOH occurred as a result of dwelling scaffolds at 60°C for a prolonged period of 
time. A reduction in the size of surface pores was also revealed (Figure 8.24), and 
notably this effect was more consistent when a vacuum oven was used to dry 
constructs. If drying resulted in partial degradation of PVOH it may be suggested that 
these products were more readily removed under vacuum, which would explain the 
higher rate of consolidation. Overall, these observations infer that drying scaffolds 
resulted in microstructural shrinkage but the degree of consolidation was not large 
enough to affect the dimensions of non-solid features, i.e. pore channels. 
The improved yield and compressive strength of 50wt% HA scaffolds compared with 
60wt% HA constructs can be related to the higher flowability, and reduced 
interparticle interactions of the respective precursor powders. Hence, these differences 
are evidence of the critical influence of these precursor characteristics on mechanical 
integrity. Different trends in yield and ultimate compressive strength development 
were exhibited for X and Y-axis constructs (Figures 8.26 and 8.27). This suggests that 
the rate at which strength development occurred, due to drying, for these samples was 
different, and this is attributed to the size of surface pores. 50F2X, 50F6X, 50V2X, 
and 50V6X were observed to exhibit significant shrinkage of surface pores (i.e. a 
faster reduction in void volume compared to Y-axis samples), which can be associated 
with development of strength. Therefore it may be concluded that the rate of 
consolidation of surface pores is a critical factor in compressive strength development. 
However, since samples 50F6Y and 50V6Y exhibited higher ultimate strengths it is 
suggested that this is not the only factor that contributes to compressive strength. 
Hence, more specifically it is advocated that void volume influences the strength of 
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interlayer bonds. Strength testing demonstrated that failure occurred due to 
propagation of cracks along the boundaries between layers (Figure 8.30). The lower 
maximum yield and ultimate compressive strength of X-axis scaffolds, as well as the 
catastrophic failure mechanism observed advocate that interlayer bonding is weakest 
parallel to the direction of loading. Therefore, it is concluded that it is not merely the 
strength of interlayer bonding but also the direction of part loading that infers the bulk 
compressive strength of the printed scaffolds. Anisotropic strength of 3D printed parts 
is commonly reported in the literature [325]. In all cases Y-axis scaffolds exhibited a 
larger extension at yield (Figure 8.28) and failure (Figure 8.29), which corroborates 
the assertion that interlayer bonding is weaker under parallel compression loading, and 
are the areas where crack propagation is most likely to occur. 
A range of heat treatment protocols were designed using TGA data as prerequisite 
information, since it detailed the burn out behaviour of PVOH. Ramp rate, number of 
heating stages and sintering temperature were found to determine the stability of 
sintered scaffolds (Table 8.9). Protocol HT8 resulted in the easiest to handle and most 
stable scaffolds, which was attributed to a reduction in the time between burn out of 
PVOH and consolidation of the remaining HA structure since a relatively fast ramp 
rate was used above 230°C. Some distortion, namely lateral expansion (X-axis 
samples) and variation in the size of pore channels (50F2Y and 50F6Y) were visually 
observed as a result of performing the HT8 sintering protocol. These observations are 
attributed to the solid base of scaffolds trapping evolving gases, which could have 
caused a build-up of pressure within the bottom of the structure. Partial collapse of 
constructs 50F2X and 50F6X along layer boundaries matched the typical failure 
mechanisms observed for X-axis green bodies (Figure 8.30). 
FTIR analysis of structures sintered using HT8 revealed the presence of strong bands 
between 1900 and 2300cm
-1 
in all Y-axis samples, which are associated with low 
molecular weight alkynes that are known to be a thermal degradation product of 
PVOH. These results indicate incomplete removal of degradation products of PVOH, 
which are suggested to become trapped due to consolidation of the structure. Presence 
of surface pores would facilitate evolution of gaseous by-products and hence the 
influence of post-processing methods could be considered as detrimental to this 
process since they caused observed surface pores to shrink (Figure 8.24). Specifically, 
larger bulk shrinkage of the height of Y-axis samples compared with equivalent X-axis 
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scaffolds was demonstrated (Figures 8.34 and 8.35). In contrast, generally a 
comparable shrinkage of diameter, and weight reduction were observed between 
sintered X and Y-axis constructs. A larger degree of surface pore consolidation is a 
likely explanation as to why bands corresponding to thermal degradation products 
were revealed in FTIR spectra of sintered Y-axis samples (Table 8.10). It is unclear 
why the average weight loss (±1%), as a result of sintering, corresponded to losses 
demonstrated by TGA analysis of precursors but residue of PVOH degradation 
products were shown in FTIR spectra. Complete removal of PVOH degradation 
products by increasing the dwell time of structures at either 230 or 1300°C is 
plausible. However, since dwelling at 230°C was observed to reduce the stability of 
parts it would be preferable to soak at the higher temperature (Table 8.9). 
These results advocate a trade-off between the effects of surface pore size on strength 
development, and the ability of thermal degradation products to evolve from the 
structure. In particular, the 3D interconnectivity of the inherent surface porosity would 
be crucial in facilitating gaseous removal, and since this property has not been 
characterised the degree of structural consolidation cannot be deemed as the only 
limitation. The greater relative uniformity of height and diameter shrinkage evidenced 
for X-axis scaffolds suggests these structures offer an improved 3D connectivity of the 
exhibited surface microporosity. CT scanning is recommended for future work to 
assess the degree of interconnectivity of micropores. 
Overall, microstructural analysis of sintered scaffolds exposed a significant reduction 
in the height of pore channels, strut width, and surface pores compared with green 
scaffolds (Figure 8.36 – 8.38). Therefore, as expected, it can be concluded that 
sintering resulted in bulk and microstructural consolidation. The greater shrinkage 
demonstrated for Y-axis samples infers a higher mechanical strength of these sintered 
bodies compared with X-axis scaffolds since a greater degree of consolidation 
corresponds to a larger decrease in the volume of voids. However, as aforementioned 
this observation may also explain why PVOH degradation products were trapped 
within these samples, which could be detrimental to biocompatibility. 
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8.6 Conclusions 
This chapter presents an assessment of the use of 3DP to manufacture bone tissue 
scaffolds from HA:PVOH precursors, and the experimental work completed highlights 
the potential, as well as the difficulties associated with this fabrication system. In 
summary, characterisation of precursor flowability strongly correlated with observed 
printability and can be deemed a vital prerequisite property since it influenced 
recoating of the build bed, which ultimately determined several critical physical 
criteria such as mechanical strength, microstructure, and porosity. Scaffolds produced 
from less flowable precursors (i.e. 60HA:40PVOH) were shown to be substantially 
weaker in compression and this was attributed to insufficient bonding between layers. 
Calculation of the Hausner ratio provided an indication of the influence of interparticle 
interactions on flowability, which helped explain the clumping behaviour observed in 
precursor powders with ≥60wt% HA. 
Characterisation of green bodies provided valuable information that facilitated an 
understanding of the shrinkage behaviour observed as a result of sintering. Significant 
differences in microstructure were observed between green scaffolds printed along the 
X and Y-axes, which resulted in variation of mechanical strength, and influenced the 
effectiveness of the removal of degradation products of PVOH during sintering. Post-
processing treatments were similarly shown to significantly impact mechanical 
properties, as well as the microstructure of green bodies. Compression tests 
highlighted that interlayer bonding was critical to bulk strength and when parts were 
loaded perpendicular to the direction of printing (i.e. parallel to the boundaries of 
interlayer bonding) catastrophic failure occurred. 
A maximum average compressive strength of 0.85MPa was exhibited by 50wt% HA 
green parts printed along the Y-axis and dried for 6hrs in either a furnace or vacuum 
oven (50F6Y, 50V6Y), which falls within the range reported for cancellous bone 
(Table 2.2). In contrast, a maximum compressive strength of 0.75MPa was 
demonstrated for green parts printed along the X-axis (50F6X). In comparison to 
green parts, sintered scaffolds were less easy to handle and stability was more 
variable, thus their mechanical suitability for use as a bone tissue scaffold is 
questionable. Therefore, it is recommended that further work involve the investigation 
of composites of HA and biocompatible, as well as biodegradable polymers so that a 
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sintering protocol would not need to be employed. This would remove a number of the 
most prominent difficulties highlighted in this study, namely design of a heat 
treatment protocol that results in uniform shrinkage, and does not adversely affect 
chemical composition or mechanical integrity. 
Microporosity as well as topographic surface features are known to be key 
determinants of the success of bone tissue implants [88, 108, 109]. Micrographs of 
typical green and sintered scaffolds revealed irregularities in the surface topography as 
well as the presence of surface microporosity, which is promising since these 
properties are known to be advantageous for osteoblast adhesion, capillary in growth 
(i.e. osteoconduction), and mechanical interlocking with native tissue (i.e. 
osteointegration). The size of pore channels in green as well as sintered scaffolds 
would be expected to expedite vascularisation of the scaffold, which has been shown 
to result in direct osteogenesis [87]. Since the observed sizes of pore channels were at 
the upper end of the recommended pore size it is proposed that the CAD model could 
be adapted to reduce this dimension, which is likely to improve mechanical strength. 
However, without reducing the size of precursor particles the accuracy of smaller parts 
is expected to be poorer since the resolution of the technique is limited by the 
maximum particle size of stock materials. 
In conclusion, the scaffolds produced exhibited macro- and micropores within the 
reported optimum range for bone tissue scaffolds. The demonstrated rough surface 
topography is a promising inherent advantage of 3D printed parts, and the mechanical 
integrity of green constructs were shown to fall within the range of cancellous bone. 
These features are promising since they can improve osteogenesis, osteoconduction, 
and osteointegration in-vivo [20, 84, 92, 93, 108, 109]. To improve mechanical 
performance a reduction in the pore channel dimension is suggested. A number of 
underlying precursor characteristics were found to determine the above properties and 
therefore it is advocated that powder characterisations, such as those presented here, 
should be considered an essential part of the process of selecting stock materials. 
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9. Conclusions 
Despite being the current clinical ‘gold standard’ autologous bone grafts exhibit 
numerous short comings, including the need for two surgical procedures, pain 
associated with bone harvesting, limited supply and the risk of surgical complications. 
There is subsequently a need for alternative clinical strategies to repair or regenerate 
defective bone tissue. One such strategy is to implant a synthetic porous structure 
referred to as a scaffold. In order to elicit a favourable biological outcome ideally 
these constructs should emulate the chemical and physical structure of the native 
tissue. The strategy adopted in this work in order to achieve this was to consider the 
effect of synthesis methods and conditions on material properties and the translational 
of this understanding to the biological performance of the selected biomaterial. 
Fabrication and structural properties of the scaffold structure were also investigated. 
Objectives for this project are listed in Chapter 1 and relevant literature was reviewed 
in Chapter 2. HA was selected as the candidate material due to the chemical and 
crystallographic similarity to bone mineral apatite. Chapters 3 – 6 present the 
experimental work performed with the aim of developing an understanding of how key 
reaction parameters affect material composition and ultimately biological suitability of 
HA. Results presented in Chapters 4 – 6 highlighted the sensitivity of the AP 
technique and demonstrated that changes to experimental conditions cannot be deemed 
trivial. In particular, pH and temperature conditions are vital reaction parameters that 
should be carefully considered since they were shown influence composition to a 
degree that determined the viability of MC3T3 cells. Promising improvements in the 
proliferative rate of osteoblast precursor cells were seen when CDHA was prepared in 
mixed solvent systems containing Toluene and/or Ethanolamine, and when theoretical 
substitutions of 10mol% Mg or 2mol% Zn were incorporated. 
These results were followed by studies concerning the viability of fabricating a 
scaffold structure that exhibited key physical features of cancellous bone, such as 
compressive strength, porosity, and pore interconnectivity (Chapters 7 and 8). The 
feasibility of 3DP user defined porous, interconnected scaffold structures was 
investigated. Scaffolds were shown to exhibit desirable surface topographies, 
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microporosity, and an ultimate compressive strength at the lower end of the range 
reported for cancellous bone. 
It is difficult to recommend an ‘optimised’ synthesis condition to use in combination 
with the reported 3DP fabrication method since without conducting further 
experimental work it is unclear whether combining promising conditions, for example 
Mg or Zn substitution and the use of Toluene in the solvent system, would further 
improve biological performance. Overall, compositions that were shown to enhance 
the proliferative rates of osteoblast precursor cells compared to the control (AP09) can 
be considered ‘optimised’ formulations that shall be the subject of future work. This 
chapter summarises the conclusions that can be drawn from the presented 
experimental findings. 
9.1 Synthesis of HA 
Of the three synthesis methods initially selected and experimentally investigated, AP 
was concluded to be the technique that enabled the production of materials that most 
closely met the defined product criteria: (1) phase pure HA, (2) particle size less than 
1μm, (3) degree of control of crystallinity, and (4) ability to alter stoichiometry (Table 
3.5). Hence this synthesis technique was taken forward for further study (Chapters 4 – 
6). 
9.1.1 Influence of pH, temperature and solute concentration 
It is well known that pH conditions determine the CaP phase precipitated from a 
solution and this can be explained in terms of the varying solubility of this group of 
materials according to pH values (Figure 2.7). Hence, the formation of precipitates 
containing DCPA and DCPD under less alkali conditions (pH <10) merely confirms 
what is already reported in the literature. Similar to previous authors [12, 15, 165, 205-
208], precipitates that exhibited XRD patterns which were matched to HA and no 
secondary phases were produced at a starting pH value greater than 10. However, 
concurrent FTIR analysis exposed the presence of non-apatitic HPO4
2-
 and notably 
vibrational bands associated with DCPD were demonstrated for precipitates prepared 
in a solution initially adjusted to pH 10 and uncontrolled during crystallisation (AP07). 
This suggests that precipitates were not stoichiometric HA but instead CDHA. 
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Interestingly, as-synthesised samples that exhibited no discernible difference in XRD 
patterns could be distinguished by their thermal behaviour, which was determined by 
simultaneous DTA-TGA. Compositions prepared at an initial pH value of 10 and 
either uncontrolled (AP07) or controlled (AP10) during addition, exhibited a rapid 
endothermic loss of weight between 200 – 300°C. This behaviour was attributed 
respectively to the: (1) dehydration of DCPD to DCPA and subsequent condensation 
to β-Ca2P2O7, and (2) weight loss of CDHA prepared via the hydrolysis of DCPA. An 
increase in reaction temperature also had a marked effect on composition which was 
again reflected in the observed weight loss behaviour. Samples prepared at a higher 
temperature (AP12) or at an uncontrolled pH value of 10 (AP07) notably did not 
exhibit a DTG peak between 700 and 800°C, which was demonstrated for all other 
samples. Additionally, a positive ZP was recorded for these compositions, which was 
shown to be inconsistent with other specimens that exhibited a negative surface 
charge, i.e. a deficiency of cations (CDHA). 
A live/dead assay was used to assess the cytocompatibility of CDHA substrates. 
MC3T3 cells seeded on AP07 and AP12 were revealed to be non-viable after 1 and 3 
days of culture, respectively. This was attributed to the excess acidity confirmed 
within these compositions by ZP measurements. In contrast, cells seeded onto all other 
substrates were observed to increase in number and change morphology from rounded 
to elongated, which is indicative of attachment, spreading and proliferation. A 
quantitative assessment of the ability of cytocompatible CDHA materials to support 
osteoblast proliferation was achieved by conducting MTT and Hoechst assays. 
Proliferative rates between 1 and 7 days were calculated and ANOVA tests were used 
to determine if the observed increase in cell number was statistically significant. 
Overall, the results of these cellular in-vitro tests advocate that the absolute value of 
pH and temperature strongly determine the viability of osteoblast precursor cells since 
these reaction parameters significantly affected material composition. Control of pH 
during synthesis was shown to be advantageous to cell proliferation and this is 
explained in terms of the ion speciation boundaries in solution (Figure 2.10).  
Preparation of the respective phases under different pH conditions was not shown to 
influence the affinity of particles for cells. However, differences in the intracellular 
agglomeration behaviour of AP07 – AP10 were established and this was attributed to 
variation in the sign and value of surface charge. An elongated morphology was 
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observed for MC3T3 cells that internalised AP09 and AP10 particles. These results 
advocate that consideration of reaction conditions is important not only for the specific 
objectives of this thesis but also other applications, such as drug delivery. 
9.1.2 Influence of solvent system 
IR spectra and corresponding thermal analysis confirmed the presence of non-apatitic 
HPO4
2- 
within precipitates prepared in mixed solvents systems containing 
Ethanolamine and/or Toluene with DI water suggesting AP13 – AP15 were CDHA. 
Despite this, XRD patterns of as-synthesised specimens were matched to HA alone. 
The degrees of peak broadening for materials prepared in systems containing Toluene 
were distinguishably broader. This is explained by the lower dielectric constant of 
Toluene resulting in a faster stabilisation of crystallites. 
The solvent system was not shown to influence the sign of particle ZP measured in DI 
water at 25°C. However, the degree of negativity (i.e. the value of ZP) decreased for 
those samples precipitated in mixed solvent systems (AP13 – AP15). This indicates a 
reduction in colloidal stability and is believed to be due to a lower degree of 
deprotonation in less polar solvents systems. Lower repulsive charges could lead to 
particle flocculation, which might be detrimental in spreading of stock materials in the 
3DP process. Therefore, it may be necessary to investigate the influence of particle 
surface charge on flowability as part of future work. 
It was particularly important to test the viability of cells seeded on substrates prepared 
in Ethanolamine and/or Toluene since residues of these solvents would be cytotoxic. 
Live/dead assay results were encouraging and confirmed the viability of cells seeded 
on samples AP13 – AP15, which justifies selecting Ethanolamine due to its high 
volatility. In addition, cell number, measured by metabolic activity as well as DNA 
staining, was shown to significantly increase over a 7 day culture period. Cell results 
were promising in that, the proliferative rate of metabolically active osteoblasts seeded 
on CDHA substrates prepared in a mixed DI water and Toluene system (AP14) was 
more than double the control sample (AP09) that was prepared in pure DI water. This 
improved performance was linked to the 20% larger surface area exhibited by particles 
of AP14. In contrast, a greater increase in cell number measured by DNA staining was 
demonstrated on substrates prepared in a mixed DI water, Toluene and Ethanolamine 
solvent system (AP15). When these results were compared to corresponding 
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assessments (Chapter 4) it is suggested that a higher HPO4
2-
 content, which is likely to 
result in a faster rate of dissolution due to the reduction in stoichiometry, is 
responsible for the observed relative increase in cell number. 
In summary, Chapter 5 presents a novel experimental assessment of the influence of 
solvent polarity on the material properties of CDHA. The in-vitro tests performed 
exposed promising capabilities of substrates prepared in mixed solvent systems to 
support proliferation of osteoblast precursor cells to a higher degree than control 
samples. It is concluded that the solvent polarity should be carefully considered and 
potentially chosen according to the end application. It is recognised that further 
characterisations are necessary to improve the understanding of the underlying 
scientific reasons for the observed results, in particular surface roughness and 
dissolution. 
9.1.3 Influence of divalent cations 
XRF was used to confirm the presence as well as accuracy of Sr, Mg, or Zn 
substitutions and revealed a significantly greater accuracy of Sr (93%) doping 
compared with Mg (10.3%) and Zn (12%). This is attributed to the relative ionic sizes 
of Sr
2+
, Mg
2+
 and Zn
2+
, which are known to be 116, 75 and 65% the size of Ca
2+
. 
Notably, XRF does not enabled differentiation of surface absorbed or lattice 
incorporation of ions; however the shifts observed for characteristic XRD peaks of HA 
are convincing evidence that additional cations were at least partially incorporated into 
the apatite structure. Calculation of Ca+Mx:P ratios revealed that AP16 – AP18 were 
not stoichiometric HA but exhibited ratios typical of CDHA, which is consistent with 
FTIR and DTA-TGA studies that demonstrated the presence of HPO4
2-
. 
Remarkably, an 80% increase in the number of metabolically active cells observed 
between 1 and 7 days of culture was demonstrated on AP17 compared with the control 
CDHA specimen (AP07). This sample was shown to contain Mg as confirmed by 
XRF, thermally degraded to whitlockite below 600°C and exhibited a 45% smaller 
crystallite size. These chemical and physical variations due to the addition of Mg have 
been previously reported in the literature [129, 319]. Incorporation of Zn (AP18) was 
shown to facilitate a 40% higher degree of osteoblast proliferation. In addition to 
compositional variations evidenced by XRD, FTIR and DTA-TGA, a relatively low 
crystallinity and larger surface area were used to explain the improved proliferative 
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rate of MC3T3 cells seeded on samples that contained Mg (AP17) and Zn (AP18). 
Interestingly, the surface morphology of pellets immersed in SBF that contained 
additional divalent cations were indicative of a higher degree of surface degradation 
compared with other self-prepared CDHA. Hence, it was concluded that an assessment 
of dissolution rate should be included in future work. 
9.1.4 Summary of HA synthesis work 
Much research has been conducted in the area of synthesising CaPs, including HA. 
However, relatively few authors have combined the knowledge of material properties 
and biological performance of precursors [18]. It is more common to assess only the 
in-vitro or in-vivo performance of the entire scaffold structure. The overriding 
objective of Chapters 4 – 6 was to investigate a number of reaction parameters that 
have previously been reported (pH, temperature, solute concentration, divalent cation 
substitutions), as well as novel factors (Toluene and Ethanolamine), to influence 
material characteristics known to play a part in the response of bone cells. A number 
of in-vitro tests were used to determine any variations in the in-vitro performance of 
these various substrates. A range of characterisation techniques were performed and 
concurrent analysis contributed to the established knowledge regarding the effects of 
these reaction parameters. In particular, compositional and physical variations 
revealed by DTA-TGA, FTIR, ZP, and surface area measurements helped to shed light 
on the observed differences in biological performance. 
Use of the live/dead assay is justified since results enabled a distinction to be made 
between cytotoxic and cytocompatible samples. Particularly, this assay pulled out the 
non-viability of MC3T3 cells on AP12, which was not achieved by the combination of 
the reported MTT assay and standard ANOVA testing. It is also important to consider 
the suitability of the MTT and Hoechst assays. Advantages of the MTT assay can be 
summarised as: precision, relatively fast processing time (since no washing steps are 
used), and the ability to quantitatively measure proliferation [291]. In comparison, 
Hoechst dyes, such as H33258 have been noted for their superior sensitivity and 
specificity for DNA. Furthermore, freezing of cultures enabled experiments to be 
analysed in a single batch thus reducing processing time. It is also suggested this helps 
to improve intra- and inter-experimental standardisation [326]. These assays are 
reported to be a more accurate estimation of cell number than, for example counting 
cells that include/exclude an appropriate dye or ALP estimation [327]. The advantages 
Chapter 9: Conclusions 
256 
 
listed above are considered justification of the selection and use of MTT and Hoechst 
assays to determine cell proliferation. 
It is also possible to draw an overall conclusion regarding the applicability of the 
modified ANOVA test. This method was used and compared with F ratios calculated 
using the standard ANOVA test that is widely used in the literature to determine if the 
observed increase in cell number within data sets is statistical significant. The reported 
modified ANOVA test was formulated since lag cell growth, generally up to day 3 or 
5, was observed for MTT and Hoechst assay results. Hence it was suggested that 
striping back the lag rate would help to differentiate between substrates that 
demonstrated different exponential growth phases. This assertion was confirmed since 
a number of substrates that exhibited relatively low proliferative rates were pulled out 
as non-significant using the modified ANOVA test. MC3T3 cells were shown to be 
non-viable on AP12 after day 3 using the live/dead assay however interestingly the 
standardised ANOVA test confirmed the increase in metabolically cells over the 7 day 
period as statistically significant. In contrast, the modified test identified this sample as 
non-significant since the F ratio calculated considered the full data set and hence 
crucial information was not lost. In addition, different proliferation trends were 
observed for some samples (e.g. AP13, AP17) and in these cases consideration of the 
full data set enabled such samples to be statistically distinguished. Overall, the ability 
to distinguish a number of samples using the modified ANOVA method was a useful 
tool for this project. Simultaneous application of both statistical tests highlights the 
importance of selecting a suitable statistical test to answer a specific experimental 
question. Knowledge of statistics is an important prerequisite to achieve this and 
ensure that the data is analysed as accurately as possible by setting appropriate 
hypotheses. 
9.2 3DP of HA scaffolds for applications in bone tissue 
engineering 
A number of inherent advantages of 3D printed scaffolds intended for use in the repair 
or replacement of bone were highlighted in the reviewed literature, for example 
surface roughness. The initial experimental study (Chapter 7) performed confirmed 
that these desirable characteristics could feasibly be fabricated from combinations of 
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as-received HA and ball milled PVOH. Specifically, precursors with a maximum HA 
content of 80wt% were primarily deemed as printable. However, a more detailed 
assessment revealed that scaffolds fabricated from 80HA:20PVOH and 
70HA:30PVOH exhibited insufficient interlayer bonding, which caused inadequate 
part stability and ultimately structural failure. 
A number of precursor characteristics were measured directly and indirectly in an 
effort to understand the structural differences between scaffolds printed from different 
HA:PVOH compositions. In particular, the ability of powders to flow was deemed 
critical since it determines the ability to recoat the build bed, which was shown to 
ultimately influence the resolution and mechanical strength of printed parts. 
Flowability was directly measured using two funnel tests: (1) flow time, and (2) angle 
of repose. These results were shown to correlate with observed printability. A higher 
fraction of smaller HA particles, established by particle size analysis, was shown to 
result in clumping of precursors that contained ≥60wt% HA. This behaviour reduced 
spreadability and caused disruptions in the topography of the build bed. 
De-powdering of 3D printed constructs has been identified as a difficulty associated 
with this fabrication method [262]. Ultrasound and compressed air were investigated 
as methods to de-powder loose material from the surface and pore channels of printed 
scaffolds. Attachment of a syringe needle to the nozzle of a commercial airbrush 
system enabled a fine and controlled stream of air to be blown, which was shown to 
unclog pores and remove loose surface powder in a time efficient manner without 
damaging parts. 
Post-processing of green scaffolds by drying in a furnace or vacuum oven for 2 or 6hrs 
was evidenced to result in bulk and microstructural shrinkage. These affects were 
shown to be more consistent when a vacuum oven was used. Since weight loss was 
also recorded, it was suggested that partial degradation of PVOH simultaneously 
occurred as a result of post-processing. 
The mechanical strength of green scaffolds was tested under compressive loading and 
these results revealed a higher yield and ultimate compressive strength for 50wt% HA 
parts compared with those prepared from 60HA:40PVOH. This was explained in 
terms of the higher flowability and lower interparticulate interactions demonstrated for 
the 50HA:50PVOH precursor powder. Micrographs of green scaffolds revealed the 
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presence of micron sized surface pores, which were shown to consolidate as a result of 
drying. The rate of shrinkage of such voids was shown to infer the development rate, 
and ultimate strength of interlayer bonding. When parts were loaded parallel to the 
direction of layers crack propagation was shown to occur along these boundaries and 
led to catastrophic failure. Improvement in the ultimate strength and degree of strain 
exhibited for Y-axis scaffolds was attributed to the perpendicular application of 
compressive loading. Anisotropic behaviour of 3D printed parts is commonly reported 
in the literature [325]. 
An understanding of the burn out and high temperature behaviour of PVOH and HA 
precursors, respectively was useful in designing heat treatment protocols to sinter 
scaffolds as characterised by DTA-TGA. Residue of PVOH thermal degradation 
products were revealed in sintered Y-axis scaffolds and this was linked to the higher 
degree of bulk shrinkage, and consolidation of surface pores, which are suggested to 
facilitate evolution of gaseous by-products. Thus, it is concluded that there is a trade-
off between the effect of surface pore size on strength and the ability to facilitate 
evolution of PVOH degradation products. 
In summary, flowability of precursor materials was verified to be a critical prerequisite 
property to ensure mechanical stability, and was also shown to influence 
microstructure, as well as porosity. The difference in the mechanical strength as well 
as failure mechanisms of X and Y-axis printed scaffolds demonstrated that it is 
important to consider the direction of loading since interlayer bonding was shown to 
be weaker under parallel compressive forces. The maximum strength of X-axis green 
scaffolds was measured to be approximately 0.75MPa (50F6X) and for Y-axis samples 
dried for 6hrs in either a furnace or vacuum oven an ultimate compressive strength of 
0.85MPa was exhibited, which falls within the range reported for cancellous bone. 
These results are considered promising and it is expected that the improvements 
proposed in Chapter 10 will assist in further optimisation. The key physical features 
exhibited by these 3D printed scaffolds, namely porosity, interconnected macropores, 
as well as surface microporosity and roughness, are expected to be favourable for 
osteogenesis, osteoconduction, and osteointegration of the structures in-vivo. 
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10. Future work 
The experimental work performed achieved the first four initial project objectives 
outlined in Chapter 1. However, it is difficult to conclude a single ‘optimised’ 
synthesis condition without conducting further experimental work due to the 
complexity of the crystallisation process. Enhanced biological performances were 
highlighted, in particular, for samples prepared in mixed DI water, Toluene and/or 
Ethanolamine systems, as well as substituted with Mg and Zn. Future work is 
suggested to include optimisation of the value of these conditions (i.e. the level of 
substitution and solvent system ratio) and an investigation of the effects of combining 
these two reaction parameters on material properties and ultimately the biological 
performance of substrates using the techniques reported in this thesis. 
The development of osteoprecursor cells seeded on a biomaterial substrate is 
characterised by a sequence of events: (1) cell adhesion and spreading, (2) cell 
proliferation, (3) ECM biosynthesis, (4) ECM development and maturation, as well as 
(5) ECM mineralisation [328]. Since adhesion and spreading is considered a critical 
stage that influences the capacity of cells to proliferate and differentiate, visualisation 
of this process could provide complementary information to the results presented in 
this thesis [18, 329]. Additionally, analysis of the dissolution rate of substrates and 
characterisation of surface area, as well as roughness are proposed since these material 
characteristics are known to play a key role in mineralisation and cellular attachment, 
respectively. A combination of these additional material characterisations and SEM 
and/or confocal imaging of osteoblasts on substrates will assist in furthering the 
understanding gained from MTT and Hoechst assay results presented here. 
This study highlighted the potential of 3DP to enable the fabrication of porous scaffold 
structures from HA:PVOH precursor materials. Structures were shown to exhibit 
advantageous properties, including surface microporosity, roughness, and the 
compressive strength of a number of green parts were demonstrated to fall within the 
reported range of cancellous bone. Complete removal of thermal degradation products 
of PVOH and the reduced ease of handling of sintered structures were notable 
difficulties associated with this system. Replacement of PVOH with a biocompatible 
polymer, such as PGA, PLA or PLGA, which does not need to be burnt out from the 
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structure, is thus recommended as a more suitable precursor system. Regardless, of the 
material system it is suggested that future work should include an assessment of the 
3D interconnectivity of any microporosity since this property is a key determinant of 
the suitability of the scaffold for application in bone tissue engineering [103, 104]. 
Micro-CT analysis is an extremely valuable tool with analytical techniques that would 
enable an assessment of 3D interconnectivity as well as total porosity. Therefore 
characterisation of scaffolds using this technique is recommended and may shed light 
on any differences in the 3D microstructure of X and Y-axis scaffolds. It is also 
advised that the initial CAD model could be tailored, specifically the size of pore 
channels, to improve the mechanical strength of scaffolds. 
In addition, further work is to be focused on translating the knowledge gained 
concerning synthesis of HA to 3DP of scaffold structures physically suitable for 
application in bone tissue engineering. It is likely that there will be constraints to this 
process since this project has highlighted a number of specific material properties that 
determine biological performance and several powder characteristics were shown to 
influence the physical attributes of the end product. It therefore may be sensible to 
select a range of ‘optimised’ synthesis conditions, produce bulk quantities, and 
characterise properties of these powders that were concluded to be critical to the 
success of 3DP, for example flowability, particle size distribution, as well as bulk and 
tapped density. These additional characterisations may enable selection of an ‘optimal’ 
synthesis condition that not only exhibits an enhanced biological performance but is 
also suitable for 3DP.  
Surface charge is suggested to be an additional factor that could be influential in 
determining powder flowability. Powders that exhibit a lower surface charge are more 
likely to clump during spreading since repulsive forces determine colloidal stability. 
Characterisation of ZP in DI water, and more specifically a suspension of the binder 
solution at the temperature maintained during printing, is strongly recommended for 
printable powder compositions. In order to determine the surface chemistry of dried 
powders characterisation by XPS is also proposed. 
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Appendix A - modified ANOVA test 
A typical distribution observed for MTT assay is displayed in Figure A.1. Typically an 
ANOVA test analyses the variance (σ2) from the mean (μ) within and between data 
sets (Figure A.2). 
 
Figure A.1: Example of MTT assay data set 
 
 
 
 Figure A.2: ANOVA test analysis 
μD1 = mean day 1, μD7 = mean day 7, μD7, 1 = mean days 1 and 7, σb = σ between sets, σw = σ within 
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In order to take account of the lag growth phase typically observed for mammalian 
cells the ANOVA test was modified so that the variance was calculated from a linear 
trend line (Figure A.3). Linear regression was performed between either days 1 to 3 or 
days 1 to 5, which were suggested to be the lag phases in experimental data. Thus this 
modified method enables lag growth to be calculated and effectively strips it back 
from the experimental data, making the analysis of the exponential proliferation phase 
more rigorous and less sensitive to individual erroneous measurements and outliers. 
Figure A.4 demonstrates the well-established phases of mammalian cell growth. 
 
 
Figure A.3: Typical linear regression performed in modified ANOVA test 
μD7, 1 = mean days 1 and 7, σb = σ between sets, σw = σ within set 
 
 
Figure A.4: Standard cell growth curve [330] 
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